id	sid	tid	token	lemma	pos
dpc-2081	1	1	dermatology	dermatology	NOUN
dpc-2081	1	2	:	:	PUNCT
dpc-2081	1	3	practical	practical	ADJ
dpc-2081	1	4	and	and	CCONJ
dpc-2081	1	5	conceptual	conceptual	ADJ
dpc-2081	1	6	original	original	ADJ
dpc-2081	1	7	article	article	NOUN
dpc-2081	1	8	|	|	ADV
dpc-2081	1	9	dermatol	dermatol	ADJ
dpc-2081	1	10	pract	pract	NOUN
dpc-2081	1	11	concept	concept	NOUN
dpc-2081	1	12	.	.	PUNCT
dpc-2081	2	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	2	2	1	1	NUM
dpc-2081	2	3	increased	increase	VERB
dpc-2081	2	4	prevalence	prevalence	NOUN
dpc-2081	2	5	of	of	ADP
dpc-2081	2	6	bipolar	bipolar	ADJ
dpc-2081	2	7	disorders	disorder	NOUN
dpc-2081	2	8	in	in	ADP
dpc-2081	2	9	hidradenitis	hidradenitis	PROPN
dpc-2081	2	10	suppurativa	suppurativa	NOUN
dpc-2081	2	11	:	:	PUNCT
dpc-2081	2	12	more	more	ADJ
dpc-2081	2	13	than	than	ADP
dpc-2081	2	14	a	a	DET
dpc-2081	2	15	striking	striking	ADJ
dpc-2081	2	16	co	co	NOUN
dpc-2081	2	17	-	-	NOUN
dpc-2081	2	18	existence	existence	NOUN
dpc-2081	2	19	?	?	PUNCT
dpc-2081	3	1	pelin	pelin	PROPN
dpc-2081	3	2	esme1	esme1	PROPN
dpc-2081	3	3	,	,	PUNCT
dpc-2081	3	4	aysenur	aysenur	NOUN
dpc-2081	3	5	botsali1	botsali1	NOUN
dpc-2081	3	6	1	1	NUM
dpc-2081	3	7	department	department	NOUN
dpc-2081	3	8	of	of	ADP
dpc-2081	3	9	dermatology	dermatology	NOUN
dpc-2081	3	10	and	and	CCONJ
dpc-2081	3	11	venereology	venereology	NOUN
dpc-2081	3	12	,	,	PUNCT
dpc-2081	3	13	university	university	NOUN
dpc-2081	3	14	of	of	ADP
dpc-2081	3	15	health	health	PROPN
dpc-2081	3	16	sciences	sciences	PROPN
dpc-2081	3	17	,	,	PUNCT
dpc-2081	3	18	gulhane	gulhane	NOUN
dpc-2081	3	19	training	training	NOUN
dpc-2081	3	20	and	and	CCONJ
dpc-2081	3	21	research	research	NOUN
dpc-2081	3	22	hospital	hospital	NOUN
dpc-2081	3	23	,	,	PUNCT
dpc-2081	3	24	ankara	ankara	PROPN
dpc-2081	3	25	,	,	PUNCT
dpc-2081	3	26	turkey	turkey	PROPN
dpc-2081	3	27	key	key	ADJ
dpc-2081	3	28	words	word	NOUN
dpc-2081	3	29	:	:	PUNCT
dpc-2081	3	30	hidradenitis	hidradenitis	PROPN
dpc-2081	3	31	suppurativa	suppurativa	PROPN
dpc-2081	3	32	,	,	PUNCT
dpc-2081	3	33	bipolar	bipolar	ADJ
dpc-2081	3	34	disorders	disorder	NOUN
dpc-2081	3	35	,	,	PUNCT
dpc-2081	3	36	psychiatric	psychiatric	NOUN
dpc-2081	3	37	,	,	PUNCT
dpc-2081	3	38	co	co	NOUN
dpc-2081	3	39	-	-	NOUN
dpc-2081	3	40	morbidity	morbidity	NOUN
dpc-2081	3	41	,	,	PUNCT
dpc-2081	3	42	co	co	NOUN
dpc-2081	3	43	-	-	NOUN
dpc-2081	3	44	existence	existence	NOUN
dpc-2081	3	45	citation	citation	NOUN
dpc-2081	3	46	:	:	PUNCT
dpc-2081	3	47	esme	esme	PROPN
dpc-2081	3	48	p	p	PROPN
dpc-2081	3	49	,	,	PUNCT
dpc-2081	3	50	botsali	botsali	PROPN
dpc-2081	3	51	a.	a.	PROPN
dpc-2081	3	52	increased	increase	VERB
dpc-2081	3	53	prevalence	prevalence	NOUN
dpc-2081	3	54	of	of	ADP
dpc-2081	3	55	bipolar	bipolar	ADJ
dpc-2081	3	56	disorders	disorder	NOUN
dpc-2081	3	57	in	in	ADP
dpc-2081	3	58	hidradenitis	hidradenitis	PROPN
dpc-2081	3	59	suppurativa	suppurativa	NOUN
dpc-2081	3	60	:	:	PUNCT
dpc-2081	3	61	more	more	ADJ
dpc-2081	3	62	than	than	ADP
dpc-2081	3	63	a	a	DET
dpc-2081	3	64	striking	striking	ADJ
dpc-2081	3	65	co	co	NOUN
dpc-2081	3	66	-	-	NOUN
dpc-2081	3	67	existence	existence	NOUN
dpc-2081	3	68	?	?	PUNCT
dpc-2081	4	1	dermatol	dermatol	NOUN
dpc-2081	4	2	pract	pract	PROPN
dpc-2081	4	3	concept	concept	NOUN
dpc-2081	4	4	.	.	PUNCT
dpc-2081	5	1	2022;12(4):e2022208	2022;12(4):e2022208	X
dpc-2081	5	2	.	.	PUNCT
dpc-2081	5	3	doi	doi	NOUN
dpc-2081	5	4	:	:	PUNCT
dpc-2081	5	5	https://doi.org/10.5826/dpc.1204a208	https://doi.org/10.5826/dpc.1204a208	NOUN
dpc-2081	5	6	accepted	accept	VERB
dpc-2081	5	7	:	:	PUNCT
dpc-2081	5	8	march	march	PROPN
dpc-2081	5	9	7	7	NUM
dpc-2081	5	10	,	,	PUNCT
dpc-2081	5	11	2022	2022	NUM
dpc-2081	5	12	;	;	PUNCT
dpc-2081	5	13	published	publish	VERB
dpc-2081	5	14	:	:	PUNCT
dpc-2081	5	15	october	october	PROPN
dpc-2081	5	16	2022	2022	NUM
dpc-2081	6	1	copyright	copyright	NOUN
dpc-2081	6	2	:	:	PUNCT
dpc-2081	6	3	©	©	PROPN
dpc-2081	6	4	2022	2022	NUM
dpc-2081	6	5	esme	esme	PROPN
dpc-2081	6	6	et	et	PROPN
dpc-2081	6	7	al	al	PROPN
dpc-2081	6	8	.	.	PUNCT
dpc-2081	7	1	this	this	PRON
dpc-2081	7	2	is	be	AUX
dpc-2081	7	3	an	an	DET
dpc-2081	7	4	open	open	ADJ
dpc-2081	7	5	-	-	PUNCT
dpc-2081	7	6	access	access	NOUN
dpc-2081	7	7	article	article	NOUN
dpc-2081	7	8	distributed	distribute	VERB
dpc-2081	7	9	under	under	ADP
dpc-2081	7	10	the	the	DET
dpc-2081	7	11	terms	term	NOUN
dpc-2081	7	12	of	of	ADP
dpc-2081	7	13	the	the	DET
dpc-2081	7	14	creative	creative	ADJ
dpc-2081	7	15	commons	common	NOUN
dpc-2081	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2081	7	17	license	license	NOUN
dpc-2081	7	18	(	(	PUNCT
dpc-2081	7	19	by	by	ADP
dpc-2081	7	20	-	-	PUNCT
dpc-2081	7	21	nc-4.0	nc-4.0	NOUN
dpc-2081	7	22	)	)	PUNCT
dpc-2081	7	23	,	,	PUNCT
dpc-2081	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2081	7	25	,	,	PUNCT
dpc-2081	7	26	which	which	PRON
dpc-2081	7	27	permits	permit	VERB
dpc-2081	7	28	unrestricted	unrestricted	ADJ
dpc-2081	7	29	noncommercial	noncommercial	ADJ
dpc-2081	7	30	use	use	NOUN
dpc-2081	7	31	,	,	PUNCT
dpc-2081	7	32	distribution	distribution	NOUN
dpc-2081	7	33	,	,	PUNCT
dpc-2081	7	34	and	and	CCONJ
dpc-2081	7	35	reproduction	reproduction	NOUN
dpc-2081	7	36	in	in	ADP
dpc-2081	7	37	any	any	DET
dpc-2081	7	38	medium	medium	NOUN
dpc-2081	7	39	,	,	PUNCT
dpc-2081	7	40	provided	provide	VERB
dpc-2081	7	41	the	the	DET
dpc-2081	7	42	original	original	ADJ
dpc-2081	7	43	authors	author	NOUN
dpc-2081	7	44	and	and	CCONJ
dpc-2081	7	45	source	source	NOUN
dpc-2081	7	46	are	be	AUX
dpc-2081	7	47	credited	credit	VERB
dpc-2081	7	48	.	.	PUNCT
dpc-2081	8	1	funding	funding	NOUN
dpc-2081	8	2	:	:	PUNCT
dpc-2081	8	3	none	none	NOUN
dpc-2081	8	4	.	.	PUNCT
dpc-2081	9	1	competing	compete	VERB
dpc-2081	9	2	interests	interest	NOUN
dpc-2081	9	3	:	:	PUNCT
dpc-2081	9	4	none	none	NOUN
dpc-2081	9	5	.	.	PUNCT
dpc-2081	10	1	authorship	authorship	NOUN
dpc-2081	10	2	:	:	PUNCT
dpc-2081	10	3	all	all	DET
dpc-2081	10	4	authors	author	NOUN
dpc-2081	10	5	have	have	AUX
dpc-2081	10	6	contributed	contribute	VERB
dpc-2081	10	7	significantly	significantly	ADV
dpc-2081	10	8	to	to	ADP
dpc-2081	10	9	this	this	DET
dpc-2081	10	10	publication	publication	NOUN
dpc-2081	10	11	.	.	PUNCT
dpc-2081	11	1	corresponding	correspond	VERB
dpc-2081	11	2	author	author	NOUN
dpc-2081	11	3	:	:	PUNCT
dpc-2081	11	4	aysenur	aysenur	NOUN
dpc-2081	11	5	botsali	botsali	PROPN
dpc-2081	11	6	,	,	PUNCT
dpc-2081	11	7	department	department	NOUN
dpc-2081	11	8	of	of	ADP
dpc-2081	11	9	dermatology	dermatology	NOUN
dpc-2081	11	10	and	and	CCONJ
dpc-2081	11	11	venereology	venereology	NOUN
dpc-2081	11	12	,	,	PUNCT
dpc-2081	11	13	university	university	NOUN
dpc-2081	11	14	of	of	ADP
dpc-2081	11	15	health	health	PROPN
dpc-2081	11	16	sciences	sciences	PROPN
dpc-2081	11	17	,	,	PUNCT
dpc-2081	11	18	gulhane	gulhane	NOUN
dpc-2081	11	19	training	training	NOUN
dpc-2081	11	20	and	and	CCONJ
dpc-2081	11	21	research	research	NOUN
dpc-2081	11	22	hospital	hospital	NOUN
dpc-2081	11	23	,	,	PUNCT
dpc-2081	11	24	ankara	ankara	PROPN
dpc-2081	11	25	,	,	PUNCT
dpc-2081	11	26	general	general	PROPN
dpc-2081	11	27	dr	dr	PROPN
dpc-2081	11	28	.	.	PROPN
dpc-2081	11	29	tevfik	tevfik	PROPN
dpc-2081	11	30	saglam	saglam	PROPN
dpc-2081	11	31	street	street	PROPN
dpc-2081	11	32	,	,	PUNCT
dpc-2081	11	33	kecioren	kecioren	PROPN
dpc-2081	11	34	/	/	SYM
dpc-2081	11	35	ankara	ankara	PROPN
dpc-2081	11	36	,	,	PUNCT
dpc-2081	11	37	zip	zip	NOUN
dpc-2081	11	38	code:06010	code:06010	NOUN
dpc-2081	11	39	,	,	PUNCT
dpc-2081	11	40	turkey	turkey	NOUN
dpc-2081	11	41	,	,	PUNCT
dpc-2081	11	42	e	e	NOUN
dpc-2081	11	43	-	-	NOUN
dpc-2081	11	44	mail	mail	NOUN
dpc-2081	11	45	:	:	PUNCT
dpc-2081	11	46	abotsali@hotmail.com	abotsali@hotmail.com	X
dpc-2081	11	47	introduction	introduction	NOUN
dpc-2081	11	48	:	:	PUNCT
dpc-2081	11	49	hidradenitis	hidradenitis	PROPN
dpc-2081	11	50	suppurativa	suppurativa	PROPN
dpc-2081	11	51	(	(	PUNCT
dpc-2081	11	52	hs	hs	X
dpc-2081	11	53	)	)	PUNCT
dpc-2081	11	54	is	be	AUX
dpc-2081	11	55	a	a	DET
dpc-2081	11	56	chronic	chronic	ADJ
dpc-2081	11	57	inflammatory	inflammatory	ADJ
dpc-2081	11	58	skin	skin	NOUN
dpc-2081	11	59	disorder	disorder	NOUN
dpc-2081	11	60	of	of	ADP
dpc-2081	11	61	the	the	DET
dpc-2081	11	62	hair	hair	NOUN
dpc-2081	11	63	follicle	follicle	NOUN
dpc-2081	11	64	characterized	characterize	VERB
dpc-2081	11	65	by	by	ADP
dpc-2081	11	66	intense	intense	ADJ
dpc-2081	11	67	discharge	discharge	NOUN
dpc-2081	11	68	and	and	CCONJ
dpc-2081	11	69	pain	pain	NOUN
dpc-2081	11	70	.	.	PUNCT
dpc-2081	12	1	recently	recently	ADV
dpc-2081	12	2	,	,	PUNCT
dpc-2081	12	3	hs	hs	PROPN
dpc-2081	12	4	intrinsic	intrinsic	PROPN
dpc-2081	12	5	association	association	PROPN
dpc-2081	12	6	with	with	ADP
dpc-2081	12	7	neuropsychiatric	neuropsychiatric	ADJ
dpc-2081	12	8	disorders	disorder	NOUN
dpc-2081	12	9	has	have	AUX
dpc-2081	12	10	become	become	VERB
dpc-2081	12	11	a	a	DET
dpc-2081	12	12	focus	focus	NOUN
dpc-2081	12	13	of	of	ADP
dpc-2081	12	14	attention	attention	NOUN
dpc-2081	12	15	,	,	PUNCT
dpc-2081	12	16	and	and	CCONJ
dpc-2081	12	17	bipolar	bipolar	ADJ
dpc-2081	12	18	disorder	disorder	NOUN
dpc-2081	12	19	(	(	PUNCT
dpc-2081	12	20	bd	bd	PROPN
dpc-2081	12	21	)	)	PUNCT
dpc-2081	12	22	emerged	emerge	VERB
dpc-2081	12	23	as	as	ADP
dpc-2081	12	24	a	a	DET
dpc-2081	12	25	relevant	relevant	ADJ
dpc-2081	12	26	topic	topic	NOUN
dpc-2081	12	27	for	for	ADP
dpc-2081	12	28	such	such	DET
dpc-2081	12	29	an	an	DET
dpc-2081	12	30	association	association	NOUN
dpc-2081	12	31	.	.	PUNCT
dpc-2081	13	1	objectives	objective	NOUN
dpc-2081	13	2	:	:	PUNCT
dpc-2081	13	3	this	this	DET
dpc-2081	13	4	study	study	NOUN
dpc-2081	13	5	aimed	aim	VERB
dpc-2081	13	6	to	to	PART
dpc-2081	13	7	evaluate	evaluate	VERB
dpc-2081	13	8	bd	bd	PROPN
dpc-2081	13	9	prevalence	prevalence	NOUN
dpc-2081	13	10	among	among	ADP
dpc-2081	13	11	hs	hs	PROPN
dpc-2081	13	12	patients	patient	NOUN
dpc-2081	13	13	and	and	CCONJ
dpc-2081	13	14	present	present	VERB
dpc-2081	13	15	the	the	DET
dpc-2081	13	16	hs	hs	PROPN
dpc-2081	13	17	and	and	CCONJ
dpc-2081	13	18	bd	bd	PROPN
dpc-2081	13	19	overlap	overlap	NOUN
dpc-2081	13	20	patients	patient	NOUN
dpc-2081	13	21	demographics	demographic	NOUN
dpc-2081	13	22	,	,	PUNCT
dpc-2081	13	23	detailed	detail	VERB
dpc-2081	13	24	clinical	clinical	ADJ
dpc-2081	13	25	characteristics	characteristic	NOUN
dpc-2081	13	26	with	with	ADP
dpc-2081	13	27	a	a	DET
dpc-2081	13	28	discussion	discussion	NOUN
dpc-2081	13	29	on	on	ADP
dpc-2081	13	30	aggravating	aggravating	ADJ
dpc-2081	13	31	factors	factor	NOUN
dpc-2081	13	32	.	.	PUNCT
dpc-2081	14	1	methods	method	NOUN
dpc-2081	14	2	:	:	PUNCT
dpc-2081	14	3	a	a	DET
dpc-2081	14	4	retrospective	retrospective	ADJ
dpc-2081	14	5	chart	chart	NOUN
dpc-2081	14	6	review	review	NOUN
dpc-2081	14	7	of	of	ADP
dpc-2081	14	8	247	247	NUM
dpc-2081	14	9	hs	hs	NOUN
dpc-2081	14	10	outpatients	outpatient	NOUN
dpc-2081	14	11	(	(	PUNCT
dpc-2081	14	12	group-1	group-1	NOUN
dpc-2081	14	13	)	)	PUNCT
dpc-2081	14	14	identified	identify	VERB
dpc-2081	14	15	nine	nine	NUM
dpc-2081	14	16	patients	patient	NOUN
dpc-2081	14	17	with	with	ADP
dpc-2081	14	18	bd	bd	PROPN
dpc-2081	14	19	.	.	PUNCT
dpc-2081	14	20	the	the	DET
dpc-2081	14	21	frequency	frequency	NOUN
dpc-2081	14	22	of	of	ADP
dpc-2081	14	23	bd	bd	PROPN
dpc-2081	14	24	in	in	ADP
dpc-2081	14	25	hs	hs	PROPN
dpc-2081	14	26	patients	patient	NOUN
dpc-2081	14	27	is	be	AUX
dpc-2081	14	28	compared	compare	VERB
dpc-2081	14	29	to	to	ADP
dpc-2081	14	30	psoriasis	psoriasis	NOUN
dpc-2081	14	31	patients	patient	NOUN
dpc-2081	14	32	(	(	PUNCT
dpc-2081	14	33	group-2	group-2	PROPN
dpc-2081	14	34	)	)	PUNCT
dpc-2081	14	35	and	and	CCONJ
dpc-2081	14	36	controls	control	NOUN
dpc-2081	14	37	(	(	PUNCT
dpc-2081	14	38	group-3	group-3	X
dpc-2081	14	39	)	)	PUNCT
dpc-2081	14	40	in	in	ADP
dpc-2081	14	41	ageand	ageand	NOUN
dpc-2081	14	42	gender	gender	NOUN
dpc-2081	14	43	-	-	PUNCT
dpc-2081	14	44	matched	match	VERB
dpc-2081	14	45	groups	group	NOUN
dpc-2081	14	46	.	.	PUNCT
dpc-2081	15	1	the	the	DET
dpc-2081	15	2	demographic	demographic	ADJ
dpc-2081	15	3	and	and	CCONJ
dpc-2081	15	4	clinical	clinical	ADJ
dpc-2081	15	5	features	feature	NOUN
dpc-2081	15	6	of	of	ADP
dpc-2081	15	7	the	the	DET
dpc-2081	15	8	9	9	NUM
dpc-2081	15	9	patients	patient	NOUN
dpc-2081	15	10	revealing	reveal	VERB
dpc-2081	15	11	hs	hs	PROPN
dpc-2081	15	12	-	-	PROPN
dpc-2081	15	13	bd	bd	PROPN
dpc-2081	15	14	co	co	NOUN
dpc-2081	15	15	-	-	NOUN
dpc-2081	15	16	existence	existence	NOUN
dpc-2081	15	17	were	be	AUX
dpc-2081	15	18	analyzed	analyze	VERB
dpc-2081	15	19	.	.	PUNCT
dpc-2081	16	1	results	result	NOUN
dpc-2081	16	2	:	:	PUNCT
dpc-2081	17	1	bd	bd	PROPN
dpc-2081	17	2	(	(	PUNCT
dpc-2081	17	3	n	n	NOUN
dpc-2081	17	4	=	=	SYM
dpc-2081	17	5	9	9	NUM
dpc-2081	17	6	)	)	PUNCT
dpc-2081	17	7	was	be	AUX
dpc-2081	17	8	the	the	DET
dpc-2081	17	9	7th	7th	ADJ
dpc-2081	17	10	most	most	ADV
dpc-2081	17	11	common	common	ADJ
dpc-2081	17	12	co	co	NOUN
dpc-2081	17	13	-	-	NOUN
dpc-2081	17	14	morbidity	morbidity	NOUN
dpc-2081	17	15	in	in	ADP
dpc-2081	17	16	the	the	DET
dpc-2081	17	17	hs	hs	PROPN
dpc-2081	17	18	cohort	cohort	PROPN
dpc-2081	17	19	.	.	PUNCT
dpc-2081	18	1	the	the	DET
dpc-2081	18	2	frequency	frequency	NOUN
dpc-2081	18	3	of	of	ADP
dpc-2081	18	4	bd	bd	PROPN
dpc-2081	18	5	is	be	AUX
dpc-2081	18	6	detected	detect	VERB
dpc-2081	18	7	as	as	ADP
dpc-2081	18	8	3.6	3.6	NUM
dpc-2081	18	9	%	%	NOUN
dpc-2081	18	10	in	in	ADP
dpc-2081	18	11	group	group	NOUN
dpc-2081	18	12	1	1	NUM
dpc-2081	18	13	,	,	PUNCT
dpc-2081	18	14	0.7	0.7	NUM
dpc-2081	18	15	%	%	NOUN
dpc-2081	18	16	(	(	PUNCT
dpc-2081	18	17	n	n	NOUN
dpc-2081	18	18	=	=	SYM
dpc-2081	18	19	1	1	NUM
dpc-2081	18	20	)	)	PUNCT
dpc-2081	18	21	in	in	ADP
dpc-2081	18	22	group	group	NOUN
dpc-2081	18	23	2	2	NUM
dpc-2081	18	24	,	,	PUNCT
dpc-2081	18	25	and	and	CCONJ
dpc-2081	18	26	0.6	0.6	NUM
dpc-2081	18	27	%	%	NOUN
dpc-2081	18	28	(	(	PUNCT
dpc-2081	18	29	n	n	NOUN
dpc-2081	18	30	=	=	SYM
dpc-2081	18	31	1	1	NUM
dpc-2081	18	32	)	)	PUNCT
dpc-2081	18	33	in	in	ADP
dpc-2081	18	34	group	group	NOUN
dpc-2081	18	35	3	3	NUM
dpc-2081	18	36	,	,	PUNCT
dpc-2081	18	37	respectively	respectively	ADV
dpc-2081	18	38	.	.	PUNCT
dpc-2081	19	1	group	group	NOUN
dpc-2081	19	2	1	1	NUM
dpc-2081	19	3	demonstrated	demonstrate	VERB
dpc-2081	19	4	an	an	DET
dpc-2081	19	5	increased	increased	ADJ
dpc-2081	19	6	prevalence	prevalence	NOUN
dpc-2081	19	7	of	of	ADP
dpc-2081	19	8	bd	bd	PROPN
dpc-2081	19	9	compared	compare	VERB
dpc-2081	19	10	to	to	ADP
dpc-2081	19	11	other	other	ADJ
dpc-2081	19	12	groups	group	NOUN
dpc-2081	19	13	(	(	PUNCT
dpc-2081	19	14	p	p	NOUN
dpc-2081	19	15	=	=	NOUN
dpc-2081	19	16	0.001	0.001	NUM
dpc-2081	19	17	)	)	PUNCT
dpc-2081	19	18	.	.	PUNCT
dpc-2081	20	1	of	of	ADP
dpc-2081	20	2	the	the	DET
dpc-2081	20	3	9	9	NUM
dpc-2081	20	4	 	 	SPACE
dpc-2081	20	5	patients	patient	NOUN
dpc-2081	20	6	revealing	reveal	VERB
dpc-2081	20	7	hs	hs	PROPN
dpc-2081	20	8	and	and	CCONJ
dpc-2081	20	9	bd	bd	PROPN
dpc-2081	20	10	co	co	NOUN
dpc-2081	20	11	-	-	NOUN
dpc-2081	20	12	existence	existence	NOUN
dpc-2081	20	13	,	,	PUNCT
dpc-2081	20	14	66.6	66.6	NUM
dpc-2081	20	15	%	%	NOUN
dpc-2081	20	16	were	be	AUX
dpc-2081	20	17	active	active	ADJ
dpc-2081	20	18	smokers	smoker	NOUN
dpc-2081	20	19	,	,	PUNCT
dpc-2081	20	20	66.6	66.6	NUM
dpc-2081	20	21	%	%	NOUN
dpc-2081	20	22	were	be	AUX
dpc-2081	20	23	obese	obese	ADJ
dpc-2081	20	24	and	and	CCONJ
dpc-2081	20	25	44.4	44.4	NUM
dpc-2081	20	26	 	 	SPACE
dpc-2081	20	27	%	%	NOUN
dpc-2081	20	28	had	have	VERB
dpc-2081	20	29	metabolic	metabolic	NOUN
dpc-2081	20	30	syndrome	syndrome	NOUN
dpc-2081	20	31	.	.	PUNCT
dpc-2081	21	1	conclusions	conclusion	NOUN
dpc-2081	21	2	:	:	PUNCT
dpc-2081	21	3	this	this	DET
dpc-2081	21	4	study	study	NOUN
dpc-2081	21	5	results	result	NOUN
dpc-2081	21	6	reveal	reveal	VERB
dpc-2081	21	7	that	that	SCONJ
dpc-2081	21	8	the	the	DET
dpc-2081	21	9	prevalence	prevalence	NOUN
dpc-2081	21	10	of	of	ADP
dpc-2081	21	11	bd	bd	PROPN
dpc-2081	21	12	in	in	ADP
dpc-2081	21	13	hs	hs	PROPN
dpc-2081	21	14	patients	patient	NOUN
dpc-2081	21	15	is	be	AUX
dpc-2081	21	16	higher	high	ADJ
dpc-2081	21	17	than	than	ADP
dpc-2081	21	18	psoriasis	psoriasis	NOUN
dpc-2081	21	19	patients	patient	NOUN
dpc-2081	21	20	and	and	CCONJ
dpc-2081	21	21	controls	control	NOUN
dpc-2081	21	22	.	.	PUNCT
dpc-2081	22	1	the	the	DET
dpc-2081	22	2	pathogenetic	pathogenetic	ADJ
dpc-2081	22	3	mechanisms	mechanism	NOUN
dpc-2081	22	4	underlying	underlie	VERB
dpc-2081	22	5	bd	bd	PROPN
dpc-2081	22	6	and	and	CCONJ
dpc-2081	22	7	hs	hs	PROPN
dpc-2081	22	8	co	co	NOUN
dpc-2081	22	9	-	-	NOUN
dpc-2081	22	10	existence	existence	NOUN
dpc-2081	22	11	needs	need	VERB
dpc-2081	22	12	to	to	PART
dpc-2081	22	13	be	be	AUX
dpc-2081	22	14	investigated	investigate	VERB
dpc-2081	22	15	further	far	ADV
dpc-2081	22	16	.	.	PUNCT
dpc-2081	23	1	abstract	abstract	ADJ
dpc-2081	23	2	2	2	NUM
dpc-2081	23	3	original	original	ADJ
dpc-2081	23	4	article	article	NOUN
dpc-2081	23	5	|	|	ADV
dpc-2081	23	6	dermatol	dermatol	ADJ
dpc-2081	23	7	pract	pract	NOUN
dpc-2081	23	8	concept	concept	NOUN
dpc-2081	23	9	.	.	PUNCT
dpc-2081	24	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	24	2	introduction	introduction	NOUN
dpc-2081	24	3	hidradenitis	hidradenitis	PROPN
dpc-2081	24	4	suppurativa	suppurativa	PROPN
dpc-2081	24	5	(	(	PUNCT
dpc-2081	24	6	hs	hs	X
dpc-2081	24	7	)	)	PUNCT
dpc-2081	24	8	is	be	AUX
dpc-2081	24	9	a	a	DET
dpc-2081	24	10	highly	highly	ADV
dpc-2081	24	11	painful	painful	ADJ
dpc-2081	24	12	and	and	CCONJ
dpc-2081	24	13	extremely	extremely	ADV
dpc-2081	24	14	destructive	destructive	ADJ
dpc-2081	24	15	,	,	PUNCT
dpc-2081	24	16	inflammatory	inflammatory	ADJ
dpc-2081	24	17	skin	skin	NOUN
dpc-2081	24	18	disease	disease	NOUN
dpc-2081	24	19	of	of	ADP
dpc-2081	24	20	the	the	DET
dpc-2081	24	21	hair	hair	NOUN
dpc-2081	24	22	follicle	follicle	VERB
dpc-2081	24	23	with	with	ADP
dpc-2081	24	24	substantial	substantial	ADJ
dpc-2081	24	25	negative	negative	ADJ
dpc-2081	24	26	psychosocial	psychosocial	ADJ
dpc-2081	24	27	impacts	impact	NOUN
dpc-2081	24	28	on	on	ADP
dpc-2081	24	29	patients	patient	NOUN
dpc-2081	24	30	.	.	PUNCT
dpc-2081	25	1	many	many	ADJ
dpc-2081	25	2	hs	hs	PROPN
dpc-2081	25	3	patients	patient	NOUN
dpc-2081	25	4	suffer	suffer	VERB
dpc-2081	25	5	from	from	ADP
dpc-2081	25	6	psychiatric	psychiatric	ADJ
dpc-2081	25	7	conditions	condition	NOUN
dpc-2081	25	8	,	,	PUNCT
dpc-2081	25	9	such	such	ADJ
dpc-2081	25	10	as	as	ADP
dpc-2081	25	11	depression	depression	NOUN
dpc-2081	25	12	,	,	PUNCT
dpc-2081	25	13	anxiety	anxiety	NOUN
dpc-2081	25	14	,	,	PUNCT
dpc-2081	25	15	impaired	impaired	ADJ
dpc-2081	25	16	self	self	NOUN
dpc-2081	25	17	-	-	PUNCT
dpc-2081	25	18	esteem	esteem	NOUN
dpc-2081	25	19	,	,	PUNCT
dpc-2081	25	20	and	and	CCONJ
dpc-2081	25	21	stigmatization	stigmatization	NOUN
dpc-2081	25	22	.	.	PUNCT
dpc-2081	26	1	therefore	therefore	ADV
dpc-2081	26	2	,	,	PUNCT
dpc-2081	26	3	a	a	DET
dpc-2081	26	4	psychiatric	psychiatric	ADJ
dpc-2081	26	5	evaluation	evaluation	NOUN
dpc-2081	26	6	of	of	ADP
dpc-2081	26	7	hs	hs	PROPN
dpc-2081	26	8	patients	patient	NOUN
dpc-2081	26	9	is	be	AUX
dpc-2081	26	10	strongly	strongly	ADV
dpc-2081	26	11	recommended	recommend	VERB
dpc-2081	26	12	[	[	PUNCT
dpc-2081	26	13	1	1	NUM
dpc-2081	26	14	]	]	PUNCT
dpc-2081	26	15	.	.	PUNCT
dpc-2081	27	1	through	through	ADP
dpc-2081	27	2	the	the	DET
dpc-2081	27	3	evaluation	evaluation	NOUN
dpc-2081	27	4	of	of	ADP
dpc-2081	27	5	neuro	neuro	NOUN
dpc-2081	27	6	-	-	PUNCT
dpc-2081	27	7	psychiatric	psychiatric	ADJ
dpc-2081	27	8	disorders	disorder	NOUN
dpc-2081	27	9	in	in	ADP
dpc-2081	27	10	hs	hs	PROPN
dpc-2081	27	11	patients	patient	NOUN
dpc-2081	27	12	,	,	PUNCT
dpc-2081	27	13	bipolar	bipolar	ADJ
dpc-2081	27	14	disorders	disorder	NOUN
dpc-2081	27	15	(	(	PUNCT
dpc-2081	27	16	bd	bd	NOUN
dpc-2081	27	17	)	)	PUNCT
dpc-2081	27	18	have	have	AUX
dpc-2081	27	19	just	just	ADV
dpc-2081	27	20	begun	begin	VERB
dpc-2081	27	21	to	to	PART
dpc-2081	27	22	attract	attract	VERB
dpc-2081	27	23	attention	attention	NOUN
dpc-2081	27	24	[	[	X
dpc-2081	27	25	2,3	2,3	NUM
dpc-2081	27	26	]	]	PUNCT
dpc-2081	27	27	.	.	PUNCT
dpc-2081	28	1	hs	hs	PROPN
dpc-2081	28	2	and	and	CCONJ
dpc-2081	28	3	bd	bd	PROPN
dpc-2081	28	4	are	be	AUX
dpc-2081	28	5	relatively	relatively	ADV
dpc-2081	28	6	common	common	ADJ
dpc-2081	28	7	conditions	condition	NOUN
dpc-2081	28	8	affecting	affect	VERB
dpc-2081	28	9	more	more	ADJ
dpc-2081	28	10	than	than	ADP
dpc-2081	28	11	1	1	NUM
dpc-2081	28	12	%	%	NOUN
dpc-2081	28	13	of	of	ADP
dpc-2081	28	14	the	the	DET
dpc-2081	28	15	population	population	NOUN
dpc-2081	28	16	for	for	ADP
dpc-2081	28	17	each	each	DET
dpc-2081	28	18	condition	condition	NOUN
dpc-2081	28	19	.	.	PUNCT
dpc-2081	29	1	the	the	DET
dpc-2081	29	2	onset	onset	NOUN
dpc-2081	29	3	of	of	ADP
dpc-2081	29	4	these	these	DET
dpc-2081	29	5	chronic	chronic	NOUN
dpc-2081	29	6	,	,	PUNCT
dpc-2081	29	7	fluctuating	fluctuate	VERB
dpc-2081	29	8	diseases	disease	NOUN
dpc-2081	29	9	is	be	AUX
dpc-2081	29	10	typically	typically	ADV
dpc-2081	29	11	in	in	ADP
dpc-2081	29	12	young	young	ADJ
dpc-2081	29	13	adulthood	adulthood	NOUN
dpc-2081	29	14	and	and	CCONJ
dpc-2081	29	15	both	both	PRON
dpc-2081	29	16	are	be	AUX
dpc-2081	29	17	considered	consider	VERB
dpc-2081	29	18	as	as	ADP
dpc-2081	29	19	leading	lead	VERB
dpc-2081	29	20	causes	cause	NOUN
dpc-2081	29	21	of	of	ADP
dpc-2081	29	22	disability	disability	NOUN
dpc-2081	29	23	among	among	ADP
dpc-2081	29	24	young	young	ADJ
dpc-2081	29	25	people	people	NOUN
dpc-2081	30	1	[	[	X
dpc-2081	30	2	4	4	NUM
dpc-2081	30	3	-	-	SYM
dpc-2081	30	4	6	6	NUM
dpc-2081	30	5	]	]	PUNCT
dpc-2081	30	6	.	.	PUNCT
dpc-2081	31	1	a	a	DET
dpc-2081	31	2	substantial	substantial	ADJ
dpc-2081	31	3	proportion	proportion	NOUN
dpc-2081	31	4	of	of	ADP
dpc-2081	31	5	bd	bd	PROPN
dpc-2081	31	6	patients	patient	NOUN
dpc-2081	31	7	report	report	VERB
dpc-2081	31	8	a	a	DET
dpc-2081	31	9	positive	positive	ADJ
dpc-2081	31	10	family	family	NOUN
dpc-2081	31	11	history	history	NOUN
dpc-2081	31	12	for	for	ADP
dpc-2081	31	13	bd	bd	PROPN
dpc-2081	31	14	connoting	connote	VERB
dpc-2081	31	15	the	the	DET
dpc-2081	31	16	contribution	contribution	NOUN
dpc-2081	31	17	of	of	ADP
dpc-2081	31	18	genetics	genetic	NOUN
dpc-2081	31	19	;	;	PUNCT
dpc-2081	31	20	however	however	ADV
dpc-2081	31	21	similar	similar	ADJ
dpc-2081	31	22	to	to	ADP
dpc-2081	31	23	hs	hs	PROPN
dpc-2081	31	24	,	,	PUNCT
dpc-2081	31	25	the	the	DET
dpc-2081	31	26	multifactorial	multifactorial	ADJ
dpc-2081	31	27	model	model	NOUN
dpc-2081	31	28	including	include	VERB
dpc-2081	31	29	gene	gene	NOUN
dpc-2081	31	30	environment	environment	NOUN
dpc-2081	31	31	interactions	interaction	NOUN
dpc-2081	31	32	is	be	AUX
dpc-2081	31	33	accepted	accept	VERB
dpc-2081	31	34	as	as	ADP
dpc-2081	31	35	the	the	DET
dpc-2081	31	36	best	good	ADJ
dpc-2081	31	37	concept	concept	NOUN
dpc-2081	31	38	to	to	PART
dpc-2081	31	39	explain	explain	VERB
dpc-2081	31	40	bd	bd	PROPN
dpc-2081	31	41	etiopathogenesis	etiopathogenesis	NOUN
dpc-2081	32	1	[	[	X
dpc-2081	32	2	7	7	NUM
dpc-2081	32	3	]	]	PUNCT
dpc-2081	32	4	.	.	PUNCT
dpc-2081	33	1	furthermore	furthermore	ADV
dpc-2081	33	2	,	,	PUNCT
dpc-2081	33	3	numerous	numerous	ADJ
dpc-2081	33	4	associations	association	NOUN
dpc-2081	33	5	have	have	AUX
dpc-2081	33	6	been	be	AUX
dpc-2081	33	7	purported	purport	VERB
dpc-2081	33	8	between	between	ADP
dpc-2081	33	9	bipolar	bipolar	ADJ
dpc-2081	33	10	disorder	disorder	NOUN
dpc-2081	33	11	and	and	CCONJ
dpc-2081	33	12	other	other	ADJ
dpc-2081	33	13	medical	medical	ADJ
dpc-2081	33	14	co	co	NOUN
dpc-2081	33	15	-	-	NOUN
dpc-2081	33	16	morbidities	morbidity	NOUN
dpc-2081	33	17	including	include	VERB
dpc-2081	33	18	cardiovascular	cardiovascular	ADJ
dpc-2081	33	19	disorders	disorder	NOUN
dpc-2081	33	20	,	,	PUNCT
dpc-2081	33	21	diabetes	diabetes	NOUN
dpc-2081	33	22	and	and	CCONJ
dpc-2081	33	23	obesity	obesity	NOUN
dpc-2081	33	24	[	[	X
dpc-2081	33	25	8	8	NUM
dpc-2081	33	26	-	-	SYM
dpc-2081	33	27	11	11	NUM
dpc-2081	33	28	]	]	PUNCT
dpc-2081	33	29	.	.	PUNCT
dpc-2081	34	1	the	the	DET
dpc-2081	34	2	higher	high	ADJ
dpc-2081	34	3	prevalence	prevalence	NOUN
dpc-2081	34	4	of	of	ADP
dpc-2081	34	5	these	these	DET
dpc-2081	34	6	medical	medical	ADJ
dpc-2081	34	7	co	co	NOUN
dpc-2081	34	8	-	-	NOUN
dpc-2081	34	9	morbidities	morbidity	NOUN
dpc-2081	34	10	in	in	ADP
dpc-2081	34	11	bd	bd	PROPN
dpc-2081	34	12	is	be	AUX
dpc-2081	34	13	principally	principally	ADV
dpc-2081	34	14	explained	explain	VERB
dpc-2081	34	15	via	via	ADP
dpc-2081	34	16	three	three	NUM
dpc-2081	34	17	perspectives	perspective	NOUN
dpc-2081	34	18	including	include	VERB
dpc-2081	34	19	the	the	DET
dpc-2081	34	20	adverse	adverse	ADJ
dpc-2081	34	21	effects	effect	NOUN
dpc-2081	34	22	of	of	ADP
dpc-2081	34	23	pharmacological	pharmacological	ADJ
dpc-2081	34	24	treatments	treatment	NOUN
dpc-2081	34	25	,	,	PUNCT
dpc-2081	34	26	genetic	genetic	ADJ
dpc-2081	34	27	vulnerability	vulnerability	NOUN
dpc-2081	34	28	,	,	PUNCT
dpc-2081	34	29	and	and	CCONJ
dpc-2081	34	30	lifestyle	lifestyle	NOUN
dpc-2081	34	31	(	(	PUNCT
dpc-2081	34	32	eg	eg	NOUN
dpc-2081	34	33	smoking	smoking	NOUN
dpc-2081	34	34	,	,	PUNCT
dpc-2081	34	35	malnutrition	malnutrition	NOUN
dpc-2081	34	36	,	,	PUNCT
dpc-2081	34	37	and	and	CCONJ
dpc-2081	34	38	sedentary	sedentary	ADJ
dpc-2081	34	39	life	life	NOUN
dpc-2081	34	40	-	-	PUNCT
dpc-2081	34	41	style	style	NOUN
dpc-2081	34	42	)	)	PUNCT
dpc-2081	35	1	[	[	X
dpc-2081	35	2	4,12	4,12	X
dpc-2081	35	3	]	]	PUNCT
dpc-2081	35	4	.	.	PUNCT
dpc-2081	36	1	population	population	NOUN
dpc-2081	36	2	-	-	PUNCT
dpc-2081	36	3	based	base	VERB
dpc-2081	36	4	studies	study	NOUN
dpc-2081	36	5	were	be	AUX
dpc-2081	36	6	conducted	conduct	VERB
dpc-2081	36	7	to	to	PART
dpc-2081	36	8	search	search	VERB
dpc-2081	36	9	for	for	ADP
dpc-2081	36	10	an	an	DET
dpc-2081	36	11	intrinsic	intrinsic	ADJ
dpc-2081	36	12	relationship	relationship	NOUN
dpc-2081	36	13	between	between	ADP
dpc-2081	36	14	hs	hs	PROPN
dpc-2081	36	15	and	and	CCONJ
dpc-2081	36	16	bd	bd	PROPN
dpc-2081	36	17	with	with	ADP
dpc-2081	36	18	conflicting	conflicting	ADJ
dpc-2081	36	19	results	result	NOUN
dpc-2081	36	20	[	[	X
dpc-2081	36	21	2,3,13	2,3,13	NUM
dpc-2081	36	22	]	]	PUNCT
dpc-2081	36	23	.	.	PUNCT
dpc-2081	37	1	some	some	DET
dpc-2081	37	2	studies	study	NOUN
dpc-2081	37	3	reported	report	VERB
dpc-2081	37	4	a	a	DET
dpc-2081	37	5	remarkably	remarkably	ADV
dpc-2081	37	6	increased	increase	VERB
dpc-2081	37	7	prevalence	prevalence	NOUN
dpc-2081	37	8	of	of	ADP
dpc-2081	37	9	bd	bd	PROPN
dpc-2081	37	10	among	among	ADP
dpc-2081	37	11	hs	hs	PROPN
dpc-2081	37	12	patients	patient	NOUN
dpc-2081	37	13	;	;	PUNCT
dpc-2081	37	14	however	however	ADV
dpc-2081	37	15	,	,	PUNCT
dpc-2081	37	16	others	other	NOUN
dpc-2081	37	17	did	do	AUX
dpc-2081	37	18	not	not	PART
dpc-2081	37	19	confirm	confirm	VERB
dpc-2081	37	20	such	such	DET
dpc-2081	37	21	an	an	DET
dpc-2081	37	22	association	association	NOUN
dpc-2081	37	23	.	.	PUNCT
dpc-2081	38	1	lithium	lithium	NOUN
dpc-2081	38	2	,	,	PUNCT
dpc-2081	38	3	one	one	NUM
dpc-2081	38	4	of	of	ADP
dpc-2081	38	5	the	the	DET
dpc-2081	38	6	most	most	ADV
dpc-2081	38	7	effective	effective	ADJ
dpc-2081	38	8	treatments	treatment	NOUN
dpc-2081	38	9	for	for	ADP
dpc-2081	38	10	the	the	DET
dpc-2081	38	11	prevention	prevention	NOUN
dpc-2081	38	12	of	of	ADP
dpc-2081	38	13	both	both	CCONJ
dpc-2081	38	14	manic	manic	ADJ
dpc-2081	38	15	and	and	CCONJ
dpc-2081	38	16	depressive	depressive	ADJ
dpc-2081	38	17	episodes	episode	NOUN
dpc-2081	38	18	is	be	AUX
dpc-2081	38	19	also	also	ADV
dpc-2081	38	20	acknowledged	acknowledge	VERB
dpc-2081	38	21	as	as	ADP
dpc-2081	38	22	an	an	DET
dpc-2081	38	23	extrinsic	extrinsic	ADJ
dpc-2081	38	24	factor	factor	NOUN
dpc-2081	38	25	to	to	PART
dpc-2081	38	26	exacerbate	exacerbate	VERB
dpc-2081	38	27	hs	hs	PROPN
dpc-2081	38	28	lesions	lesion	NOUN
dpc-2081	38	29	[	[	X
dpc-2081	38	30	14	14	NUM
dpc-2081	38	31	]	]	PUNCT
dpc-2081	38	32	.	.	PUNCT
dpc-2081	39	1	additionally	additionally	ADV
dpc-2081	39	2	,	,	PUNCT
dpc-2081	39	3	similar	similar	ADJ
dpc-2081	39	4	to	to	ADP
dpc-2081	39	5	bd	bd	PROPN
dpc-2081	39	6	,	,	PUNCT
dpc-2081	39	7	smoking	smoking	NOUN
dpc-2081	39	8	and	and	CCONJ
dpc-2081	39	9	obesity	obesity	NOUN
dpc-2081	39	10	are	be	AUX
dpc-2081	39	11	strongly	strongly	ADV
dpc-2081	39	12	linked	link	VERB
dpc-2081	39	13	to	to	ADP
dpc-2081	39	14	hs	hs	PROPN
dpc-2081	39	15	pathogenesis	pathogenesis	PROPN
dpc-2081	39	16	(	(	PUNCT
dpc-2081	39	17	4	4	NUM
dpc-2081	39	18	)	)	PUNCT
dpc-2081	39	19	.	.	PUNCT
dpc-2081	40	1	bd	bd	PROPN
dpc-2081	40	2	and	and	CCONJ
dpc-2081	40	3	hs	hs	PROPN
dpc-2081	40	4	are	be	AUX
dpc-2081	40	5	complex	complex	ADJ
dpc-2081	40	6	traits	trait	NOUN
dpc-2081	40	7	influenced	influence	VERB
dpc-2081	40	8	by	by	ADP
dpc-2081	40	9	numerous	numerous	ADJ
dpc-2081	40	10	common	common	ADJ
dpc-2081	40	11	genetic	genetic	ADJ
dpc-2081	40	12	variants	variant	NOUN
dpc-2081	40	13	;	;	PUNCT
dpc-2081	40	14	however	however	ADV
dpc-2081	40	15	,	,	PUNCT
dpc-2081	40	16	the	the	DET
dpc-2081	40	17	existence	existence	NOUN
dpc-2081	40	18	of	of	ADP
dpc-2081	40	19	a	a	DET
dpc-2081	40	20	genetic	genetic	ADJ
dpc-2081	40	21	association	association	NOUN
dpc-2081	40	22	between	between	ADP
dpc-2081	40	23	hs	hs	PROPN
dpc-2081	40	24	and	and	CCONJ
dpc-2081	40	25	bd	bd	PROPN
dpc-2081	40	26	has	have	AUX
dpc-2081	40	27	nott	nott	ADV
dpc-2081	40	28	been	be	AUX
dpc-2081	40	29	investigated	investigate	VERB
dpc-2081	40	30	[	[	PUNCT
dpc-2081	40	31	15,16	15,16	NUM
dpc-2081	40	32	]	]	PUNCT
dpc-2081	40	33	.	.	PUNCT
dpc-2081	41	1	objectives	objective	VERB
dpc-2081	41	2	this	this	DET
dpc-2081	41	3	study	study	NOUN
dpc-2081	41	4	aimed	aim	VERB
dpc-2081	41	5	to	to	PART
dpc-2081	41	6	evaluate	evaluate	VERB
dpc-2081	41	7	bd	bd	PROPN
dpc-2081	41	8	prevalence	prevalence	NOUN
dpc-2081	41	9	among	among	ADP
dpc-2081	41	10	hs	hs	PROPN
dpc-2081	41	11	patients	patient	NOUN
dpc-2081	41	12	and	and	CCONJ
dpc-2081	41	13	present	present	VERB
dpc-2081	41	14	the	the	DET
dpc-2081	41	15	hs	hs	PROPN
dpc-2081	41	16	and	and	CCONJ
dpc-2081	41	17	bd	bd	PROPN
dpc-2081	41	18	overlap	overlap	NOUN
dpc-2081	41	19	patients	patient	NOUN
dpc-2081	41	20	’	'	PUNCT
dpc-2081	41	21	demographics	demographic	NOUN
dpc-2081	41	22	,	,	PUNCT
dpc-2081	41	23	detailed	detail	VERB
dpc-2081	41	24	clinical	clinical	ADJ
dpc-2081	41	25	characteristics	characteristic	NOUN
dpc-2081	41	26	with	with	ADP
dpc-2081	41	27	a	a	DET
dpc-2081	41	28	discussion	discussion	NOUN
dpc-2081	41	29	on	on	ADP
dpc-2081	41	30	aggravating	aggravating	ADJ
dpc-2081	41	31	factors	factor	NOUN
dpc-2081	41	32	.	.	PUNCT
dpc-2081	42	1	methods	method	NOUN
dpc-2081	42	2	the	the	DET
dpc-2081	42	3	patients	patient	NOUN
dpc-2081	42	4	diagnosed	diagnose	VERB
dpc-2081	42	5	and	and	CCONJ
dpc-2081	42	6	followed	follow	VERB
dpc-2081	42	7	up	up	ADP
dpc-2081	42	8	in	in	ADP
dpc-2081	42	9	the	the	DET
dpc-2081	42	10	hs	hs	PROPN
dpc-2081	42	11	outpatient	outpatient	PROPN
dpc-2081	42	12	clinic	clinic	NOUN
dpc-2081	42	13	of	of	ADP
dpc-2081	42	14	gülhane	gülhane	NOUN
dpc-2081	42	15	training	training	NOUN
dpc-2081	42	16	and	and	CCONJ
dpc-2081	42	17	research	research	NOUN
dpc-2081	42	18	hospital	hospital	NOUN
dpc-2081	42	19	of	of	ADP
dpc-2081	42	20	the	the	DET
dpc-2081	42	21	university	university	PROPN
dpc-2081	42	22	of	of	ADP
dpc-2081	42	23	health	health	PROPN
dpc-2081	42	24	sciences	science	NOUN
dpc-2081	42	25	between	between	ADP
dpc-2081	42	26	september	september	PROPN
dpc-2081	42	27	2018	2018	NUM
dpc-2081	42	28	and	and	CCONJ
dpc-2081	42	29	november	november	PROPN
dpc-2081	42	30	2020	2020	NUM
dpc-2081	42	31	were	be	AUX
dpc-2081	42	32	included	include	VERB
dpc-2081	42	33	.	.	PUNCT
dpc-2081	43	1	the	the	DET
dpc-2081	43	2	authors	author	NOUN
dpc-2081	43	3	conducted	conduct	VERB
dpc-2081	43	4	a	a	DET
dpc-2081	43	5	retrospective	retrospective	ADJ
dpc-2081	43	6	chart	chart	NOUN
dpc-2081	43	7	review	review	NOUN
dpc-2081	43	8	to	to	PART
dpc-2081	43	9	extract	extract	VERB
dpc-2081	43	10	the	the	DET
dpc-2081	43	11	variables	variable	NOUN
dpc-2081	43	12	of	of	ADP
dpc-2081	43	13	interest	interest	NOUN
dpc-2081	43	14	,	,	PUNCT
dpc-2081	43	15	including	include	VERB
dpc-2081	43	16	the	the	DET
dpc-2081	43	17	patients	patient	NOUN
dpc-2081	43	18	demographic	demographic	ADJ
dpc-2081	43	19	and	and	CCONJ
dpc-2081	43	20	clinical	clinical	ADJ
dpc-2081	43	21	features	feature	NOUN
dpc-2081	43	22	(	(	PUNCT
dpc-2081	43	23	age	age	NOUN
dpc-2081	43	24	,	,	PUNCT
dpc-2081	43	25	gender	gender	NOUN
dpc-2081	43	26	,	,	PUNCT
dpc-2081	43	27	age	age	NOUN
dpc-2081	43	28	of	of	ADP
dpc-2081	43	29	onset	onset	NOUN
dpc-2081	43	30	,	,	PUNCT
dpc-2081	43	31	disease	disease	NOUN
dpc-2081	43	32	duration	duration	NOUN
dpc-2081	43	33	,	,	PUNCT
dpc-2081	43	34	hurley	hurley	NOUN
dpc-2081	43	35	stage	stage	NOUN
dpc-2081	43	36	,	,	PUNCT
dpc-2081	43	37	international	international	ADJ
dpc-2081	43	38	hidradenitis	hidradenitis	PROPN
dpc-2081	43	39	suppurativa	suppurativa	PROPN
dpc-2081	43	40	severity	severity	PROPN
dpc-2081	43	41	score	score	NOUN
dpc-2081	43	42	system	system	NOUN
dpc-2081	43	43	(	(	PUNCT
dpc-2081	43	44	ihs4	ihs4	PROPN
dpc-2081	43	45	)	)	PUNCT
dpc-2081	43	46	,	,	PUNCT
dpc-2081	43	47	accompanying	accompany	VERB
dpc-2081	43	48	medical	medical	ADJ
dpc-2081	43	49	co	co	NOUN
dpc-2081	43	50	-	-	NOUN
dpc-2081	43	51	morbidities	morbidity	NOUN
dpc-2081	43	52	,	,	PUNCT
dpc-2081	43	53	particularly	particularly	ADV
dpc-2081	43	54	psychiatric	psychiatric	ADJ
dpc-2081	43	55	disorders	disorder	NOUN
dpc-2081	43	56	,	,	PUNCT
dpc-2081	43	57	medications	medication	NOUN
dpc-2081	43	58	)	)	PUNCT
dpc-2081	43	59	.	.	PUNCT
dpc-2081	44	1	the	the	DET
dpc-2081	44	2	patients	patient	NOUN
dpc-2081	44	3	in	in	ADP
dpc-2081	44	4	this	this	DET
dpc-2081	44	5	manuscript	manuscript	NOUN
dpc-2081	44	6	have	have	AUX
dpc-2081	44	7	given	give	VERB
dpc-2081	44	8	informed	informed	ADJ
dpc-2081	44	9	consent	consent	NOUN
dpc-2081	44	10	to	to	ADP
dpc-2081	44	11	publication	publication	NOUN
dpc-2081	44	12	of	of	ADP
dpc-2081	44	13	their	their	PRON
dpc-2081	44	14	case	case	NOUN
dpc-2081	44	15	details	detail	NOUN
dpc-2081	44	16	.	.	PUNCT
dpc-2081	45	1	besides	besides	SCONJ
dpc-2081	45	2	,	,	PUNCT
dpc-2081	45	3	two	two	NUM
dpc-2081	45	4	study	study	NOUN
dpc-2081	45	5	groups	group	NOUN
dpc-2081	45	6	,	,	PUNCT
dpc-2081	45	7	including	include	VERB
dpc-2081	45	8	ageand	ageand	NOUN
dpc-2081	45	9	gender	gender	NOUN
dpc-2081	45	10	matched	match	VERB
dpc-2081	45	11	patients	patient	NOUN
dpc-2081	45	12	,	,	PUNCT
dpc-2081	45	13	were	be	AUX
dpc-2081	45	14	enrolled	enrol	VERB
dpc-2081	45	15	.	.	PUNCT
dpc-2081	46	1	these	these	DET
dpc-2081	46	2	groups	group	NOUN
dpc-2081	46	3	were	be	AUX
dpc-2081	46	4	composed	compose	VERB
dpc-2081	46	5	of	of	ADP
dpc-2081	46	6	psoriasis	psoriasis	NOUN
dpc-2081	46	7	patients	patient	NOUN
dpc-2081	46	8	(	(	PUNCT
dpc-2081	46	9	group-2	group-2	PROPN
dpc-2081	46	10	)	)	PUNCT
dpc-2081	46	11	and	and	CCONJ
dpc-2081	46	12	patients	patient	NOUN
dpc-2081	46	13	admitted	admit	VERB
dpc-2081	46	14	with	with	ADP
dpc-2081	46	15	a	a	DET
dpc-2081	46	16	non	non	ADJ
dpc-2081	46	17	-	-	ADJ
dpc-2081	46	18	inflammatory	inflammatory	ADJ
dpc-2081	46	19	skin	skin	NOUN
dpc-2081	46	20	disease	disease	NOUN
dpc-2081	46	21	(	(	PUNCT
dpc-2081	46	22	eg	eg	NOUN
dpc-2081	46	23	,	,	PUNCT
dpc-2081	46	24	xerosis	xerosis	NOUN
dpc-2081	46	25	,	,	PUNCT
dpc-2081	46	26	tinea	tinea	NOUN
dpc-2081	46	27	pedis	pedis	NOUN
dpc-2081	46	28	,	,	PUNCT
dpc-2081	46	29	and	and	CCONJ
dpc-2081	46	30	localized	localized	ADJ
dpc-2081	46	31	dermatitis	dermatitis	NOUN
dpc-2081	46	32	)	)	PUNCT
dpc-2081	46	33	to	to	ADP
dpc-2081	46	34	the	the	DET
dpc-2081	46	35	outpatient	outpatient	NOUN
dpc-2081	46	36	clinic	clinic	NOUN
dpc-2081	46	37	of	of	ADP
dpc-2081	46	38	the	the	DET
dpc-2081	46	39	same	same	ADJ
dpc-2081	46	40	tertiary	tertiary	ADJ
dpc-2081	46	41	center	center	NOUN
dpc-2081	46	42	(	(	PUNCT
dpc-2081	46	43	group-3	group-3	PROPN
dpc-2081	46	44	)	)	PUNCT
dpc-2081	46	45	.	.	PUNCT
dpc-2081	47	1	among	among	ADP
dpc-2081	47	2	the	the	DET
dpc-2081	47	3	selection	selection	NOUN
dpc-2081	47	4	of	of	ADP
dpc-2081	47	5	the	the	DET
dpc-2081	47	6	study	study	NOUN
dpc-2081	47	7	population	population	NOUN
dpc-2081	47	8	,	,	PUNCT
dpc-2081	47	9	all	all	PRON
dpc-2081	47	10	of	of	ADP
dpc-2081	47	11	the	the	DET
dpc-2081	47	12	psoriasis	psoriasis	NOUN
dpc-2081	47	13	patients	patient	NOUN
dpc-2081	47	14	received	receive	VERB
dpc-2081	47	15	at	at	ADV
dpc-2081	47	16	least	least	ADV
dpc-2081	47	17	one	one	NUM
dpc-2081	47	18	systemic	systemic	ADJ
dpc-2081	47	19	agent	agent	NOUN
dpc-2081	47	20	,	,	PUNCT
dpc-2081	47	21	including	include	VERB
dpc-2081	47	22	conventional	conventional	ADJ
dpc-2081	47	23	drugs	drug	NOUN
dpc-2081	47	24	or	or	CCONJ
dpc-2081	47	25	biologic	biologic	ADJ
dpc-2081	47	26	agents	agent	NOUN
dpc-2081	47	27	.	.	PUNCT
dpc-2081	48	1	only	only	ADV
dpc-2081	48	2	the	the	DET
dpc-2081	48	3	cases	case	NOUN
dpc-2081	48	4	with	with	ADP
dpc-2081	48	5	missing	miss	VERB
dpc-2081	48	6	data	datum	NOUN
dpc-2081	48	7	were	be	AUX
dpc-2081	48	8	excluded	exclude	VERB
dpc-2081	48	9	from	from	ADP
dpc-2081	48	10	the	the	DET
dpc-2081	48	11	overall	overall	ADJ
dpc-2081	48	12	study	study	NOUN
dpc-2081	48	13	population	population	NOUN
dpc-2081	48	14	,	,	PUNCT
dpc-2081	48	15	and	and	CCONJ
dpc-2081	48	16	no	no	DET
dpc-2081	48	17	additional	additional	ADJ
dpc-2081	48	18	specific	specific	ADJ
dpc-2081	48	19	exclusion	exclusion	NOUN
dpc-2081	48	20	criteria	criterion	NOUN
dpc-2081	48	21	were	be	AUX
dpc-2081	48	22	used	use	VERB
dpc-2081	48	23	.	.	PUNCT
dpc-2081	49	1	the	the	DET
dpc-2081	49	2	authors	author	NOUN
dpc-2081	49	3	analyzed	analyze	VERB
dpc-2081	49	4	patients	patient	NOUN
dpc-2081	49	5	revealing	reveal	VERB
dpc-2081	49	6	bd	bd	PROPN
dpc-2081	49	7	and	and	CCONJ
dpc-2081	49	8	hs	hs	PROPN
dpc-2081	49	9	co	co	NOUN
dpc-2081	49	10	-	-	NOUN
dpc-2081	49	11	existence	existence	NOUN
dpc-2081	49	12	,	,	PUNCT
dpc-2081	49	13	particularly	particularly	ADV
dpc-2081	49	14	for	for	ADP
dpc-2081	49	15	possible	possible	ADJ
dpc-2081	49	16	aggravating	aggravating	ADJ
dpc-2081	49	17	factors	factor	NOUN
dpc-2081	49	18	.	.	PUNCT
dpc-2081	50	1	the	the	DET
dpc-2081	50	2	national	national	ADJ
dpc-2081	50	3	cholesterol	cholesterol	PROPN
dpc-2081	50	4	education	education	NOUN
dpc-2081	50	5	program	program	NOUN
dpc-2081	50	6	(	(	PUNCT
dpc-2081	50	7	ncep	ncep	NOUN
dpc-2081	50	8	)	)	PUNCT
dpc-2081	50	9	adult	adult	NOUN
dpc-2081	50	10	treatment	treatment	NOUN
dpc-2081	50	11	panel	panel	NOUN
dpc-2081	50	12	iii	iii	X
dpc-2081	50	13	(	(	PUNCT
dpc-2081	50	14	atp	atp	PROPN
dpc-2081	50	15	iii)-2001	iii)-2001	SYM
dpc-2081	50	16	metabolic	metabolic	NOUN
dpc-2081	50	17	syndrome	syndrome	NOUN
dpc-2081	50	18	diagnosis	diagnosis	NOUN
dpc-2081	50	19	criteria	criterion	NOUN
dpc-2081	50	20	was	be	AUX
dpc-2081	50	21	implemented	implement	VERB
dpc-2081	50	22	to	to	PART
dpc-2081	50	23	evaluate	evaluate	VERB
dpc-2081	50	24	metabolic	metabolic	NOUN
dpc-2081	50	25	syndrome	syndrome	NOUN
dpc-2081	50	26	as	as	SCONJ
dpc-2081	50	27	it	it	PRON
dpc-2081	50	28	is	be	AUX
dpc-2081	50	29	the	the	DET
dpc-2081	50	30	most	most	ADV
dpc-2081	50	31	cited	cite	VERB
dpc-2081	50	32	definition	definition	NOUN
dpc-2081	50	33	for	for	ADP
dpc-2081	50	34	metabolic	metabolic	NOUN
dpc-2081	50	35	syndrome	syndrome	NOUN
dpc-2081	50	36	.	.	PUNCT
dpc-2081	51	1	statistical	statistical	ADJ
dpc-2081	51	2	analysis	analysis	NOUN
dpc-2081	51	3	statistical	statistical	ADJ
dpc-2081	51	4	analyses	analysis	NOUN
dpc-2081	51	5	were	be	AUX
dpc-2081	51	6	performed	perform	VERB
dpc-2081	51	7	using	use	VERB
dpc-2081	51	8	the	the	DET
dpc-2081	51	9	statistics	statistic	NOUN
dpc-2081	51	10	package	package	NOUN
dpc-2081	51	11	for	for	ADP
dpc-2081	51	12	the	the	DET
dpc-2081	51	13	social	social	ADJ
dpc-2081	51	14	sciences	sciences	PROPN
dpc-2081	51	15	(	(	PUNCT
dpc-2081	51	16	spss	spss	PROPN
dpc-2081	51	17	)	)	PUNCT
dpc-2081	51	18	for	for	ADP
dpc-2081	51	19	windows	window	NOUN
dpc-2081	51	20	version	version	NOUN
dpc-2081	51	21	22.0	22.0	NUM
dpc-2081	51	22	(	(	PUNCT
dpc-2081	51	23	ibm	ibm	PROPN
dpc-2081	51	24	,	,	PUNCT
dpc-2081	51	25	armonk	armonk	PROPN
dpc-2081	51	26	,	,	PUNCT
dpc-2081	51	27	ny	ny	PROPN
dpc-2081	51	28	,	,	PUNCT
dpc-2081	51	29	usa	usa	PROPN
dpc-2081	51	30	)	)	PUNCT
dpc-2081	51	31	.	.	PUNCT
dpc-2081	52	1	numerical	numerical	PROPN
dpc-2081	52	2	variables	variable	NOUN
dpc-2081	52	3	were	be	AUX
dpc-2081	52	4	presented	present	VERB
dpc-2081	52	5	as	as	ADP
dpc-2081	52	6	mean	mean	NOUN
dpc-2081	52	7	±	±	NUM
dpc-2081	52	8	sd	sd	NOUN
dpc-2081	52	9	or	or	CCONJ
dpc-2081	52	10	median	median	ADJ
dpc-2081	52	11	(	(	PUNCT
dpc-2081	52	12	min	min	NOUN
dpc-2081	52	13	-	-	PUNCT
dpc-2081	52	14	max	max	NOUN
dpc-2081	52	15	)	)	PUNCT
dpc-2081	52	16	.	.	PUNCT
dpc-2081	53	1	categorical	categorical	ADJ
dpc-2081	53	2	variables	variable	NOUN
dpc-2081	53	3	were	be	AUX
dpc-2081	53	4	shown	show	VERB
dpc-2081	53	5	by	by	ADP
dpc-2081	53	6	number	number	NOUN
dpc-2081	53	7	and	and	CCONJ
dpc-2081	53	8	percentage	percentage	NOUN
dpc-2081	53	9	.	.	PUNCT
dpc-2081	54	1	p	p	X
dpc-2081	54	2	<	<	X
dpc-2081	54	3	0.05	0.05	NUM
dpc-2081	54	4	was	be	AUX
dpc-2081	54	5	considered	consider	VERB
dpc-2081	54	6	significant	significant	ADJ
dpc-2081	54	7	in	in	ADP
dpc-2081	54	8	all	all	DET
dpc-2081	54	9	comparisons	comparison	NOUN
dpc-2081	54	10	.	.	PUNCT
dpc-2081	55	1	this	this	DET
dpc-2081	55	2	study	study	NOUN
dpc-2081	55	3	must	must	AUX
dpc-2081	55	4	recruit	recruit	VERB
dpc-2081	55	5	59	59	NUM
dpc-2081	55	6	individuals	individual	NOUN
dpc-2081	55	7	for	for	SCONJ
dpc-2081	55	8	each	each	DET
dpc-2081	55	9	group	group	NOUN
dpc-2081	55	10	to	to	PART
dpc-2081	55	11	have	have	VERB
dpc-2081	55	12	80	80	NUM
dpc-2081	55	13	%	%	NOUN
dpc-2081	55	14	power	power	NOUN
dpc-2081	55	15	with	with	ADP
dpc-2081	55	16	5	5	NUM
dpc-2081	55	17	%	%	NOUN
dpc-2081	55	18	type	type	NOUN
dpc-2081	55	19	i	i	PRON
dpc-2081	55	20	error	error	NOUN
dpc-2081	55	21	level	level	NOUN
dpc-2081	55	22	to	to	PART
dpc-2081	55	23	detect	detect	VERB
dpc-2081	55	24	clinically	clinically	ADV
dpc-2081	55	25	significant	significant	ADJ
dpc-2081	55	26	difference	difference	NOUN
dpc-2081	55	27	of	of	ADP
dpc-2081	55	28	1	1	NUM
dpc-2081	55	29	%	%	NOUN
dpc-2081	55	30	prevalence	prevalence	NOUN
dpc-2081	55	31	when	when	SCONJ
dpc-2081	55	32	the	the	DET
dpc-2081	55	33	expected	expect	VERB
dpc-2081	55	34	value	value	NOUN
dpc-2081	55	35	in	in	ADP
dpc-2081	55	36	the	the	DET
dpc-2081	55	37	control	control	NOUN
dpc-2081	55	38	group	group	NOUN
dpc-2081	55	39	is	be	AUX
dpc-2081	55	40	1	1	NUM
dpc-2081	55	41	%	%	NOUN
dpc-2081	55	42	.	.	PUNCT
dpc-2081	56	1	results	result	VERB
dpc-2081	56	2	a	a	DET
dpc-2081	56	3	total	total	NOUN
dpc-2081	56	4	of	of	ADP
dpc-2081	56	5	247	247	NUM
dpc-2081	56	6	hs	hs	PROPN
dpc-2081	56	7	patients	patient	NOUN
dpc-2081	56	8	(	(	PUNCT
dpc-2081	56	9	group	group	NOUN
dpc-2081	56	10	1	1	NUM
dpc-2081	56	11	)	)	PUNCT
dpc-2081	56	12	,	,	PUNCT
dpc-2081	56	13	consisting	consist	VERB
dpc-2081	56	14	of	of	ADP
dpc-2081	56	15	105	105	NUM
dpc-2081	56	16	females	female	NOUN
dpc-2081	56	17	and	and	CCONJ
dpc-2081	56	18	142	142	NUM
dpc-2081	56	19	males	male	NOUN
dpc-2081	56	20	,	,	PUNCT
dpc-2081	56	21	between	between	ADP
dpc-2081	56	22	14	14	NUM
dpc-2081	56	23	-	-	SYM
dpc-2081	56	24	68	68	NUM
dpc-2081	56	25	years	year	NOUN
dpc-2081	56	26	of	of	ADP
dpc-2081	56	27	age	age	NOUN
dpc-2081	56	28	(	(	PUNCT
dpc-2081	56	29	mean	mean	INTJ
dpc-2081	56	30	age	age	NOUN
dpc-2081	56	31	:	:	PUNCT
dpc-2081	56	32	33.48	33.48	NUM
dpc-2081	56	33	±	±	NUM
dpc-2081	56	34	11.6	11.6	NUM
dpc-2081	56	35	years	year	NOUN
dpc-2081	56	36	)	)	PUNCT
dpc-2081	56	37	,	,	PUNCT
dpc-2081	56	38	were	be	AUX
dpc-2081	56	39	eligible	eligible	ADJ
dpc-2081	56	40	for	for	ADP
dpc-2081	56	41	inclusion	inclusion	NOUN
dpc-2081	56	42	in	in	ADP
dpc-2081	56	43	the	the	DET
dpc-2081	56	44	study	study	NOUN
dpc-2081	56	45	.	.	PUNCT
dpc-2081	57	1	the	the	DET
dpc-2081	57	2	mean	mean	ADJ
dpc-2081	57	3	disease	disease	NOUN
dpc-2081	57	4	duration	duration	NOUN
dpc-2081	57	5	was	be	AUX
dpc-2081	57	6	7.3	7.3	NUM
dpc-2081	57	7	±	±	NUM
dpc-2081	57	8	6.9	6.9	NUM
dpc-2081	57	9	years	year	NOUN
dpc-2081	57	10	(	(	PUNCT
dpc-2081	57	11	range	range	NOUN
dpc-2081	57	12	0	0	NUM
dpc-2081	57	13	-	-	SYM
dpc-2081	57	14	35	35	NUM
dpc-2081	57	15	)	)	PUNCT
dpc-2081	57	16	.	.	PUNCT
dpc-2081	58	1	of	of	ADP
dpc-2081	58	2	247	247	NUM
dpc-2081	58	3	patients	patient	NOUN
dpc-2081	58	4	,	,	PUNCT
dpc-2081	58	5	186	186	NUM
dpc-2081	58	6	(	(	PUNCT
dpc-2081	58	7	75,3	75,3	NUM
dpc-2081	58	8	%	%	NOUN
dpc-2081	58	9	)	)	PUNCT
dpc-2081	58	10	and	and	CCONJ
dpc-2081	58	11	14	14	NUM
dpc-2081	58	12	(	(	PUNCT
dpc-2081	58	13	5,6	5,6	NUM
dpc-2081	58	14	%	%	NOUN
dpc-2081	58	15	)	)	PUNCT
dpc-2081	58	16	were	be	AUX
dpc-2081	58	17	active	active	ADJ
dpc-2081	58	18	and	and	CCONJ
dpc-2081	58	19	ex	ex	NOUN
dpc-2081	58	20	-	-	NOUN
dpc-2081	58	21	smokers	smoker	NOUN
dpc-2081	58	22	respectively	respectively	ADV
dpc-2081	58	23	with	with	ADP
dpc-2081	58	24	an	an	DET
dpc-2081	58	25	average	average	NOUN
dpc-2081	58	26	of	of	ADP
dpc-2081	58	27	12,7	12,7	NUM
dpc-2081	58	28	±	±	NUM
dpc-2081	58	29	14,3	14,3	NUM
dpc-2081	58	30	(	(	PUNCT
dpc-2081	58	31	range	range	NOUN
dpc-2081	58	32	1	1	NUM
dpc-2081	58	33	-	-	SYM
dpc-2081	58	34	90	90	NUM
dpc-2081	58	35	)	)	PUNCT
dpc-2081	58	36	pack	pack	NOUN
dpc-2081	58	37	-	-	PUNCT
dpc-2081	58	38	year	year	NOUN
dpc-2081	58	39	smoking	smoking	NOUN
dpc-2081	58	40	history	history	NOUN
dpc-2081	58	41	.	.	PUNCT
dpc-2081	59	1	the	the	DET
dpc-2081	59	2	mean	mean	ADJ
dpc-2081	59	3	 	 	SPACE
dpc-2081	59	4	body	body	NOUN
dpc-2081	59	5	mass	mass	NOUN
dpc-2081	59	6	index	index	NOUN
dpc-2081	59	7	(	(	PUNCT
dpc-2081	59	8	bmi	bmi	PROPN
dpc-2081	59	9	)	)	PUNCT
dpc-2081	59	10	was	be	AUX
dpc-2081	59	11	28.6	28.6	NUM
dpc-2081	59	12	±	±	NUM
dpc-2081	59	13	6,8	6,8	NUM
dpc-2081	59	14	(	(	PUNCT
dpc-2081	59	15	min	min	NOUN
dpc-2081	59	16	-	-	ADJ
dpc-2081	59	17	max:14,8	max:14,8	ADJ
dpc-2081	59	18	-	-	PUNCT
dpc-2081	59	19	85	85	NUM
dpc-2081	59	20	)	)	PUNCT
dpc-2081	59	21	and	and	CCONJ
dpc-2081	59	22	original	original	ADJ
dpc-2081	59	23	article	article	NOUN
dpc-2081	59	24	|	|	ADV
dpc-2081	59	25	dermatol	dermatol	ADJ
dpc-2081	59	26	pract	pract	NOUN
dpc-2081	59	27	concept	concept	NOUN
dpc-2081	59	28	.	.	PUNCT
dpc-2081	60	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	60	2	3	3	NUM
dpc-2081	60	3	33.2	33.2	NUM
dpc-2081	60	4	%	%	NOUN
dpc-2081	60	5	(	(	PUNCT
dpc-2081	60	6	n	n	NOUN
dpc-2081	60	7	=	=	SYM
dpc-2081	60	8	82	82	NUM
dpc-2081	60	9	)	)	PUNCT
dpc-2081	60	10	of	of	ADP
dpc-2081	60	11	the	the	DET
dpc-2081	60	12	patient	patient	ADJ
dpc-2081	60	13	bmi	bmi	NOUN
dpc-2081	60	14	were	be	AUX
dpc-2081	60	15	over	over	ADP
dpc-2081	60	16	30	30	NUM
dpc-2081	60	17	.	.	PUNCT
dpc-2081	61	1	the	the	DET
dpc-2081	61	2	distribution	distribution	NOUN
dpc-2081	61	3	of	of	ADP
dpc-2081	61	4	hurley	hurley	NOUN
dpc-2081	61	5	staging	staging	NOUN
dpc-2081	61	6	was	be	AUX
dpc-2081	61	7	as	as	SCONJ
dpc-2081	61	8	follows	follow	VERB
dpc-2081	61	9	:	:	PUNCT
dpc-2081	62	1	stage	stage	NOUN
dpc-2081	62	2	i	i	PRON
dpc-2081	62	3	(	(	PUNCT
dpc-2081	62	4	n	n	NOUN
dpc-2081	62	5	=	=	SYM
dpc-2081	62	6	82	82	NUM
dpc-2081	62	7	,	,	PUNCT
dpc-2081	62	8	33,2	33,2	NUM
dpc-2081	62	9	%	%	NOUN
dpc-2081	62	10	)	)	PUNCT
dpc-2081	62	11	,	,	PUNCT
dpc-2081	62	12	stage	stage	NOUN
dpc-2081	62	13	ii	ii	PROPN
dpc-2081	62	14	(	(	PUNCT
dpc-2081	62	15	n	n	NOUN
dpc-2081	62	16	=	=	SYM
dpc-2081	62	17	81	81	NUM
dpc-2081	62	18	,	,	PUNCT
dpc-2081	62	19	33,8	33,8	NUM
dpc-2081	62	20	%	%	NOUN
dpc-2081	62	21	)	)	PUNCT
dpc-2081	62	22	,	,	PUNCT
dpc-2081	62	23	and	and	CCONJ
dpc-2081	62	24	stage	stage	NOUN
dpc-2081	62	25	iii	iii	PROPN
dpc-2081	62	26	(	(	PUNCT
dpc-2081	62	27	n	n	NOUN
dpc-2081	62	28	=	=	SYM
dpc-2081	62	29	84	84	NUM
dpc-2081	62	30	,	,	PUNCT
dpc-2081	62	31	34	34	NUM
dpc-2081	62	32	%	%	NOUN
dpc-2081	62	33	)	)	PUNCT
dpc-2081	62	34	.	.	PUNCT
dpc-2081	63	1	among	among	ADP
dpc-2081	63	2	15	15	NUM
dpc-2081	63	3	co	co	NOUN
dpc-2081	63	4	-	-	NOUN
dpc-2081	63	5	morbidities	morbidity	NOUN
dpc-2081	63	6	detected	detect	VERB
dpc-2081	63	7	within	within	ADP
dpc-2081	63	8	the	the	DET
dpc-2081	63	9	current	current	ADJ
dpc-2081	63	10	hs	hs	PROPN
dpc-2081	63	11	cohort	cohort	PROPN
dpc-2081	63	12	,	,	PUNCT
dpc-2081	63	13	bd	bd	PROPN
dpc-2081	63	14	was	be	AUX
dpc-2081	63	15	the	the	DET
dpc-2081	63	16	7th	7th	ADJ
dpc-2081	63	17	most	most	ADV
dpc-2081	63	18	common	common	ADJ
dpc-2081	63	19	,	,	PUNCT
dpc-2081	63	20	encountered	encounter	VERB
dpc-2081	63	21	in	in	ADP
dpc-2081	63	22	9	9	NUM
dpc-2081	63	23	(	(	PUNCT
dpc-2081	63	24	3.6	3.6	NUM
dpc-2081	63	25	%	%	NOUN
dpc-2081	63	26	)	)	PUNCT
dpc-2081	63	27	patients	patient	NOUN
dpc-2081	63	28	(	(	PUNCT
dpc-2081	63	29	table	table	NOUN
dpc-2081	63	30	1	1	NUM
dpc-2081	63	31	)	)	PUNCT
dpc-2081	63	32	.	.	PUNCT
dpc-2081	64	1	the	the	DET
dpc-2081	64	2	authors	author	NOUN
dpc-2081	64	3	reviewed	review	VERB
dpc-2081	64	4	psoriasis	psoriasis	NOUN
dpc-2081	64	5	patients	patient	NOUN
dpc-2081	64	6	(	(	PUNCT
dpc-2081	64	7	group	group	NOUN
dpc-2081	64	8	2	2	NUM
dpc-2081	64	9	,	,	PUNCT
dpc-2081	64	10	n	n	CCONJ
dpc-2081	64	11	  	  	SPACE
dpc-2081	64	12	=	=	NOUN
dpc-2081	64	13	  	  	SPACE
dpc-2081	64	14	135	135	NUM
dpc-2081	64	15	)	)	PUNCT
dpc-2081	64	16	and	and	CCONJ
dpc-2081	64	17	patients	patient	NOUN
dpc-2081	64	18	without	without	ADP
dpc-2081	64	19	an	an	DET
dpc-2081	64	20	inflammatory	inflammatory	ADJ
dpc-2081	64	21	skin	skin	NOUN
dpc-2081	64	22	disorder	disorder	NOUN
dpc-2081	64	23	(	(	PUNCT
dpc-2081	64	24	group	group	NOUN
dpc-2081	64	25	3	3	NUM
dpc-2081	64	26	,	,	PUNCT
dpc-2081	64	27	n	n	NOUN
dpc-2081	64	28	=	=	SYM
dpc-2081	64	29	152	152	NUM
dpc-2081	64	30	)	)	PUNCT
dpc-2081	64	31	for	for	ADP
dpc-2081	64	32	the	the	DET
dpc-2081	64	33	presence	presence	NOUN
dpc-2081	64	34	of	of	ADP
dpc-2081	64	35	bd	bd	PROPN
dpc-2081	64	36	.	.	PUNCT
dpc-2081	65	1	only	only	ADV
dpc-2081	65	2	one	one	NUM
dpc-2081	65	3	patient	patient	NOUN
dpc-2081	65	4	had	have	VERB
dpc-2081	65	5	bd	bd	PROPN
dpc-2081	65	6	diagnosis	diagnosis	NOUN
dpc-2081	65	7	per	per	ADP
dpc-2081	65	8	group	group	NOUN
dpc-2081	65	9	2	2	NUM
dpc-2081	65	10	(	(	PUNCT
dpc-2081	65	11	0.7	0.7	NUM
dpc-2081	65	12	%	%	NOUN
dpc-2081	65	13	,	,	PUNCT
dpc-2081	65	14	n:1/135	n:1/135	X
dpc-2081	65	15	)	)	PUNCT
dpc-2081	65	16	and	and	CCONJ
dpc-2081	65	17	group	group	NOUN
dpc-2081	65	18	3	3	NUM
dpc-2081	65	19	(	(	PUNCT
dpc-2081	65	20	0.6	0.6	NUM
dpc-2081	65	21	%	%	NOUN
dpc-2081	65	22	,	,	PUNCT
dpc-2081	65	23	n:1/152	n:1/152	NUM
dpc-2081	65	24	)	)	PUNCT
dpc-2081	65	25	.	.	PUNCT
dpc-2081	66	1	the	the	DET
dpc-2081	66	2	patient	patient	NOUN
dpc-2081	66	3	in	in	ADP
dpc-2081	66	4	group	group	NOUN
dpc-2081	66	5	2	2	NUM
dpc-2081	66	6	was	be	AUX
dpc-2081	66	7	a	a	DET
dpc-2081	66	8	40	40	NUM
dpc-2081	66	9	-	-	PUNCT
dpc-2081	66	10	year	year	NOUN
dpc-2081	66	11	-	-	PUNCT
dpc-2081	66	12	old	old	ADJ
dpc-2081	66	13	male	male	NOUN
dpc-2081	66	14	.	.	PUNCT
dpc-2081	67	1	he	he	PRON
dpc-2081	67	2	had	have	AUX
dpc-2081	67	3	been	be	AUX
dpc-2081	67	4	diagnosed	diagnose	VERB
dpc-2081	67	5	with	with	ADP
dpc-2081	67	6	psoriasis	psoriasis	NOUN
dpc-2081	67	7	9	9	NUM
dpc-2081	67	8	years	year	NOUN
dpc-2081	67	9	ago	ago	ADV
dpc-2081	67	10	and	and	CCONJ
dpc-2081	67	11	bp	bp	PROPN
dpc-2081	67	12	onset	onset	PROPN
dpc-2081	67	13	was	be	AUX
dpc-2081	67	14	noted	note	VERB
dpc-2081	67	15	within	within	ADP
dpc-2081	67	16	the	the	DET
dpc-2081	67	17	following	following	ADJ
dpc-2081	67	18	year	year	NOUN
dpc-2081	67	19	.	.	PUNCT
dpc-2081	68	1	his	his	PRON
dpc-2081	68	2	bmi	bmi	NOUN
dpc-2081	68	3	was	be	AUX
dpc-2081	68	4	33.9	33.9	NUM
dpc-2081	68	5	and	and	CCONJ
dpc-2081	68	6	he	he	PRON
dpc-2081	68	7	had	have	AUX
dpc-2081	68	8	never	never	ADV
dpc-2081	68	9	smoked	smoke	VERB
dpc-2081	68	10	before	before	ADV
dpc-2081	68	11	.	.	PUNCT
dpc-2081	69	1	he	he	PRON
dpc-2081	69	2	revealed	reveal	VERB
dpc-2081	69	3	chronic	chronic	ADJ
dpc-2081	69	4	plaque	plaque	NOUN
dpc-2081	69	5	psoriasis	psoriasis	NOUN
dpc-2081	69	6	without	without	ADP
dpc-2081	69	7	psoriatic	psoriatic	ADJ
dpc-2081	69	8	arthritis	arthritis	NOUN
dpc-2081	69	9	.	.	PUNCT
dpc-2081	70	1	his	his	PRON
dpc-2081	70	2	previous	previous	ADJ
dpc-2081	70	3	medical	medical	ADJ
dpc-2081	70	4	history	history	NOUN
dpc-2081	70	5	was	be	AUX
dpc-2081	70	6	unremarkable	unremarkable	ADJ
dpc-2081	70	7	.	.	PUNCT
dpc-2081	71	1	the	the	DET
dpc-2081	71	2	initial	initial	ADJ
dpc-2081	71	3	treatment	treatment	NOUN
dpc-2081	71	4	choice	choice	NOUN
dpc-2081	71	5	for	for	ADP
dpc-2081	71	6	this	this	DET
dpc-2081	71	7	patient	patient	NOUN
dpc-2081	71	8	was	be	AUX
dpc-2081	71	9	methotrexate	methotrexate	VERB
dpc-2081	71	10	which	which	PRON
dpc-2081	71	11	was	be	AUX
dpc-2081	71	12	replaced	replace	VERB
dpc-2081	71	13	by	by	ADP
dpc-2081	71	14	certolizumab	certolizumab	NOUN
dpc-2081	71	15	pegol	pegol	PROPN
dpc-2081	71	16	injections	injection	NOUN
dpc-2081	71	17	due	due	ADJ
dpc-2081	71	18	to	to	ADP
dpc-2081	71	19	inefficacy	inefficacy	NOUN
dpc-2081	71	20	.	.	PUNCT
dpc-2081	72	1	psoriasis	psoriasis	NOUN
dpc-2081	72	2	area	area	NOUN
dpc-2081	72	3	severity	severity	NOUN
dpc-2081	72	4	index	index	NOUN
dpc-2081	72	5	[	[	X
dpc-2081	72	6	pasi	pasi	X
dpc-2081	72	7	]	]	X
dpc-2081	72	8	score	score	NOUN
dpc-2081	72	9	reduced	reduce	VERB
dpc-2081	72	10	from	from	ADP
dpc-2081	72	11	the	the	DET
dpc-2081	72	12	baseline	baseline	NOUN
dpc-2081	72	13	value	value	NOUN
dpc-2081	72	14	of	of	ADP
dpc-2081	72	15	8	8	NUM
dpc-2081	72	16	to	to	PART
dpc-2081	72	17	1.5	1.5	NUM
dpc-2081	72	18	on	on	ADP
dpc-2081	72	19	the	the	DET
dpc-2081	72	20	6th	6th	ADJ
dpc-2081	72	21	month	month	NOUN
dpc-2081	72	22	of	of	ADP
dpc-2081	72	23	certolizumab	certolizumab	NOUN
dpc-2081	72	24	pegol	pegol	PROPN
dpc-2081	72	25	treatment	treatment	NOUN
dpc-2081	72	26	.	.	PUNCT
dpc-2081	73	1	the	the	DET
dpc-2081	73	2	dermatological	dermatological	ADJ
dpc-2081	73	3	diagnosis	diagnosis	NOUN
dpc-2081	73	4	of	of	ADP
dpc-2081	73	5	the	the	DET
dpc-2081	73	6	bd	bd	PROPN
dpc-2081	73	7	case	case	NOUN
dpc-2081	73	8	in	in	ADP
dpc-2081	73	9	the	the	DET
dpc-2081	73	10	control	control	NOUN
dpc-2081	73	11	group	group	NOUN
dpc-2081	73	12	was	be	AUX
dpc-2081	73	13	basal	basal	ADJ
dpc-2081	73	14	cell	cell	NOUN
dpc-2081	73	15	carcinoma	carcinoma	NOUN
dpc-2081	73	16	.	.	PUNCT
dpc-2081	74	1	the	the	DET
dpc-2081	74	2	prevalence	prevalence	NOUN
dpc-2081	74	3	of	of	ADP
dpc-2081	74	4	bd	bd	PROPN
dpc-2081	74	5	in	in	ADP
dpc-2081	74	6	the	the	DET
dpc-2081	74	7	hs	hs	PROPN
dpc-2081	74	8	cohort	cohort	NOUN
dpc-2081	74	9	(	(	PUNCT
dpc-2081	74	10	3.6	3.6	NUM
dpc-2081	74	11	%	%	NOUN
dpc-2081	74	12	)	)	PUNCT
dpc-2081	74	13	was	be	AUX
dpc-2081	74	14	4.5	4.5	NUM
dpc-2081	74	15	and	and	CCONJ
dpc-2081	74	16	6	6	NUM
dpc-2081	74	17	times	time	NOUN
dpc-2081	74	18	higher	high	ADJ
dpc-2081	74	19	than	than	ADP
dpc-2081	74	20	in	in	ADP
dpc-2081	74	21	the	the	DET
dpc-2081	74	22	psoriasis	psoriasis	NOUN
dpc-2081	74	23	cohort	cohort	NOUN
dpc-2081	74	24	(	(	PUNCT
dpc-2081	74	25	0.7	0.7	NUM
dpc-2081	74	26	%	%	NOUN
dpc-2081	74	27	)	)	PUNCT
dpc-2081	74	28	and	and	CCONJ
dpc-2081	74	29	controls	control	NOUN
dpc-2081	74	30	(	(	PUNCT
dpc-2081	74	31	0.6	0.6	NUM
dpc-2081	74	32	%	%	NOUN
dpc-2081	74	33	)	)	PUNCT
dpc-2081	75	1	(	(	PUNCT
dpc-2081	75	2	p	p	X
dpc-2081	75	3	=	=	NOUN
dpc-2081	75	4	0.001	0.001	NUM
dpc-2081	75	5	for	for	ADP
dpc-2081	75	6	group1	group1	PROPN
dpc-2081	75	7	-	-	PUNCT
dpc-2081	75	8	2	2	NUM
dpc-2081	75	9	and	and	CCONJ
dpc-2081	75	10	group	group	NOUN
dpc-2081	75	11	1	1	NUM
dpc-2081	75	12	-	-	SYM
dpc-2081	75	13	3	3	NUM
dpc-2081	75	14	)	)	PUNCT
dpc-2081	75	15	.	.	PUNCT
dpc-2081	76	1	table	table	NOUN
dpc-2081	76	2	2	2	NUM
dpc-2081	76	3	exhibits	exhibit	VERB
dpc-2081	76	4	the	the	DET
dpc-2081	76	5	demographic	demographic	ADJ
dpc-2081	76	6	and	and	CCONJ
dpc-2081	76	7	clinical	clinical	ADJ
dpc-2081	76	8	characteristics	characteristic	NOUN
dpc-2081	76	9	of	of	ADP
dpc-2081	76	10	11	11	NUM
dpc-2081	76	11	patients	patient	NOUN
dpc-2081	76	12	with	with	ADP
dpc-2081	76	13	bd.the	bd.the	DET
dpc-2081	76	14	majority	majority	NOUN
dpc-2081	76	15	of	of	ADP
dpc-2081	76	16	the	the	DET
dpc-2081	76	17	patients	patient	NOUN
dpc-2081	76	18	with	with	ADP
dpc-2081	76	19	bd	bd	PROPN
dpc-2081	76	20	were	be	AUX
dpc-2081	76	21	male	male	ADJ
dpc-2081	76	22	(	(	PUNCT
dpc-2081	76	23	n=7/11	n=7/11	NOUN
dpc-2081	76	24	)	)	PUNCT
dpc-2081	76	25	.	.	PUNCT
dpc-2081	77	1	similarly	similarly	ADV
dpc-2081	77	2	,	,	PUNCT
dpc-2081	77	3	6/9	6/9	NUM
dpc-2081	77	4	of	of	ADP
dpc-2081	77	5	the	the	DET
dpc-2081	77	6	patients	patient	NOUN
dpc-2081	77	7	with	with	ADP
dpc-2081	77	8	hs	hs	PROPN
dpc-2081	77	9	and	and	CCONJ
dpc-2081	77	10	bp	bp	PROPN
dpc-2081	77	11	were	be	AUX
dpc-2081	77	12	male	male	ADJ
dpc-2081	77	13	.	.	PUNCT
dpc-2081	78	1	family	family	NOUN
dpc-2081	78	2	history	history	NOUN
dpc-2081	78	3	of	of	ADP
dpc-2081	78	4	hs	hs	PROPN
dpc-2081	78	5	or	or	CCONJ
dpc-2081	78	6	bd	bd	PROPN
dpc-2081	78	7	was	be	AUX
dpc-2081	78	8	present	present	ADJ
dpc-2081	78	9	in	in	ADP
dpc-2081	78	10	4/9	4/9	NUM
dpc-2081	78	11	(	(	PUNCT
dpc-2081	78	12	44.4	44.4	NUM
dpc-2081	78	13	%	%	NOUN
dpc-2081	78	14	)	)	PUNCT
dpc-2081	78	15	of	of	ADP
dpc-2081	78	16	the	the	DET
dpc-2081	78	17	patients	patient	NOUN
dpc-2081	78	18	with	with	ADP
dpc-2081	78	19	hs	hs	PROPN
dpc-2081	78	20	and	and	CCONJ
dpc-2081	78	21	bd	bd	PROPN
dpc-2081	78	22	.	.	PROPN
dpc-2081	79	1	totally	totally	ADV
dpc-2081	79	2	(	(	PUNCT
dpc-2081	79	3	88.8	88.8	NUM
dpc-2081	79	4	%	%	NOUN
dpc-2081	79	5	)	)	PUNCT
dpc-2081	79	6	8	8	NUM
dpc-2081	79	7	of	of	ADP
dpc-2081	79	8	the	the	DET
dpc-2081	79	9	hs	hs	PROPN
dpc-2081	79	10	patients	patient	NOUN
dpc-2081	79	11	had	have	AUX
dpc-2081	79	12	moderate	moderate	ADJ
dpc-2081	79	13	to	to	AUX
dpc-2081	79	14	severe	severe	ADJ
dpc-2081	79	15	hs	hs	PROPN
dpc-2081	79	16	according	accord	VERB
dpc-2081	79	17	to	to	ADP
dpc-2081	79	18	the	the	DET
dpc-2081	79	19	hurley	hurley	NOUN
dpc-2081	79	20	stage	stage	NOUN
dpc-2081	79	21	and	and	CCONJ
dpc-2081	79	22	ihs4	ihs4	NOUN
dpc-2081	79	23	scores	score	NOUN
dpc-2081	79	24	.	.	PUNCT
dpc-2081	80	1	the	the	DET
dpc-2081	80	2	median	median	ADJ
dpc-2081	80	3	disease	disease	NOUN
dpc-2081	80	4	duration	duration	NOUN
dpc-2081	80	5	of	of	ADP
dpc-2081	80	6	hs	hs	PROPN
dpc-2081	80	7	and	and	CCONJ
dpc-2081	80	8	bd	bd	PROPN
dpc-2081	80	9	was	be	AUX
dpc-2081	80	10	as	as	SCONJ
dpc-2081	80	11	follows	follow	VERB
dpc-2081	80	12	,	,	PUNCT
dpc-2081	80	13	6	6	NUM
dpc-2081	80	14	(	(	PUNCT
dpc-2081	80	15	min	min	NOUN
dpc-2081	80	16	-	-	ADJ
dpc-2081	80	17	max:4	max:4	NOUN
dpc-2081	80	18	-	-	PUNCT
dpc-2081	80	19	20	20	NUM
dpc-2081	80	20	,	,	PUNCT
dpc-2081	80	21	interquartile	interquartile	ADJ
dpc-2081	80	22	range	range	NOUN
dpc-2081	80	23	[	[	X
dpc-2081	80	24	iqr	iqr	X
dpc-2081	80	25	]	]	X
dpc-2081	80	26	:	:	PUNCT
dpc-2081	80	27	11	11	NUM
dpc-2081	80	28	)	)	PUNCT
dpc-2081	80	29	and	and	CCONJ
dpc-2081	80	30	7	7	NUM
dpc-2081	80	31	(	(	PUNCT
dpc-2081	80	32	min	min	NOUN
dpc-2081	80	33	-	-	ADJ
dpc-2081	80	34	max:2	max:2	NUM
dpc-2081	80	35	-	-	SYM
dpc-2081	80	36	16	16	NUM
dpc-2081	80	37	,	,	PUNCT
dpc-2081	80	38	iqr	iqr	NOUN
dpc-2081	80	39	:	:	PUNCT
dpc-2081	80	40	10.5	10.5	NUM
dpc-2081	80	41	)	)	PUNCT
dpc-2081	80	42	of	of	ADP
dpc-2081	80	43	the	the	DET
dpc-2081	80	44	hs	hs	PROPN
dpc-2081	80	45	patients	patient	NOUN
dpc-2081	80	46	,	,	PUNCT
dpc-2081	80	47	5	5	NUM
dpc-2081	80	48	were	be	AUX
dpc-2081	80	49	on	on	ADP
dpc-2081	80	50	adalimumab	adalimumab	NOUN
dpc-2081	80	51	and	and	CCONJ
dpc-2081	80	52	4	4	NUM
dpc-2081	80	53	were	be	AUX
dpc-2081	80	54	on	on	ADP
dpc-2081	80	55	doxycycline	doxycycline	NOUN
dpc-2081	80	56	.	.	PUNCT
dpc-2081	81	1	of	of	ADP
dpc-2081	81	2	nine	nine	NUM
dpc-2081	81	3	cases	case	NOUN
dpc-2081	81	4	with	with	ADP
dpc-2081	81	5	hs	hs	PROPN
dpc-2081	81	6	and	and	CCONJ
dpc-2081	81	7	bd	bd	PROPN
dpc-2081	81	8	,	,	PUNCT
dpc-2081	81	9	4	4	NUM
dpc-2081	81	10	(	(	PUNCT
dpc-2081	81	11	44.4	44.4	NUM
dpc-2081	81	12	%	%	NOUN
dpc-2081	81	13	)	)	PUNCT
dpc-2081	81	14	had	have	VERB
dpc-2081	81	15	concurrent	concurrent	ADJ
dpc-2081	81	16	metabolic	metabolic	NOUN
dpc-2081	81	17	syndrome	syndrome	NOUN
dpc-2081	81	18	.	.	PUNCT
dpc-2081	82	1	most	most	ADV
dpc-2081	82	2	frequently	frequently	ADV
dpc-2081	82	3	used	use	VERB
dpc-2081	82	4	current	current	ADJ
dpc-2081	82	5	medications	medication	NOUN
dpc-2081	82	6	for	for	ADP
dpc-2081	82	7	bd	bd	PROPN
dpc-2081	82	8	in	in	ADP
dpc-2081	82	9	hs	hs	PROPN
dpc-2081	82	10	patients	patient	NOUN
dpc-2081	82	11	were	be	AUX
dpc-2081	82	12	lithium	lithium	NOUN
dpc-2081	82	13	(	(	PUNCT
dpc-2081	82	14	n	n	NOUN
dpc-2081	82	15	=	=	SYM
dpc-2081	82	16	5/9	5/9	NUM
dpc-2081	82	17	)	)	PUNCT
dpc-2081	82	18	and	and	CCONJ
dpc-2081	82	19	sodium	sodium	NOUN
dpc-2081	82	20	valproate	valproate	ADJ
dpc-2081	82	21	(	(	PUNCT
dpc-2081	82	22	n	n	CCONJ
dpc-2081	82	23	  	  	SPACE
dpc-2081	82	24	=	=	NOUN
dpc-2081	82	25	  	  	SPACE
dpc-2081	82	26	4/9	4/9	NUM
dpc-2081	82	27	)	)	PUNCT
dpc-2081	82	28	,	,	PUNCT
dpc-2081	82	29	respectively	respectively	ADV
dpc-2081	82	30	.	.	PUNCT
dpc-2081	83	1	of	of	ADP
dpc-2081	83	2	9	9	NUM
dpc-2081	83	3	hs	hs	NOUN
dpc-2081	83	4	patients	patient	NOUN
dpc-2081	83	5	,	,	PUNCT
dpc-2081	83	6	6had	6had	PROPN
dpc-2081	83	7	been	be	AUX
dpc-2081	83	8	prescribed	prescribe	VERB
dpc-2081	83	9	lithium	lithium	NOUN
dpc-2081	83	10	previously	previously	ADV
dpc-2081	83	11	,	,	PUNCT
dpc-2081	83	12	and	and	CCONJ
dpc-2081	83	13	3/6	3/6	NUM
dpc-2081	83	14	(	(	PUNCT
dpc-2081	83	15	50	50	NUM
dpc-2081	83	16	%	%	NOUN
dpc-2081	83	17	)	)	PUNCT
dpc-2081	83	18	reported	report	VERB
dpc-2081	83	19	exacerbations	exacerbation	NOUN
dpc-2081	83	20	under	under	ADP
dpc-2081	83	21	lithium	lithium	NOUN
dpc-2081	83	22	.	.	PUNCT
dpc-2081	84	1	because	because	SCONJ
dpc-2081	84	2	of	of	ADP
dpc-2081	84	3	uncontrolled	uncontrolled	ADJ
dpc-2081	84	4	bd	bd	NOUN
dpc-2081	84	5	despite	despite	SCONJ
dpc-2081	84	6	multiple	multiple	ADJ
dpc-2081	84	7	treatments	treatment	NOUN
dpc-2081	84	8	,	,	PUNCT
dpc-2081	84	9	lithium	lithium	NOUN
dpc-2081	84	10	had	have	VERB
dpc-2081	84	11	to	to	PART
dpc-2081	84	12	be	be	AUX
dpc-2081	84	13	continued	continue	VERB
dpc-2081	84	14	in	in	ADP
dpc-2081	84	15	two	two	NUM
dpc-2081	84	16	of	of	ADP
dpc-2081	84	17	these	these	DET
dpc-2081	84	18	3	3	NUM
dpc-2081	84	19	patients	patient	NOUN
dpc-2081	84	20	who	who	PRON
dpc-2081	84	21	described	describe	VERB
dpc-2081	84	22	exacerbations	exacerbation	NOUN
dpc-2081	84	23	.	.	PUNCT
dpc-2081	85	1	conclusions	conclusion	NOUN
dpc-2081	85	2	in	in	ADP
dpc-2081	85	3	the	the	DET
dpc-2081	85	4	current	current	ADJ
dpc-2081	85	5	study	study	NOUN
dpc-2081	85	6	,	,	PUNCT
dpc-2081	85	7	the	the	DET
dpc-2081	85	8	prevalence	prevalence	NOUN
dpc-2081	85	9	of	of	ADP
dpc-2081	85	10	bd	bd	PROPN
dpc-2081	85	11	was	be	AUX
dpc-2081	85	12	3,6	3,6	NUM
dpc-2081	85	13	%	%	NOUN
dpc-2081	85	14	.	.	PUNCT
dpc-2081	86	1	bd	bd	NOUN
dpc-2081	86	2	  	  	SPACE
dpc-2081	86	3	frequency	frequency	NOUN
dpc-2081	86	4	was	be	AUX
dpc-2081	86	5	significantly	significantly	ADV
dpc-2081	86	6	higher	high	ADJ
dpc-2081	86	7	in	in	ADP
dpc-2081	86	8	the	the	DET
dpc-2081	86	9	hs	hs	PROPN
dpc-2081	86	10	cohort	cohort	PROPN
dpc-2081	86	11	than	than	ADP
dpc-2081	86	12	the	the	DET
dpc-2081	86	13	psoriasis	psoriasis	NOUN
dpc-2081	86	14	cohort	cohort	NOUN
dpc-2081	86	15	and	and	CCONJ
dpc-2081	86	16	control	control	NOUN
dpc-2081	86	17	patients	patient	NOUN
dpc-2081	86	18	.	.	PUNCT
dpc-2081	87	1	physicians	physician	NOUN
dpc-2081	87	2	dealing	deal	VERB
dpc-2081	87	3	with	with	ADP
dpc-2081	87	4	hs	hs	PROPN
dpc-2081	87	5	patients	patient	NOUN
dpc-2081	87	6	are	be	AUX
dpc-2081	87	7	familiar	familiar	ADJ
dpc-2081	87	8	with	with	ADP
dpc-2081	87	9	psychiatric	psychiatric	ADJ
dpc-2081	87	10	complaints	complaint	NOUN
dpc-2081	87	11	,	,	PUNCT
dpc-2081	87	12	occasionally	occasionally	ADV
dpc-2081	87	13	leading	lead	VERB
dpc-2081	87	14	to	to	ADP
dpc-2081	87	15	anxiety	anxiety	NOUN
dpc-2081	87	16	and	and	CCONJ
dpc-2081	87	17	depression	depression	NOUN
dpc-2081	87	18	[	[	X
dpc-2081	87	19	17	17	NUM
dpc-2081	87	20	-	-	SYM
dpc-2081	87	21	19	19	NUM
dpc-2081	87	22	]	]	PUNCT
dpc-2081	87	23	.	.	PUNCT
dpc-2081	88	1	hs	hs	PROPN
dpc-2081	88	2	 	 	SPACE
dpc-2081	88	3	substantial	substantial	ADJ
dpc-2081	88	4	burden	burden	NOUN
dpc-2081	88	5	on	on	ADP
dpc-2081	88	6	quality	quality	NOUN
dpc-2081	88	7	of	of	ADP
dpc-2081	88	8	life	life	NOUN
dpc-2081	88	9	measures	measure	NOUN
dpc-2081	88	10	has	have	AUX
dpc-2081	88	11	been	be	AUX
dpc-2081	88	12	proposed	propose	VERB
dpc-2081	88	13	as	as	ADP
dpc-2081	88	14	the	the	DET
dpc-2081	88	15	principal	principal	ADJ
dpc-2081	88	16	causal	causal	ADJ
dpc-2081	88	17	factor	factor	NOUN
dpc-2081	88	18	for	for	ADP
dpc-2081	88	19	the	the	DET
dpc-2081	88	20	association	association	NOUN
dpc-2081	88	21	of	of	ADP
dpc-2081	88	22	hs	hs	PROPN
dpc-2081	88	23	and	and	CCONJ
dpc-2081	88	24	psychiatric	psychiatric	ADJ
dpc-2081	88	25	co	co	NOUN
dpc-2081	88	26	-	-	NOUN
dpc-2081	88	27	morbidities	morbidity	NOUN
dpc-2081	88	28	[	[	X
dpc-2081	88	29	19,20	19,20	X
dpc-2081	88	30	]	]	PUNCT
dpc-2081	88	31	.	.	PUNCT
dpc-2081	89	1	associations	association	NOUN
dpc-2081	89	2	between	between	ADP
dpc-2081	89	3	several	several	ADJ
dpc-2081	89	4	endocrinologic	endocrinologic	NOUN
dpc-2081	89	5	,	,	PUNCT
dpc-2081	89	6	metabolic	metabolic	NOUN
dpc-2081	89	7	and	and	CCONJ
dpc-2081	89	8	rheumatological	rheumatological	ADJ
dpc-2081	89	9	disorders	disorder	NOUN
dpc-2081	89	10	and	and	CCONJ
dpc-2081	89	11	hs	hs	PRON
dpc-2081	89	12	reveal	reveal	VERB
dpc-2081	89	13	that	that	SCONJ
dpc-2081	89	14	hs	hs	PROPN
dpc-2081	89	15	is	be	AUX
dpc-2081	89	16	more	more	ADJ
dpc-2081	89	17	than	than	ADP
dpc-2081	89	18	skin	skin	NOUN
dpc-2081	90	1	deep	deep	ADV
dpc-2081	90	2	[	[	X
dpc-2081	90	3	21	21	NUM
dpc-2081	90	4	]	]	PUNCT
dpc-2081	90	5	.	.	PUNCT
dpc-2081	91	1	deciphering	decipher	VERB
dpc-2081	91	2	the	the	DET
dpc-2081	91	3	interdisciplinary	interdisciplinary	ADJ
dpc-2081	91	4	links	link	NOUN
dpc-2081	91	5	is	be	AUX
dpc-2081	91	6	essential	essential	ADJ
dpc-2081	91	7	for	for	ADP
dpc-2081	91	8	hs	hs	PROPN
dpc-2081	91	9	optimal	optimal	ADJ
dpc-2081	91	10	management	management	NOUN
dpc-2081	91	11	and	and	CCONJ
dpc-2081	91	12	table	table	NOUN
dpc-2081	91	13	1	1	NUM
dpc-2081	91	14	.	.	PUNCT
dpc-2081	91	15	demographic	demographic	ADJ
dpc-2081	91	16	and	and	CCONJ
dpc-2081	91	17	clinical	clinical	ADJ
dpc-2081	91	18	characteristics	characteristic	NOUN
dpc-2081	91	19	of	of	ADP
dpc-2081	91	20	247	247	NUM
dpc-2081	91	21	hs	hs	PROPN
dpc-2081	91	22	patients	patient	NOUN
dpc-2081	91	23	demographic	demographic	ADJ
dpc-2081	91	24	and	and	CCONJ
dpc-2081	91	25	clinical	clinical	ADJ
dpc-2081	91	26	characteristics	characteristic	NOUN
dpc-2081	91	27	of	of	ADP
dpc-2081	91	28	247	247	NUM
dpc-2081	91	29	hs	hs	PROPN
dpc-2081	91	30	patients	patient	NOUN
dpc-2081	91	31	gender	gender	NOUN
dpc-2081	91	32	(	(	PUNCT
dpc-2081	91	33	female/	female/	NOUN
dpc-2081	91	34	male	male	NOUN
dpc-2081	91	35	)	)	PUNCT
dpc-2081	91	36	105	105	NUM
dpc-2081	91	37	/	/	SYM
dpc-2081	91	38	142	142	NUM
dpc-2081	91	39	age	age	NOUN
dpc-2081	91	40	,	,	PUNCT
dpc-2081	91	41	years	year	NOUN
dpc-2081	91	42	(	(	PUNCT
dpc-2081	91	43	mean±sd	mean±sd	NUM
dpc-2081	91	44	)	)	PUNCT
dpc-2081	91	45	(	(	PUNCT
dpc-2081	91	46	min	min	NOUN
dpc-2081	91	47	-	-	PUNCT
dpc-2081	91	48	max	max	NOUN
dpc-2081	91	49	)	)	PUNCT
dpc-2081	91	50	33.48±11,6	33.48±11,6	NUM
dpc-2081	91	51	(	(	PUNCT
dpc-2081	91	52	14	14	NUM
dpc-2081	91	53	-	-	SYM
dpc-2081	91	54	68	68	NUM
dpc-2081	91	55	)	)	PUNCT
dpc-2081	91	56	mean	mean	NOUN
dpc-2081	91	57	disease	disease	NOUN
dpc-2081	91	58	duration	duration	NOUN
dpc-2081	91	59	,	,	PUNCT
dpc-2081	91	60	years	year	NOUN
dpc-2081	91	61	(	(	PUNCT
dpc-2081	91	62	mean±sd	mean±sd	NUM
dpc-2081	91	63	)	)	PUNCT
dpc-2081	91	64	(	(	PUNCT
dpc-2081	91	65	min	min	NOUN
dpc-2081	91	66	-	-	PUNCT
dpc-2081	91	67	max	max	NOUN
dpc-2081	91	68	)	)	PUNCT
dpc-2081	91	69	7.3±6,9	7.3±6,9	NOUN
dpc-2081	91	70	(	(	PUNCT
dpc-2081	91	71	0	0	NUM
dpc-2081	91	72	-	-	SYM
dpc-2081	91	73	35	35	NUM
dpc-2081	91	74	)	)	PUNCT
dpc-2081	91	75	active	active	ADJ
dpc-2081	91	76	smokers	smoker	NOUN
dpc-2081	91	77	(	(	PUNCT
dpc-2081	91	78	%	%	INTJ
dpc-2081	91	79	)	)	PUNCT
dpc-2081	91	80	/	/	SYM
dpc-2081	91	81	packet	packet	NOUN
dpc-2081	91	82	-	-	PUNCT
dpc-2081	91	83	year	year	NOUN
dpc-2081	91	84	(	(	PUNCT
dpc-2081	91	85	mean±sd	mean±sd	NOUN
dpc-2081	91	86	)	)	PUNCT
dpc-2081	91	87	(	(	PUNCT
dpc-2081	91	88	min	min	NOUN
dpc-2081	91	89	-	-	PUNCT
dpc-2081	91	90	max	max	NOUN
dpc-2081	91	91	)	)	PUNCT
dpc-2081	91	92	75	75	NUM
dpc-2081	91	93	/12.7±14.3	/12.7±14.3	PUNCT
dpc-2081	92	1	(	(	PUNCT
dpc-2081	92	2	1	1	NUM
dpc-2081	92	3	-	-	SYM
dpc-2081	92	4	90	90	NUM
dpc-2081	92	5	)	)	PUNCT
dpc-2081	92	6	body	body	NOUN
dpc-2081	92	7	mass	mass	NOUN
dpc-2081	92	8	index	index	NOUN
dpc-2081	92	9	(	(	PUNCT
dpc-2081	92	10	mean±sd	mean±sd	PROPN
dpc-2081	92	11	)	)	PUNCT
dpc-2081	92	12	(	(	PUNCT
dpc-2081	92	13	min	min	NOUN
dpc-2081	92	14	-	-	PUNCT
dpc-2081	92	15	max	max	NOUN
dpc-2081	92	16	)	)	PUNCT
dpc-2081	92	17	28.6±6.8	28.6±6.8	NUM
dpc-2081	92	18	(	(	PUNCT
dpc-2081	92	19	14,8	14,8	NUM
dpc-2081	92	20	-	-	PUNCT
dpc-2081	92	21	85	85	NUM
dpc-2081	92	22	)	)	PUNCT
dpc-2081	92	23	hurley	hurley	NOUN
dpc-2081	92	24	stage	stage	NOUN
dpc-2081	92	25	(	(	PUNCT
dpc-2081	92	26	n/%	n/%	PROPN
dpc-2081	92	27	)	)	PUNCT
dpc-2081	93	1	i	i	PROPN
dpc-2081	93	2	ii	ii	VERB
dpc-2081	93	3	iii	iii	NUM
dpc-2081	93	4	82	82	NUM
dpc-2081	93	5	,	,	PUNCT
dpc-2081	93	6	33.2	33.2	NUM
dpc-2081	93	7	%	%	NOUN
dpc-2081	93	8	81	81	NUM
dpc-2081	93	9	,	,	PUNCT
dpc-2081	93	10	33.8	33.8	NUM
dpc-2081	93	11	%	%	NOUN
dpc-2081	93	12	84	84	NUM
dpc-2081	93	13	,	,	PUNCT
dpc-2081	93	14	34.0	34.0	NUM
dpc-2081	93	15	%	%	NOUN
dpc-2081	93	16	n	n	PRON
dpc-2081	93	17	(	(	PUNCT
dpc-2081	93	18	%	%	NOUN
dpc-2081	93	19	)	)	PUNCT
dpc-2081	93	20	n	n	CCONJ
dpc-2081	93	21	(	(	PUNCT
dpc-2081	93	22	%	%	NOUN
dpc-2081	93	23	)	)	PUNCT
dpc-2081	93	24	diabetes	diabetes	NOUN
dpc-2081	93	25	mellitus	mellitus	NOUN
dpc-2081	93	26	hypertension	hypertension	PROPN
dpc-2081	93	27	spondyloarthropathy/	spondyloarthropathy/	PROPN
dpc-2081	93	28	arthritis	arthritis	NOUN
dpc-2081	93	29	hyperlipidemia	hyperlipidemia	NOUN
dpc-2081	93	30	familial	familial	ADJ
dpc-2081	93	31	mediterranean	mediterranean	ADJ
dpc-2081	93	32	fever	fever	NOUN
dpc-2081	93	33	chronic	chronic	ADJ
dpc-2081	93	34	cardiac	cardiac	ADJ
dpc-2081	93	35	disease	disease	NOUN
dpc-2081	93	36	bipolar	bipolar	ADJ
dpc-2081	93	37	disorder	disorder	NOUN
dpc-2081	93	38	thyroid	thyroid	NOUN
dpc-2081	93	39	disease	disease	NOUN
dpc-2081	93	40	31	31	NUM
dpc-2081	93	41	(	(	PUNCT
dpc-2081	93	42	12.5	12.5	NUM
dpc-2081	93	43	)	)	PUNCT
dpc-2081	93	44	16	16	NUM
dpc-2081	93	45	(	(	PUNCT
dpc-2081	93	46	6.4	6.4	NUM
dpc-2081	93	47	)	)	PUNCT
dpc-2081	93	48	15	15	NUM
dpc-2081	93	49	(	(	PUNCT
dpc-2081	93	50	6.0	6.0	NUM
dpc-2081	93	51	)	)	PUNCT
dpc-2081	93	52	12	12	NUM
dpc-2081	93	53	(	(	PUNCT
dpc-2081	93	54	4.8	4.8	NUM
dpc-2081	93	55	)	)	PUNCT
dpc-2081	93	56	10	10	NUM
dpc-2081	93	57	(	(	PUNCT
dpc-2081	93	58	4.0	4.0	NUM
dpc-2081	93	59	)	)	SYM
dpc-2081	93	60	10	10	NUM
dpc-2081	93	61	(	(	PUNCT
dpc-2081	93	62	4.0	4.0	NUM
dpc-2081	93	63	)	)	PUNCT
dpc-2081	93	64	9	9	NUM
dpc-2081	93	65	(	(	PUNCT
dpc-2081	93	66	3.6	3.6	NUM
dpc-2081	93	67	)	)	SYM
dpc-2081	93	68	8	8	NUM
dpc-2081	93	69	(	(	PUNCT
dpc-2081	93	70	3.2	3.2	NUM
dpc-2081	93	71	)	)	PUNCT
dpc-2081	93	72	psoriasis	psoriasis	NOUN
dpc-2081	93	73	crohn	crohn	NOUN
dpc-2081	93	74	disease	disease	NOUN
dpc-2081	93	75	pulmoner	pulmoner	NOUN
dpc-2081	93	76	disease	disease	VERB
dpc-2081	93	77	down	down	ADP
dpc-2081	93	78	syndrome	syndrome	NOUN
dpc-2081	93	79	pyoderma	pyoderma	NOUN
dpc-2081	93	80	gangrenosum	gangrenosum	NOUN
dpc-2081	93	81	vitiligo	vitiligo	VERB
dpc-2081	93	82	multiple	multiple	ADJ
dpc-2081	93	83	sclerosis	sclerosis	NOUN
dpc-2081	93	84	5	5	NUM
dpc-2081	93	85	(	(	PUNCT
dpc-2081	93	86	2.0	2.0	NUM
dpc-2081	93	87	)	)	PUNCT
dpc-2081	93	88	4	4	NUM
dpc-2081	93	89	(	(	PUNCT
dpc-2081	93	90	1.6	1.6	NUM
dpc-2081	93	91	)	)	PUNCT
dpc-2081	93	92	4	4	NUM
dpc-2081	93	93	(	(	PUNCT
dpc-2081	93	94	1.6	1.6	NUM
dpc-2081	93	95	)	)	PUNCT
dpc-2081	93	96	2	2	NUM
dpc-2081	93	97	(	(	PUNCT
dpc-2081	93	98	0.8	0.8	NUM
dpc-2081	93	99	)	)	SYM
dpc-2081	93	100	2	2	NUM
dpc-2081	93	101	(	(	PUNCT
dpc-2081	93	102	0.8	0.8	NUM
dpc-2081	93	103	)	)	SYM
dpc-2081	93	104	1	1	NUM
dpc-2081	93	105	(	(	PUNCT
dpc-2081	93	106	0.4	0.4	NUM
dpc-2081	93	107	)	)	SYM
dpc-2081	93	108	1	1	NUM
dpc-2081	93	109	(	(	PUNCT
dpc-2081	93	110	0.4	0.4	NUM
dpc-2081	93	111	)	)	PUNCT
dpc-2081	94	1	n	n	NOUN
dpc-2081	94	2	=	=	NOUN
dpc-2081	94	3	number	number	NOUN
dpc-2081	94	4	of	of	ADP
dpc-2081	94	5	patients	patient	NOUN
dpc-2081	94	6	;	;	PUNCT
dpc-2081	94	7	sd	sd	NOUN
dpc-2081	94	8	=	=	SYM
dpc-2081	94	9	standard	standard	ADJ
dpc-2081	94	10	deviation	deviation	NOUN
dpc-2081	94	11	;	;	PUNCT
dpc-2081	94	12	%	%	NOUN
dpc-2081	94	13	percentage	percentage	NOUN
dpc-2081	94	14	of	of	ADP
dpc-2081	94	15	patients	patient	NOUN
dpc-2081	94	16	.	.	PUNCT
dpc-2081	95	1	ta	ta	X
dpc-2081	95	2	b	b	NOUN
dpc-2081	95	3	le	le	ADP
dpc-2081	95	4	2	2	NUM
dpc-2081	96	1	d	d	NOUN
dpc-2081	96	2	em	em	PRON
dpc-2081	96	3	og	og	INTJ
dpc-2081	96	4	ra	ra	PROPN
dpc-2081	96	5	ph	ph	PROPN
dpc-2081	96	6	ic	ic	PROPN
dpc-2081	96	7	a	a	PRON
dpc-2081	96	8	nd	nd	NOUN
dpc-2081	96	9	c	c	PROPN
dpc-2081	96	10	lin	lin	PROPN
dpc-2081	96	11	ic	ic	PROPN
dpc-2081	96	12	al	al	PROPN
dpc-2081	96	13	c	c	PROPN
dpc-2081	97	1	ha	ha	INTJ
dpc-2081	97	2	ra	ra	INTJ
dpc-2081	98	1	ct	ct	INTJ
dpc-2081	98	2	er	er	INTJ
dpc-2081	98	3	is	be	AUX
dpc-2081	98	4	ti	ti	X
dpc-2081	98	5	cs	cs	ADJ
dpc-2081	98	6	o	o	NOUN
dpc-2081	98	7	f	f	NOUN
dpc-2081	98	8	pa	pa	PROPN
dpc-2081	98	9	ti	ti	PROPN
dpc-2081	98	10	en	en	X
dpc-2081	98	11	ts	ts	ADP
dpc-2081	99	1	w	w	PROPN
dpc-2081	99	2	it	it	PRON
dpc-2081	100	1	h	h	NOUN
dpc-2081	100	2	bi	bi	NOUN
dpc-2081	100	3	po	po	PROPN
dpc-2081	100	4	la	la	PROPN
dpc-2081	100	5	r	r	PROPN
dpc-2081	100	6	di	di	NOUN
dpc-2081	100	7	so	so	ADV
dpc-2081	100	8	rd	rd	PROPN
dpc-2081	101	1	er	er	INTJ
dpc-2081	101	2	s	s	VERB
dpc-2081	101	3	in	in	ADP
dpc-2081	101	4	g	g	PROPN
dpc-2081	101	5	ro	ro	NOUN
dpc-2081	101	6	up	up	ADV
dpc-2081	101	7	1	1	NUM
dpc-2081	101	8	(	(	PUNCT
dpc-2081	101	9	h	h	NOUN
dpc-2081	101	10	s	s	NOUN
dpc-2081	101	11	pa	pa	NOUN
dpc-2081	101	12	ti	ti	X
dpc-2081	101	13	en	en	X
dpc-2081	101	14	ts	ts	PROPN
dpc-2081	101	15	)	)	PUNCT
dpc-2081	101	16	,	,	PUNCT
dpc-2081	101	17	g	g	PROPN
dpc-2081	101	18	ro	ro	X
dpc-2081	101	19	up	up	ADP
dpc-2081	101	20	2	2	NUM
dpc-2081	101	21	(	(	PUNCT
dpc-2081	101	22	ps	ps	PROPN
dpc-2081	101	23	or	or	CCONJ
dpc-2081	101	24	ia	ia	PROPN
dpc-2081	102	1	si	si	X
dpc-2081	102	2	s	s	PROPN
dpc-2081	102	3	pa	pa	PROPN
dpc-2081	102	4	ti	ti	X
dpc-2081	102	5	en	en	X
dpc-2081	102	6	ts	ts	ADV
dpc-2081	102	7	)	)	PUNCT
dpc-2081	102	8	an	an	DET
dpc-2081	102	9	d	d	NOUN
dpc-2081	102	10	g	g	X
dpc-2081	102	11	ro	ro	PROPN
dpc-2081	102	12	up	up	ADP
dpc-2081	102	13	3	3	NUM
dpc-2081	102	14	(	(	PUNCT
dpc-2081	102	15	c	c	NOUN
dpc-2081	102	16	on	on	ADP
dpc-2081	102	17	tr	tr	VERB
dpc-2081	102	18	ol	ol	PROPN
dpc-2081	102	19	g	g	PROPN
dpc-2081	102	20	ro	ro	X
dpc-2081	102	21	up	up	ADP
dpc-2081	102	22	)	)	PUNCT
dpc-2081	102	23	.	.	PUNCT
dpc-2081	103	1	p1	p1	NOUN
dpc-2081	103	2	p2	p2	PROPN
dpc-2081	103	3	p3	p3	PROPN
dpc-2081	103	4	p4	p4	ADJ
dpc-2081	103	5	p5	p5	ADJ
dpc-2081	103	6	p6	p6	ADJ
dpc-2081	103	7	p7	p7	VERB
dpc-2081	103	8	p8	p8	ADJ
dpc-2081	103	9	p9	p9	PROPN
dpc-2081	103	10	p1	p1	PROPN
dpc-2081	103	11	0	0	NUM
dpc-2081	103	12	p1	p1	PROPN
dpc-2081	103	13	1	1	NUM
dpc-2081	103	14	a	a	DET
dpc-2081	103	15	ge	ge	PROPN
dpc-2081	103	16	(	(	PUNCT
dpc-2081	103	17	ye	ye	PROPN
dpc-2081	103	18	ar	ar	PROPN
dpc-2081	103	19	s	s	PROPN
dpc-2081	103	20	)	)	PUNCT
dpc-2081	103	21	45	45	NUM
dpc-2081	103	22	52	52	NUM
dpc-2081	103	23	33	33	NUM
dpc-2081	103	24	43	43	NUM
dpc-2081	103	25	59	59	NUM
dpc-2081	103	26	30	30	NUM
dpc-2081	103	27	40	40	NUM
dpc-2081	103	28	33	33	NUM
dpc-2081	103	29	33	33	NUM
dpc-2081	103	30	40	40	NUM
dpc-2081	103	31	37	37	NUM
dpc-2081	103	32	g	g	PROPN
dpc-2081	103	33	en	en	X
dpc-2081	103	34	de	de	X
dpc-2081	103	35	r	r	PROPN
dpc-2081	103	36	m	m	VERB
dpc-2081	103	37	m	m	VERB
dpc-2081	103	38	m	m	VERB
dpc-2081	103	39	f	f	X
dpc-2081	104	1	f	f	PROPN
dpc-2081	105	1	m	m	VERB
dpc-2081	105	2	m	m	VERB
dpc-2081	105	3	m	m	VERB
dpc-2081	105	4	f	f	X
dpc-2081	105	5	m	m	VERB
dpc-2081	106	1	f	f	INTJ
dpc-2081	106	2	fa	fa	INTJ
dpc-2081	106	3	m	m	VERB
dpc-2081	106	4	ily	ily	ADV
dpc-2081	106	5	h	h	NOUN
dpc-2081	106	6	is	be	AUX
dpc-2081	106	7	to	to	PART
dpc-2081	106	8	ry	ry	PROPN
dpc-2081	106	9	h	h	PROPN
dpc-2081	106	10	s/	s/	NOUN
dpc-2081	106	11	ps	ps	PROPN
dpc-2081	106	12	or	or	CCONJ
dpc-2081	106	13	ia	ia	PROPN
dpc-2081	106	14	si	si	X
dpc-2081	106	15	s	s	PART
dpc-2081	106	16	+	+	PROPN
dpc-2081	107	1	+	+	PUNCT
dpc-2081	107	2	+	+	CCONJ
dpc-2081	107	3	+	+	NUM
dpc-2081	107	4	fa	fa	VERB
dpc-2081	107	5	m	m	VERB
dpc-2081	107	6	ily	ily	ADV
dpc-2081	107	7	h	h	NOUN
dpc-2081	107	8	is	be	AUX
dpc-2081	107	9	to	to	ADP
dpc-2081	107	10	ry	ry	PROPN
dpc-2081	108	1	b	b	PROPN
dpc-2081	108	2	d	d	PROPN
dpc-2081	108	3	+	+	PROPN
dpc-2081	109	1	+	+	PUNCT
dpc-2081	110	1	+	+	NOUN
dpc-2081	110	2	_	_	PUNCT
dpc-2081	111	1	+	+	CCONJ
dpc-2081	112	1	b	b	X
dpc-2081	112	2	m	m	VERB
dpc-2081	112	3	i	i	PRON
dpc-2081	112	4	25	25	NUM
dpc-2081	112	5	,	,	PUNCT
dpc-2081	112	6	7	7	NUM
dpc-2081	112	7	36	36	NUM
dpc-2081	112	8	,	,	PUNCT
dpc-2081	112	9	1	1	NUM
dpc-2081	112	10	29	29	NUM
dpc-2081	112	11	,	,	PUNCT
dpc-2081	112	12	2	2	NUM
dpc-2081	112	13	29	29	NUM
dpc-2081	112	14	,	,	PUNCT
dpc-2081	112	15	4	4	NUM
dpc-2081	112	16	30	30	NUM
dpc-2081	112	17	30	30	NUM
dpc-2081	112	18	.7	.7	NUM
dpc-2081	112	19	37	37	NUM
dpc-2081	112	20	.0	.0	NUM
dpc-2081	112	21	35	35	NUM
dpc-2081	112	22	,	,	PUNCT
dpc-2081	112	23	4	4	NUM
dpc-2081	112	24	43	43	NUM
dpc-2081	112	25	,	,	PUNCT
dpc-2081	112	26	6	6	NUM
dpc-2081	112	27	23	23	NUM
dpc-2081	112	28	.5	.5	NUM
dpc-2081	112	29	22	22	NUM
dpc-2081	112	30	.3	.3	NUM
dpc-2081	113	1	n	n	PRON
dpc-2081	114	1	c	c	NOUN
dpc-2081	114	2	e	e	NOUN
dpc-2081	114	3	pa	pa	PROPN
dpc-2081	114	4	t	t	PROPN
dpc-2081	114	5	pi	pi	PROPN
dpc-2081	114	6	ii	ii	PROPN
dpc-2081	114	7	m	m	PROPN
dpc-2081	114	8	s	s	PROPN
dpc-2081	114	9	a	a	PRON
dpc-2081	114	10	+	+	X
dpc-2081	114	11	+	+	PUNCT
dpc-2081	114	12	+	+	PUNCT
dpc-2081	114	13	+	+	CCONJ
dpc-2081	114	14	a	a	DET
dpc-2081	114	15	w	w	NOUN
dpc-2081	114	16	ai	ai	PROPN
dpc-2081	114	17	st	st	PROPN
dpc-2081	114	18	c	c	PROPN
dpc-2081	114	19	ir	ir	PROPN
dpc-2081	114	20	cu	cu	PROPN
dpc-2081	114	21	m	m	PROPN
dpc-2081	114	22	fe	fe	X
dpc-2081	114	23	re	re	X
dpc-2081	114	24	nc	nc	PROPN
dpc-2081	114	25	e	e	PROPN
dpc-2081	114	26	(	(	PUNCT
dpc-2081	114	27	c	c	NOUN
dpc-2081	114	28	m	m	VERB
dpc-2081	114	29	)	)	PUNCT
dpc-2081	114	30	87	87	NUM
dpc-2081	114	31	94	94	NUM
dpc-2081	114	32	11	11	NUM
dpc-2081	114	33	5	5	NUM
dpc-2081	114	34	98	98	NUM
dpc-2081	114	35	84	84	NUM
dpc-2081	114	36	11	11	NUM
dpc-2081	114	37	5	5	NUM
dpc-2081	114	38	13	13	NUM
dpc-2081	114	39	5	5	NUM
dpc-2081	114	40	12	12	NUM
dpc-2081	114	41	2	2	NUM
dpc-2081	114	42	11	11	NUM
dpc-2081	114	43	0	0	NUM
dpc-2081	115	1	a	a	DET
dpc-2081	115	2	t	t	X
dpc-2081	115	3	ri	ri	PROPN
dpc-2081	115	4	gl	gl	INTJ
dpc-2081	115	5	ic	ic	INTJ
dpc-2081	115	6	er	er	INTJ
dpc-2081	115	7	yd	yd	INTJ
dpc-2081	115	8	e	e	PROPN
dpc-2081	115	9	(	(	PUNCT
dpc-2081	115	10	m	m	NOUN
dpc-2081	115	11	g/	g/	NOUN
dpc-2081	115	12	dl	dl	PROPN
dpc-2081	115	13	)	)	PUNCT
dpc-2081	115	14	22	22	NUM
dpc-2081	115	15	5	5	NUM
dpc-2081	115	16	17	17	NUM
dpc-2081	115	17	9	9	NUM
dpc-2081	115	18	43	43	NUM
dpc-2081	115	19	0	0	NUM
dpc-2081	115	20	32	32	NUM
dpc-2081	115	21	0	0	NUM
dpc-2081	115	22	17	17	NUM
dpc-2081	115	23	5	5	NUM
dpc-2081	115	24	23	23	NUM
dpc-2081	115	25	5	5	NUM
dpc-2081	115	26	39	39	NUM
dpc-2081	115	27	1	1	NUM
dpc-2081	115	28	25	25	NUM
dpc-2081	115	29	9	9	NUM
dpc-2081	115	30	19	19	NUM
dpc-2081	115	31	4	4	NUM
dpc-2081	115	32	a	a	DET
dpc-2081	115	33	h	h	NOUN
dpc-2081	115	34	d	d	NOUN
dpc-2081	115	35	l	l	NOUN
dpc-2081	115	36	-c	-c	PUNCT
dpc-2081	115	37	(	(	PUNCT
dpc-2081	115	38	m	m	NOUN
dpc-2081	115	39	g/	g/	NOUN
dpc-2081	115	40	dl	dl	PROPN
dpc-2081	115	41	)	)	PUNCT
dpc-2081	115	42	30	30	NUM
dpc-2081	115	43	35	35	NUM
dpc-2081	115	44	34	34	NUM
dpc-2081	115	45	32	32	NUM
dpc-2081	115	46	35	35	NUM
dpc-2081	115	47	40	40	NUM
dpc-2081	115	48	40	40	NUM
dpc-2081	115	49	43	43	NUM
dpc-2081	115	50	59	59	NUM
dpc-2081	115	51	a	a	DET
dpc-2081	115	52	b	b	PROPN
dpc-2081	115	53	lo	lo	NOUN
dpc-2081	115	54	od	od	PROPN
dpc-2081	115	55	p	p	PROPN
dpc-2081	115	56	re	re	VERB
dpc-2081	115	57	ss	ss	INTJ
dpc-2081	115	58	ur	ur	INTJ
dpc-2081	115	59	e	e	PROPN
dpc-2081	115	60	>	>	PROPN
dpc-2081	115	61	1	1	NUM
dpc-2081	115	62	30	30	NUM
dpc-2081	115	63	/8	/8	NUM
dpc-2081	115	64	5	5	NUM
dpc-2081	115	65	m	m	NOUN
dpc-2081	115	66	m	m	VERB
dpc-2081	115	67	h	h	NOUN
dpc-2081	115	68	g	g	PROPN
dpc-2081	115	69	+	+	PROPN
dpc-2081	115	70	+	+	PUNCT
dpc-2081	115	71	+	+	CCONJ
dpc-2081	115	72	a	a	DET
dpc-2081	115	73	f	f	NOUN
dpc-2081	115	74	as	as	ADP
dpc-2081	115	75	ti	ti	PROPN
dpc-2081	115	76	ng	ng	PROPN
dpc-2081	115	77	g	g	PROPN
dpc-2081	115	78	lu	lu	PROPN
dpc-2081	115	79	co	co	PROPN
dpc-2081	115	80	se	se	X
dpc-2081	115	81	(	(	PUNCT
dpc-2081	115	82	m	m	VERB
dpc-2081	115	83	g/	g/	NOUN
dpc-2081	115	84	dl	dl	PROPN
dpc-2081	115	85	)	)	PUNCT
dpc-2081	115	86	89	89	NUM
dpc-2081	115	87	91	91	NUM
dpc-2081	115	88	18	18	NUM
dpc-2081	115	89	8	8	NUM
dpc-2081	115	90	10	10	NUM
dpc-2081	115	91	3	3	NUM
dpc-2081	115	92	95	95	NUM
dpc-2081	115	93	81	81	NUM
dpc-2081	115	94	12	12	NUM
dpc-2081	115	95	1	1	NUM
dpc-2081	115	96	99	99	NUM
dpc-2081	115	97	73	73	NUM
dpc-2081	115	98	a	a	DET
dpc-2081	115	99	ct	ct	NOUN
dpc-2081	115	100	iv	iv	NUM
dpc-2081	115	101	e	e	NOUN
dpc-2081	115	102	sm	sm	INTJ
dpc-2081	115	103	ok	ok	INTJ
dpc-2081	115	104	er	er	INTJ
dpc-2081	116	1	+	+	X
dpc-2081	116	2	+	+	PUNCT
dpc-2081	116	3	+	+	PUNCT
dpc-2081	116	4	+	+	PUNCT
dpc-2081	116	5	+	+	PUNCT
dpc-2081	116	6	+	+	CCONJ
dpc-2081	116	7	+	+	NUM
dpc-2081	116	8	h	h	VERB
dpc-2081	116	9	ur	ur	INTJ
dpc-2081	116	10	le	le	PROPN
dpc-2081	116	11	y	y	PROPN
dpc-2081	116	12	st	st	PROPN
dpc-2081	116	13	ag	ag	PROPN
dpc-2081	116	14	e	e	PROPN
dpc-2081	116	15	1	1	NUM
dpc-2081	116	16	3	3	NUM
dpc-2081	116	17	3	3	NUM
dpc-2081	116	18	2	2	NUM
dpc-2081	116	19	3	3	NUM
dpc-2081	116	20	2	2	NUM
dpc-2081	116	21	3	3	NUM
dpc-2081	116	22	3	3	NUM
dpc-2081	116	23	2	2	NUM
dpc-2081	116	24	c	c	VERB
dpc-2081	116	25	ur	ur	INTJ
dpc-2081	116	26	re	re	VERB
dpc-2081	116	27	nt	not	PART
dpc-2081	116	28	pa	pa	PROPN
dpc-2081	116	29	si	si	PROPN
dpc-2081	117	1	:1	:1	PUNCT
dpc-2081	117	2	.5	.5	NUM
dpc-2081	117	3	ih	ih	PROPN
dpc-2081	117	4	s4	s4	PROPN
dpc-2081	117	5	s	s	PART
dpc-2081	117	6	co	co	X
dpc-2081	117	7	re	re	PROPN
dpc-2081	117	8	6	6	NUM
dpc-2081	117	9	15	15	NUM
dpc-2081	117	10	18	18	NUM
dpc-2081	117	11	11	11	NUM
dpc-2081	117	12	14	14	NUM
dpc-2081	117	13	4	4	NUM
dpc-2081	117	14	9	9	NUM
dpc-2081	117	15	12	12	NUM
dpc-2081	117	16	3	3	NUM
dpc-2081	117	17	d	d	NOUN
dpc-2081	117	18	ur	ur	INTJ
dpc-2081	117	19	at	at	ADP
dpc-2081	117	20	io	io	PROPN
dpc-2081	117	21	n	n	ADP
dpc-2081	117	22	of	of	ADP
dpc-2081	117	23	h	h	NOUN
dpc-2081	117	24	s/	s/	NOUN
dpc-2081	117	25	ps	ps	PROPN
dpc-2081	117	26	or	or	CCONJ
dpc-2081	117	27	ia	ia	PROPN
dpc-2081	117	28	si	si	X
dpc-2081	117	29	s	s	PROPN
dpc-2081	117	30	(	(	PUNCT
dpc-2081	117	31	y	y	PROPN
dpc-2081	117	32	ea	ea	PROPN
dpc-2081	117	33	rs	rs	PROPN
dpc-2081	117	34	)	)	PUNCT
dpc-2081	117	35	10	10	NUM
dpc-2081	117	36	4	4	NUM
dpc-2081	117	37	6	6	NUM
dpc-2081	117	38	20	20	NUM
dpc-2081	117	39	20	20	NUM
dpc-2081	117	40	6	6	NUM
dpc-2081	117	41	5	5	NUM
dpc-2081	117	42	0	0	NUM
dpc-2081	117	43	,	,	PUNCT
dpc-2081	117	44	5	5	NUM
dpc-2081	117	45	12	12	NUM
dpc-2081	117	46	9	9	NUM
dpc-2081	117	47	d	d	NOUN
dpc-2081	117	48	ur	ur	INTJ
dpc-2081	117	49	at	at	ADP
dpc-2081	117	50	io	io	PROPN
dpc-2081	117	51	n	n	PROPN
dpc-2081	117	52	of	of	ADP
dpc-2081	117	53	b	b	PROPN
dpc-2081	117	54	d	d	PROPN
dpc-2081	117	55	(	(	PUNCT
dpc-2081	117	56	ye	ye	PROPN
dpc-2081	117	57	ar	ar	PROPN
dpc-2081	117	58	s	s	PROPN
dpc-2081	117	59	)	)	PUNCT
dpc-2081	117	60	12	12	NUM
dpc-2081	117	61	7	7	NUM
dpc-2081	117	62	2	2	NUM
dpc-2081	117	63	2	2	NUM
dpc-2081	117	64	10	10	NUM
dpc-2081	117	65	6	6	NUM
dpc-2081	117	66	16	16	NUM
dpc-2081	117	67	4	4	NUM
dpc-2081	117	68	15	15	NUM
dpc-2081	117	69	6	6	NUM
dpc-2081	117	70	12	12	NUM
dpc-2081	117	71	c	c	NOUN
dpc-2081	117	72	ur	ur	INTJ
dpc-2081	118	1	re	re	AUX
dpc-2081	118	2	nt	not	PART
dpc-2081	118	3	t	t	PROPN
dpc-2081	118	4	re	re	PROPN
dpc-2081	118	5	at	at	ADP
dpc-2081	118	6	m	m	PROPN
dpc-2081	118	7	en	en	ADP
dpc-2081	118	8	th	th	X
dpc-2081	118	9	s	s	X
dpc-2081	119	1	d	d	X
dpc-2081	119	2	ox	ox	NOUN
dpc-2081	119	3	y	y	PROPN
dpc-2081	119	4	a	a	PROPN
dpc-2081	119	5	d	d	X
dpc-2081	119	6	a	a	PRON
dpc-2081	119	7	,	,	PUNCT
dpc-2081	119	8	2	2	NUM
dpc-2081	119	9	y	y	PROPN
dpc-2081	119	10	ea	ea	NOUN
dpc-2081	119	11	rs	rs	NOUN
dpc-2081	119	12	a	a	DET
dpc-2081	119	13	d	d	NOUN
dpc-2081	119	14	a	a	PRON
dpc-2081	119	15	,	,	PUNCT
dpc-2081	119	16	2	2	NUM
dpc-2081	119	17	ye	ye	NUM
dpc-2081	119	18	ar	ar	NOUN
dpc-2081	119	19	s	s	PROPN
dpc-2081	119	20	d	d	PROPN
dpc-2081	119	21	ox	ox	PROPN
dpc-2081	119	22	y	y	PROPN
dpc-2081	119	23	,	,	PUNCT
dpc-2081	119	24	s	s	VERB
dpc-2081	119	25	ur	ur	INTJ
dpc-2081	119	26	ge	ge	PROPN
dpc-2081	119	27	ry	ry	PROPN
dpc-2081	119	28	a	a	PROPN
dpc-2081	119	29	d	d	PROPN
dpc-2081	119	30	a	a	PRON
dpc-2081	119	31	,	,	PUNCT
dpc-2081	119	32	4	4	NUM
dpc-2081	119	33	ye	ye	NOUN
dpc-2081	119	34	ar	ar	PROPN
dpc-2081	119	35	s	s	PROPN
dpc-2081	119	36	d	d	PROPN
dpc-2081	119	37	ox	ox	NOUN
dpc-2081	119	38	y	y	PROPN
dpc-2081	120	1	a	a	PROPN
dpc-2081	120	2	d	d	X
dpc-2081	120	3	a	a	PRON
dpc-2081	120	4	,	,	PUNCT
dpc-2081	120	5	6	6	NUM
dpc-2081	120	6	m	m	NOUN
dpc-2081	120	7	on	on	ADP
dpc-2081	120	8	th	th	NUM
dpc-2081	120	9	s	s	VERB
dpc-2081	120	10	a	a	DET
dpc-2081	120	11	d	d	PROPN
dpc-2081	120	12	a	a	PRON
dpc-2081	120	13	,	,	PUNCT
dpc-2081	120	14	6	6	NUM
dpc-2081	120	15	m	m	NOUN
dpc-2081	120	16	on	on	ADP
dpc-2081	120	17	th	th	NUM
dpc-2081	120	18	s	s	X
dpc-2081	120	19	d	d	X
dpc-2081	120	20	ox	ox	NOUN
dpc-2081	120	21	y	y	PROPN
dpc-2081	120	22	c	c	X
dpc-2081	120	23	er	er	INTJ
dpc-2081	120	24	to	to	ADP
dpc-2081	120	25	liz	liz	PROPN
dpc-2081	120	26	um	um	INTJ
dpc-2081	120	27	ab	ab	PROPN
dpc-2081	120	28	pe	pe	PROPN
dpc-2081	120	29	go	go	VERB
dpc-2081	120	30	l	l	PROPN
dpc-2081	121	1	c	c	AUX
dpc-2081	121	2	ur	ur	INTJ
dpc-2081	121	3	re	re	VERB
dpc-2081	121	4	nt	not	PART
dpc-2081	121	5	t	t	PROPN
dpc-2081	121	6	re	re	PROPN
dpc-2081	121	7	at	at	ADP
dpc-2081	121	8	m	m	PROPN
dpc-2081	121	9	en	en	ADP
dpc-2081	121	10	tb	tb	X
dpc-2081	121	11	d	d	X
dpc-2081	121	12	l	l	NOUN
dpc-2081	122	1	it	it	PRON
dpc-2081	122	2	hi	hi	INTJ
dpc-2081	122	3	um	um	INTJ
dpc-2081	122	4	,	,	PUNCT
dpc-2081	122	5	so	so	CCONJ
dpc-2081	122	6	di	di	INTJ
dpc-2081	122	7	um	um	INTJ
dpc-2081	122	8	va	va	PROPN
dpc-2081	122	9	lp	lp	NOUN
dpc-2081	122	10	ro	ro	X
dpc-2081	122	11	at	at	ADP
dpc-2081	122	12	e	e	PROPN
dpc-2081	122	13	,	,	PUNCT
dpc-2081	122	14	qu	qu	PROPN
dpc-2081	122	15	et	et	PROPN
dpc-2081	122	16	ia	ia	PROPN
dpc-2081	122	17	pi	pi	PROPN
dpc-2081	122	18	ne	ne	PROPN
dpc-2081	122	19	,	,	PUNCT
dpc-2081	122	20	bu	bu	ADP
dpc-2081	122	21	pr	pr	ADP
dpc-2081	122	22	op	op	NOUN
dpc-2081	122	23	io	io	PROPN
dpc-2081	122	24	n	n	ADV
dpc-2081	123	1	l	l	NOUN
dpc-2081	124	1	it	it	PRON
dpc-2081	124	2	hi	hi	INTJ
dpc-2081	124	3	um	um	INTJ
dpc-2081	124	4	,	,	PUNCT
dpc-2081	124	5	z	z	NOUN
dpc-2081	124	6	ip	ip	NOUN
dpc-2081	124	7	ra	ra	PROPN
dpc-2081	124	8	si	si	X
dpc-2081	124	9	do	do	AUX
dpc-2081	124	10	ne	ne	PROPN
dpc-2081	124	11	hy	hy	PROPN
dpc-2081	124	12	dr	dr	PROPN
dpc-2081	124	13	oc	oc	PROPN
dpc-2081	124	14	hl	hl	PROPN
dpc-2081	124	15	or	or	CCONJ
dpc-2081	124	16	i	i	PROPN
dpc-2081	124	17	d	d	PROPN
dpc-2081	124	18	e	e	PROPN
dpc-2081	124	19	l	l	NOUN
dpc-2081	124	20	it	it	PRON
dpc-2081	124	21	hi	hi	INTJ
dpc-2081	124	22	um	um	INTJ
dpc-2081	124	23	,	,	PUNCT
dpc-2081	124	24	qu	qu	PROPN
dpc-2081	124	25	et	et	PROPN
dpc-2081	124	26	ia	ia	PROPN
dpc-2081	124	27	pi	pi	PROPN
dpc-2081	124	28	ne	ne	PROPN
dpc-2081	124	29	t	t	PROPN
dpc-2081	124	30	ri	ri	PROPN
dpc-2081	124	31	flu	flu	PROPN
dpc-2081	124	32	op	op	PROPN
dpc-2081	124	33	er	er	INTJ
dpc-2081	124	34	az	az	PROPN
dpc-2081	124	35	in	in	ADP
dpc-2081	124	36	e	e	PROPN
dpc-2081	124	37	hy	hy	PROPN
dpc-2081	124	38	dr	dr	PROPN
dpc-2081	124	39	oc	oc	PROPN
dpc-2081	124	40	hl	hl	PROPN
dpc-2081	124	41	or	or	CCONJ
dpc-2081	124	42	i	i	PROPN
dpc-2081	124	43	d	d	PROPN
dpc-2081	124	44	e	e	PROPN
dpc-2081	124	45	,	,	PUNCT
dpc-2081	125	1	v	v	X
dpc-2081	125	2	en	en	X
dpc-2081	125	3	la	la	PROPN
dpc-2081	125	4	fa	fa	X
dpc-2081	125	5	xi	xi	PROPN
dpc-2081	125	6	ne	ne	PROPN
dpc-2081	125	7	l	l	NOUN
dpc-2081	126	1	it	it	PRON
dpc-2081	126	2	hi	hi	INTJ
dpc-2081	126	3	um	um	INTJ
dpc-2081	126	4	,	,	PUNCT
dpc-2081	126	5	la	la	PROPN
dpc-2081	126	6	m	m	VERB
dpc-2081	126	7	ot	ot	INTJ
dpc-2081	126	8	ri	ri	PROPN
dpc-2081	126	9	gi	gi	INTJ
dpc-2081	126	10	ne	ne	PROPN
dpc-2081	126	11	so	so	ADV
dpc-2081	126	12	di	di	INTJ
dpc-2081	126	13	um	um	INTJ
dpc-2081	126	14	va	va	PROPN
dpc-2081	126	15	lp	lp	NOUN
dpc-2081	126	16	ro	ro	X
dpc-2081	126	17	at	at	ADP
dpc-2081	126	18	e	e	NOUN
dpc-2081	126	19	,	,	PUNCT
dpc-2081	126	20	ar	ar	NOUN
dpc-2081	126	21	ip	ip	NOUN
dpc-2081	126	22	ip	ip	NOUN
dpc-2081	126	23	ra	ra	PROPN
dpc-2081	126	24	zo	zo	PROPN
dpc-2081	126	25	le	le	X
dpc-2081	126	26	l	l	NOUN
dpc-2081	127	1	it	it	PRON
dpc-2081	127	2	hi	hi	INTJ
dpc-2081	127	3	um	um	INTJ
dpc-2081	127	4	,	,	PUNCT
dpc-2081	127	5	r	r	NOUN
dpc-2081	127	6	is	be	AUX
dpc-2081	127	7	pe	pe	INTJ
dpc-2081	127	8	ri	ri	PROPN
dpc-2081	127	9	do	do	AUX
dpc-2081	127	10	ne	ne	PROPN
dpc-2081	127	11	so	so	ADV
dpc-2081	127	12	di	di	INTJ
dpc-2081	127	13	um	um	INTJ
dpc-2081	127	14	va	va	PROPN
dpc-2081	127	15	lp	lp	NOUN
dpc-2081	127	16	ro	ro	X
dpc-2081	127	17	at	at	ADP
dpc-2081	127	18	e	e	PROPN
dpc-2081	127	19	,	,	PUNCT
dpc-2081	127	20	flu	flu	NOUN
dpc-2081	127	21	ox	ox	NOUN
dpc-2081	127	22	et	et	PROPN
dpc-2081	127	23	in	in	ADP
dpc-2081	127	24	e	e	PROPN
dpc-2081	127	25	so	so	ADV
dpc-2081	127	26	di	di	INTJ
dpc-2081	127	27	um	um	INTJ
dpc-2081	127	28	va	va	PROPN
dpc-2081	127	29	lp	lp	NOUN
dpc-2081	127	30	ro	ro	INTJ
dpc-2081	127	31	at	at	ADP
dpc-2081	127	32	e	e	PROPN
dpc-2081	127	33	so	so	ADV
dpc-2081	127	34	di	di	INTJ
dpc-2081	127	35	um	um	INTJ
dpc-2081	127	36	va	va	PROPN
dpc-2081	127	37	lp	lp	NOUN
dpc-2081	127	38	ro	ro	X
dpc-2081	128	1	at	at	ADP
dpc-2081	128	2	e	e	X
dpc-2081	128	3	l	l	NOUN
dpc-2081	129	1	it	it	PRON
dpc-2081	129	2	hi	hi	INTJ
dpc-2081	129	3	um	um	INTJ
dpc-2081	129	4	c	c	NOUN
dpc-2081	129	5	om	om	PROPN
dpc-2081	129	6	or	or	CCONJ
dpc-2081	129	7	bi	bi	NOUN
dpc-2081	129	8	di	di	NOUN
dpc-2081	129	9	ti	ti	PROPN
dpc-2081	129	10	es	es	X
dpc-2081	129	11	d	d	PROPN
dpc-2081	129	12	m	m	PROPN
dpc-2081	129	13	,	,	PUNCT
dpc-2081	129	14	h	h	NOUN
dpc-2081	129	15	l	l	NOUN
dpc-2081	129	16	h	h	NOUN
dpc-2081	130	1	t	t	PROPN
dpc-2081	130	2	,	,	PUNCT
dpc-2081	130	3	d	d	PROPN
dpc-2081	130	4	m	m	PROPN
dpc-2081	130	5	,	,	PUNCT
dpc-2081	130	6	sp	sp	ADP
dpc-2081	130	7	on	on	ADP
dpc-2081	130	8	dy	dy	X
dpc-2081	130	9	la	la	PROPN
dpc-2081	130	10	rt	rt	PROPN
dpc-2081	130	11	hr	hr	NOUN
dpc-2081	130	12	it	it	PRON
dpc-2081	130	13	is	be	AUX
dpc-2081	130	14	,	,	PUNCT
dpc-2081	130	15	fm	fm	PROPN
dpc-2081	130	16	f	f	PROPN
dpc-2081	130	17	h	h	PROPN
dpc-2081	130	18	l	l	NOUN
dpc-2081	130	19	,	,	PUNCT
dpc-2081	131	1	h	h	PROPN
dpc-2081	131	2	t	t	PROPN
dpc-2081	131	3	gl	gl	PROPN
dpc-2081	131	4	au	au	PROPN
dpc-2081	131	5	co	co	PROPN
dpc-2081	131	6	m	m	PROPN
dpc-2081	131	7	a	a	DET
dpc-2081	131	8	h	h	NOUN
dpc-2081	132	1	t	t	NOUN
dpc-2081	132	2	h	h	NOUN
dpc-2081	133	1	yp	yp	PROPN
dpc-2081	134	1	er	er	INTJ
dpc-2081	134	2	tr	tr	PUNCT
dpc-2081	134	3	ig	ig	PROPN
dpc-2081	134	4	ly	ly	X
dpc-2081	134	5	ce	ce	PROPN
dpc-2081	134	6	ri	ri	PROPN
dpc-2081	134	7	de	de	PROPN
dpc-2081	134	8	m	m	PROPN
dpc-2081	134	9	ia	ia	PROPN
dpc-2081	134	10	a	a	DET
dpc-2081	134	11	da	da	X
dpc-2081	134	12	=	=	PUNCT
dpc-2081	134	13	a	a	DET
dpc-2081	134	14	da	da	PROPN
dpc-2081	134	15	lim	lim	PROPN
dpc-2081	134	16	um	um	INTJ
dpc-2081	134	17	ab	ab	PROPN
dpc-2081	134	18	;	;	PUNCT
dpc-2081	134	19	b	b	X
dpc-2081	134	20	d	d	X
dpc-2081	134	21	=	=	SYM
dpc-2081	134	22	b	b	PROPN
dpc-2081	134	23	ip	ip	NOUN
dpc-2081	134	24	ol	ol	PROPN
dpc-2081	134	25	ar	ar	PROPN
dpc-2081	134	26	d	d	PROPN
dpc-2081	134	27	is	be	AUX
dpc-2081	134	28	or	or	CCONJ
dpc-2081	134	29	de	de	X
dpc-2081	134	30	rs	rs	NOUN
dpc-2081	134	31	;	;	PUNCT
dpc-2081	135	1	b	b	X
dpc-2081	135	2	m	m	VERB
dpc-2081	135	3	i	i	NOUN
dpc-2081	135	4	=	=	PUNCT
dpc-2081	135	5	bo	bo	PROPN
dpc-2081	135	6	dy	dy	X
dpc-2081	135	7	m	m	NOUN
dpc-2081	135	8	as	as	ADP
dpc-2081	135	9	s	s	PRON
dpc-2081	135	10	in	in	ADP
dpc-2081	135	11	de	de	X
dpc-2081	135	12	x	x	X
dpc-2081	135	13	;	;	PUNCT
dpc-2081	135	14	d	d	X
dpc-2081	135	15	ox	ox	NOUN
dpc-2081	135	16	y	y	PROPN
dpc-2081	135	17	=	=	PUNCT
dpc-2081	135	18	do	do	VERB
dpc-2081	135	19	xy	xy	NOUN
dpc-2081	136	1	cy	cy	INTJ
dpc-2081	136	2	cl	cl	NOUN
dpc-2081	136	3	in	in	ADP
dpc-2081	136	4	e	e	NOUN
dpc-2081	136	5	;	;	PUNCT
dpc-2081	136	6	f	f	X
dpc-2081	136	7	=	=	SYM
dpc-2081	136	8	f	f	PROPN
dpc-2081	136	9	em	em	PROPN
dpc-2081	136	10	al	al	PROPN
dpc-2081	136	11	e	e	PROPN
dpc-2081	136	12	;	;	PUNCT
dpc-2081	136	13	m	m	VERB
dpc-2081	136	14	=	=	NOUN
dpc-2081	136	15	m	m	VERB
dpc-2081	136	16	al	al	PROPN
dpc-2081	136	17	e	e	PROPN
dpc-2081	136	18	;	;	PUNCT
dpc-2081	136	19	p	p	X
dpc-2081	136	20	=	=	PUNCT
dpc-2081	136	21	p	p	X
dpc-2081	136	22	at	at	ADP
dpc-2081	136	23	ie	ie	ADV
dpc-2081	136	24	nt	not	PART
dpc-2081	136	25	;	;	PUNCT
dpc-2081	136	26	p	p	NOUN
dpc-2081	136	27	1p9	1p9	NUM
dpc-2081	136	28	=	=	SYM
dpc-2081	137	1	h	h	NOUN
dpc-2081	138	1	i	i	PROPN
dpc-2081	138	2	d	d	PROPN
dpc-2081	138	3	ra	ra	PROPN
dpc-2081	138	4	de	de	PROPN
dpc-2081	138	5	ni	ni	PROPN
dpc-2081	138	6	ti	ti	PROPN
dpc-2081	138	7	s	s	PROPN
dpc-2081	138	8	su	su	NOUN
dpc-2081	139	1	pp	pp	ADV
dpc-2081	139	2	ur	ur	INTJ
dpc-2081	139	3	at	at	ADP
dpc-2081	139	4	iv	iv	NUM
dpc-2081	139	5	a	a	PRON
dpc-2081	139	6	;	;	PUNCT
dpc-2081	140	1	p	p	PROPN
dpc-2081	140	2	10	10	NUM
dpc-2081	140	3	=	=	SYM
dpc-2081	140	4	p	p	NOUN
dpc-2081	140	5	so	so	ADV
dpc-2081	140	6	ri	ri	PROPN
dpc-2081	140	7	as	as	SCONJ
dpc-2081	140	8	is	be	AUX
dpc-2081	140	9	;	;	PUNCT
dpc-2081	140	10	p	p	NOUN
dpc-2081	140	11	11	11	NUM
dpc-2081	140	12	=	=	SYM
dpc-2081	140	13	b	b	PROPN
dpc-2081	140	14	as	as	ADP
dpc-2081	140	15	al	al	PROPN
dpc-2081	140	16	c	c	PROPN
dpc-2081	140	17	el	el	PROPN
dpc-2081	140	18	l	l	PROPN
dpc-2081	140	19	c	c	PROPN
dpc-2081	140	20	ar	ar	PROPN
dpc-2081	140	21	ci	ci	PROPN
dpc-2081	140	22	no	no	PRON
dpc-2081	140	23	m	m	ADV
dpc-2081	140	24	a	a	DET
dpc-2081	140	25	a	a	NOUN
dpc-2081	140	26	n	n	NOUN
dpc-2081	140	27	c	c	NOUN
dpc-2081	140	28	e	e	NOUN
dpc-2081	140	29	pa	pa	PROPN
dpc-2081	140	30	t	t	PROPN
dpc-2081	140	31	pi	pi	PROPN
dpc-2081	140	32	ii	ii	PROPN
dpc-2081	140	33	m	m	NOUN
dpc-2081	140	34	s	s	PART
dpc-2081	140	35	:	:	PUNCT
dpc-2081	140	36	p	p	X
dpc-2081	140	37	re	re	X
dpc-2081	140	38	se	se	PROPN
dpc-2081	140	39	nc	nc	PROPN
dpc-2081	140	40	e	e	PROPN
dpc-2081	140	41	of	of	ADP
dpc-2081	140	42	a	a	DET
dpc-2081	140	43	t	t	X
dpc-2081	140	44	le	le	X
dpc-2081	140	45	as	as	ADP
dpc-2081	140	46	t	t	PROPN
dpc-2081	140	47	3	3	NUM
dpc-2081	140	48	of	of	ADP
dpc-2081	140	49	t	t	PROPN
dpc-2081	140	50	he	he	PRON
dpc-2081	140	51	5	5	NUM
dpc-2081	140	52	it	it	PRON
dpc-2081	140	53	em	em	PRON
dpc-2081	140	54	s	s	VERB
dpc-2081	140	55	m	m	PROPN
dpc-2081	140	56	ar	ar	PROPN
dpc-2081	140	57	ke	ke	PROPN
dpc-2081	140	58	d.	d.	PROPN
dpc-2081	140	59	original	original	ADJ
dpc-2081	140	60	article	article	NOUN
dpc-2081	140	61	|	|	ADV
dpc-2081	140	62	dermatol	dermatol	ADJ
dpc-2081	140	63	pract	pract	NOUN
dpc-2081	140	64	concept	concept	NOUN
dpc-2081	140	65	.	.	PUNCT
dpc-2081	141	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	141	2	5	5	NUM
dpc-2081	141	3	lesions	lesion	NOUN
dpc-2081	141	4	in	in	ADP
dpc-2081	141	5	25	25	NUM
dpc-2081	141	6	%	%	NOUN
dpc-2081	141	7	and	and	CCONJ
dpc-2081	141	8	75	75	NUM
dpc-2081	141	9	%	%	NOUN
dpc-2081	141	10	of	of	ADP
dpc-2081	141	11	the	the	DET
dpc-2081	141	12	patients	patient	NOUN
dpc-2081	141	13	[	[	X
dpc-2081	141	14	2	2	NUM
dpc-2081	141	15	]	]	PUNCT
dpc-2081	141	16	.	.	PUNCT
dpc-2081	142	1	in	in	ADP
dpc-2081	142	2	the	the	DET
dpc-2081	142	3	current	current	ADJ
dpc-2081	142	4	study	study	NOUN
dpc-2081	142	5	,	,	PUNCT
dpc-2081	142	6	six	six	NUM
dpc-2081	142	7	of	of	ADP
dpc-2081	142	8	nine	nine	NUM
dpc-2081	142	9	bd	bd	PROPN
dpc-2081	142	10	patients	patient	NOUN
dpc-2081	142	11	with	with	ADP
dpc-2081	142	12	a	a	DET
dpc-2081	142	13	history	history	NOUN
dpc-2081	142	14	of	of	ADP
dpc-2081	142	15	lithium	lithium	NOUN
dpc-2081	142	16	use	use	NOUN
dpc-2081	142	17	experienced	experience	VERB
dpc-2081	142	18	hs	hs	PROPN
dpc-2081	142	19	exacerbations	exacerbation	NOUN
dpc-2081	142	20	.	.	PUNCT
dpc-2081	143	1	accordingly	accordingly	ADV
dpc-2081	143	2	,	,	PUNCT
dpc-2081	143	3	a	a	DET
dpc-2081	143	4	key	key	ADJ
dpc-2081	143	5	question	question	NOUN
dpc-2081	143	6	for	for	ADP
dpc-2081	143	7	the	the	DET
dpc-2081	143	8	physicians	physician	NOUN
dpc-2081	143	9	encountering	encounter	VERB
dpc-2081	143	10	hs	hs	PROPN
dpc-2081	143	11	and	and	CCONJ
dpc-2081	143	12	bd	bd	PROPN
dpc-2081	143	13	co	co	NOUN
dpc-2081	143	14	-	-	NOUN
dpc-2081	143	15	existence	existence	NOUN
dpc-2081	143	16	is	be	AUX
dpc-2081	143	17	as	as	SCONJ
dpc-2081	143	18	follows	follow	VERB
dpc-2081	143	19	:	:	PUNCT
dpc-2081	143	20	should	should	AUX
dpc-2081	143	21	lithium	lithium	VERB
dpc-2081	143	22	be	be	AUX
dpc-2081	143	23	avoided	avoid	VERB
dpc-2081	143	24	in	in	ADP
dpc-2081	143	25	these	these	DET
dpc-2081	143	26	cases	case	NOUN
dpc-2081	143	27	even	even	ADV
dpc-2081	143	28	in	in	ADP
dpc-2081	143	29	the	the	DET
dpc-2081	143	30	earliest	early	ADJ
dpc-2081	143	31	stages	stage	NOUN
dpc-2081	143	32	of	of	ADP
dpc-2081	143	33	hs	hs	PRON
dpc-2081	143	34	to	to	PART
dpc-2081	143	35	prevent	prevent	VERB
dpc-2081	143	36	hs	hs	PROPN
dpc-2081	143	37	progression	progression	NOUN
dpc-2081	143	38	?	?	PUNCT
dpc-2081	144	1	the	the	DET
dpc-2081	144	2	correct	correct	ADJ
dpc-2081	144	3	response	response	NOUN
dpc-2081	144	4	relies	rely	VERB
dpc-2081	144	5	on	on	ADP
dpc-2081	144	6	each	each	DET
dpc-2081	144	7	patient	patient	NOUN
dpc-2081	144	8	’s	’s	PART
dpc-2081	144	9	individual	individual	ADJ
dpc-2081	144	10	features	feature	NOUN
dpc-2081	144	11	and	and	CCONJ
dpc-2081	144	12	the	the	DET
dpc-2081	144	13	interdisciplinary	interdisciplinary	ADJ
dpc-2081	144	14	interactions	interaction	NOUN
dpc-2081	144	15	.	.	PUNCT
dpc-2081	145	1	considering	consider	VERB
dpc-2081	145	2	other	other	ADJ
dpc-2081	145	3	treatment	treatment	NOUN
dpc-2081	145	4	options	option	NOUN
dpc-2081	145	5	may	may	AUX
dpc-2081	145	6	be	be	AUX
dpc-2081	145	7	more	more	ADV
dpc-2081	145	8	appropriate	appropriate	ADJ
dpc-2081	145	9	,	,	PUNCT
dpc-2081	145	10	if	if	SCONJ
dpc-2081	145	11	not	not	PART
dpc-2081	145	12	,	,	PUNCT
dpc-2081	145	13	indeed	indeed	ADV
dpc-2081	145	14	required	require	VERB
dpc-2081	145	15	for	for	ADP
dpc-2081	145	16	bd	bd	PROPN
dpc-2081	145	17	management	management	PROPN
dpc-2081	145	18	.	.	PUNCT
dpc-2081	146	1	however	however	ADV
dpc-2081	146	2	,	,	PUNCT
dpc-2081	146	3	in	in	ADP
dpc-2081	146	4	the	the	DET
dpc-2081	146	5	current	current	ADJ
dpc-2081	146	6	cohort	cohort	NOUN
dpc-2081	146	7	,	,	PUNCT
dpc-2081	146	8	three	three	NUM
dpc-2081	146	9	cases	case	NOUN
dpc-2081	146	10	never	never	ADV
dpc-2081	146	11	used	use	VERB
dpc-2081	146	12	lithium	lithium	NOUN
dpc-2081	146	13	.	.	PUNCT
dpc-2081	147	1	additionally	additionally	ADV
dpc-2081	147	2	,	,	PUNCT
dpc-2081	147	3	six	six	NUM
dpc-2081	147	4	cases	case	NOUN
dpc-2081	147	5	defined	define	VERB
dpc-2081	147	6	hs	hs	PRON
dpc-2081	147	7	onset	onset	VERB
dpc-2081	147	8	before	before	ADP
dpc-2081	147	9	or	or	CCONJ
dpc-2081	147	10	concurrent	concurrent	ADJ
dpc-2081	147	11	with	with	ADP
dpc-2081	147	12	bd	bd	PROPN
dpc-2081	147	13	diagnosis	diagnosis	NOUN
dpc-2081	147	14	,	,	PUNCT
dpc-2081	147	15	highlighting	highlight	VERB
dpc-2081	147	16	additional	additional	ADJ
dpc-2081	147	17	factors	factor	NOUN
dpc-2081	147	18	’	'	PUNCT
dpc-2081	147	19	contribution	contribution	NOUN
dpc-2081	147	20	.	.	PUNCT
dpc-2081	148	1	some	some	DET
dpc-2081	148	2	immunological	immunological	ADJ
dpc-2081	148	3	studies	study	NOUN
dpc-2081	148	4	have	have	AUX
dpc-2081	148	5	highlighted	highlight	VERB
dpc-2081	148	6	the	the	DET
dpc-2081	148	7	increased	increase	VERB
dpc-2081	148	8	level	level	NOUN
dpc-2081	148	9	of	of	ADP
dpc-2081	148	10	tumor	tumor	NOUN
dpc-2081	148	11	necrosis	necrosis	NOUN
dpc-2081	148	12	factor	factor	NOUN
dpc-2081	148	13	-	-	PUNCT
dpc-2081	148	14	alpha	alpha	NOUN
dpc-2081	148	15	(	(	PUNCT
dpc-2081	148	16	tnf)-α	tnf)-α	PROPN
dpc-2081	148	17	,	,	PUNCT
dpc-2081	148	18	soluble	soluble	ADJ
dpc-2081	148	19	interleukin	interleukin	NOUN
dpc-2081	148	20	(	(	PUNCT
dpc-2081	148	21	il)-2	il)-2	NOUN
dpc-2081	148	22	receptor	receptor	NOUN
dpc-2081	148	23	,	,	PUNCT
dpc-2081	148	24	soluble	soluble	ADJ
dpc-2081	148	25	tnf	tnf	PROPN
dpc-2081	148	26	receptor	receptor	NOUN
dpc-2081	148	27	1	1	NUM
dpc-2081	148	28	(	(	PUNCT
dpc-2081	148	29	tnfr1	tnfr1	NOUN
dpc-2081	148	30	)	)	PUNCT
dpc-2081	148	31	,	,	PUNCT
dpc-2081	148	32	il-26	il-26	PUNCT
dpc-2081	148	33	and	and	CCONJ
dpc-2081	148	34	il-6	il-6	NOUN
dpc-2081	148	35	levels	level	NOUN
dpc-2081	148	36	in	in	ADP
dpc-2081	148	37	bd	bd	PROPN
dpc-2081	148	38	,	,	PUNCT
dpc-2081	148	39	just	just	ADV
dpc-2081	148	40	as	as	SCONJ
dpc-2081	148	41	hs	hs	PROPN
dpc-2081	148	42	[	[	X
dpc-2081	148	43	2,8,29	2,8,29	NUM
dpc-2081	148	44	]	]	X
dpc-2081	148	45	.	.	PUNCT
dpc-2081	149	1	hs	hs	PROPN
dpc-2081	149	2	is	be	AUX
dpc-2081	149	3	distinguished	distinguish	VERB
dpc-2081	149	4	among	among	ADP
dpc-2081	149	5	other	other	ADJ
dpc-2081	149	6	inflammatory	inflammatory	ADJ
dpc-2081	149	7	skin	skin	NOUN
dpc-2081	149	8	diseases	disease	NOUN
dpc-2081	149	9	related	relate	VERB
dpc-2081	149	10	to	to	ADP
dpc-2081	149	11	the	the	DET
dpc-2081	149	12	substantially	substantially	ADV
dpc-2081	149	13	increased	increase	VERB
dpc-2081	149	14	cytokine	cytokine	ADJ
dpc-2081	149	15	burden	burden	NOUN
dpc-2081	149	16	[	[	X
dpc-2081	149	17	30	30	NUM
dpc-2081	149	18	]	]	PUNCT
dpc-2081	149	19	.	.	PUNCT
dpc-2081	150	1	thus	thus	ADV
dpc-2081	150	2	,	,	PUNCT
dpc-2081	150	3	the	the	DET
dpc-2081	150	4	cns	cns	PROPN
dpc-2081	150	5	effects	effect	NOUN
dpc-2081	150	6	of	of	ADP
dpc-2081	150	7	the	the	DET
dpc-2081	150	8	altered	alter	VERB
dpc-2081	150	9	cytokine	cytokine	NOUN
dpc-2081	150	10	pattern	pattern	NOUN
dpc-2081	150	11	may	may	AUX
dpc-2081	150	12	be	be	AUX
dpc-2081	150	13	more	more	ADV
dpc-2081	150	14	pronounced	pronounced	ADJ
dpc-2081	150	15	compared	compare	VERB
dpc-2081	150	16	to	to	ADP
dpc-2081	150	17	other	other	ADJ
dpc-2081	150	18	inflammatory	inflammatory	ADJ
dpc-2081	150	19	skin	skin	NOUN
dpc-2081	150	20	diseases	disease	NOUN
dpc-2081	150	21	.	.	PUNCT
dpc-2081	151	1	upon	upon	SCONJ
dpc-2081	151	2	study	study	NOUN
dpc-2081	151	3	design	design	NOUN
dpc-2081	151	4	,	,	PUNCT
dpc-2081	151	5	to	to	PART
dpc-2081	151	6	search	search	VERB
dpc-2081	151	7	for	for	ADP
dpc-2081	151	8	the	the	DET
dpc-2081	151	9	confounding	confound	VERB
dpc-2081	151	10	role	role	NOUN
dpc-2081	151	11	of	of	ADP
dpc-2081	151	12	chronic	chronic	ADJ
dpc-2081	151	13	inflammation	inflammation	NOUN
dpc-2081	151	14	on	on	ADP
dpc-2081	151	15	bd	bd	PROPN
dpc-2081	151	16	,	,	PUNCT
dpc-2081	151	17	the	the	DET
dpc-2081	151	18	authors	author	NOUN
dpc-2081	151	19	selected	select	VERB
dpc-2081	151	20	the	the	DET
dpc-2081	151	21	age	age	NOUN
dpc-2081	151	22	and	and	CCONJ
dpc-2081	151	23	gender	gender	NOUN
dpc-2081	151	24	-	-	PUNCT
dpc-2081	151	25	matched	match	VERB
dpc-2081	151	26	controls	control	NOUN
dpc-2081	151	27	from	from	ADP
dpc-2081	151	28	psoriasis	psoriasis	NOUN
dpc-2081	151	29	patients	patient	NOUN
dpc-2081	151	30	,	,	PUNCT
dpc-2081	151	31	the	the	DET
dpc-2081	151	32	prototypic	prototypic	ADJ
dpc-2081	151	33	chronic	chronic	ADJ
dpc-2081	151	34	inflammatory	inflammatory	ADJ
dpc-2081	151	35	skin	skin	NOUN
dpc-2081	151	36	disease	disease	NOUN
dpc-2081	151	37	which	which	PRON
dpc-2081	151	38	is	be	AUX
dpc-2081	151	39	also	also	ADV
dpc-2081	151	40	linked	link	VERB
dpc-2081	151	41	to	to	ADP
dpc-2081	151	42	metabolic	metabolic	NOUN
dpc-2081	151	43	syndrome	syndrome	NOUN
dpc-2081	151	44	and	and	CCONJ
dpc-2081	151	45	obesity	obesity	NOUN
dpc-2081	151	46	[	[	X
dpc-2081	151	47	31	31	NUM
dpc-2081	151	48	]	]	PUNCT
dpc-2081	151	49	.	.	PUNCT
dpc-2081	152	1	moreover	moreover	ADV
dpc-2081	152	2	,	,	PUNCT
dpc-2081	152	3	another	another	DET
dpc-2081	152	4	control	control	NOUN
dpc-2081	152	5	group	group	NOUN
dpc-2081	152	6	was	be	AUX
dpc-2081	152	7	assigned	assign	VERB
dpc-2081	152	8	among	among	ADP
dpc-2081	152	9	outpatients	outpatient	NOUN
dpc-2081	152	10	without	without	ADP
dpc-2081	152	11	a	a	DET
dpc-2081	152	12	chronic	chronic	ADJ
dpc-2081	152	13	inflammatory	inflammatory	ADJ
dpc-2081	152	14	skin	skin	NOUN
dpc-2081	152	15	and/or	and/or	CCONJ
dpc-2081	152	16	systemic	systemic	ADJ
dpc-2081	152	17	disease	disease	NOUN
dpc-2081	152	18	.	.	PUNCT
dpc-2081	153	1	the	the	DET
dpc-2081	153	2	results	result	NOUN
dpc-2081	153	3	of	of	ADP
dpc-2081	153	4	the	the	DET
dpc-2081	153	5	study	study	NOUN
dpc-2081	153	6	pointed	point	VERB
dpc-2081	153	7	out	out	ADP
dpc-2081	153	8	an	an	DET
dpc-2081	153	9	increased	increase	VERB
dpc-2081	153	10	prevalence	prevalence	NOUN
dpc-2081	153	11	of	of	ADP
dpc-2081	153	12	bd	bd	PROPN
dpc-2081	153	13	in	in	ADP
dpc-2081	153	14	only	only	ADV
dpc-2081	153	15	hs	hs	PROPN
dpc-2081	153	16	patients	patient	NOUN
dpc-2081	153	17	but	but	CCONJ
dpc-2081	153	18	not	not	PART
dpc-2081	153	19	psoriasis	psoriasis	NOUN
dpc-2081	153	20	patients	patient	NOUN
dpc-2081	153	21	compared	compare	VERB
dpc-2081	153	22	to	to	ADP
dpc-2081	153	23	that	that	PRON
dpc-2081	153	24	of	of	ADP
dpc-2081	153	25	the	the	DET
dpc-2081	153	26	control	control	NOUN
dpc-2081	153	27	group	group	NOUN
dpc-2081	153	28	.	.	PUNCT
dpc-2081	154	1	the	the	DET
dpc-2081	154	2	association	association	NOUN
dpc-2081	154	3	between	between	ADP
dpc-2081	154	4	the	the	DET
dpc-2081	154	5	inflammatory	inflammatory	ADJ
dpc-2081	154	6	cytokines	cytokine	NOUN
dpc-2081	154	7	and	and	CCONJ
dpc-2081	154	8	bd	bd	PROPN
dpc-2081	154	9	warrants	warrant	NOUN
dpc-2081	154	10	further	further	ADJ
dpc-2081	154	11	investigation	investigation	NOUN
dpc-2081	154	12	related	relate	VERB
dpc-2081	154	13	to	to	ADP
dpc-2081	154	14	both	both	CCONJ
dpc-2081	154	15	diagnostic	diagnostic	ADJ
dpc-2081	154	16	and	and	CCONJ
dpc-2081	154	17	also	also	ADV
dpc-2081	154	18	possible	possible	ADJ
dpc-2081	154	19	therapeutic	therapeutic	ADJ
dpc-2081	154	20	insights	insight	NOUN
dpc-2081	154	21	.	.	PUNCT
dpc-2081	155	1	due	due	ADP
dpc-2081	155	2	to	to	ADP
dpc-2081	155	3	the	the	DET
dpc-2081	155	4	shared	share	VERB
dpc-2081	155	5	immunologic	immunologic	ADJ
dpc-2081	155	6	pathways	pathway	NOUN
dpc-2081	155	7	,	,	PUNCT
dpc-2081	155	8	a	a	DET
dpc-2081	155	9	single	single	ADJ
dpc-2081	155	10	immunomodulatory	immunomodulatory	ADJ
dpc-2081	155	11	drug	drug	NOUN
dpc-2081	155	12	has	have	VERB
dpc-2081	155	13	the	the	DET
dpc-2081	155	14	potential	potential	NOUN
dpc-2081	155	15	to	to	PART
dpc-2081	155	16	relieve	relieve	VERB
dpc-2081	155	17	both	both	DET
dpc-2081	155	18	hs	hs	PROPN
dpc-2081	155	19	and	and	CCONJ
dpc-2081	155	20	bd	bd	PROPN
dpc-2081	155	21	symptoms	symptom	NOUN
dpc-2081	155	22	.	.	PUNCT
dpc-2081	156	1	while	while	SCONJ
dpc-2081	156	2	the	the	DET
dpc-2081	156	3	anhedonia	anhedonia	NOUN
dpc-2081	156	4	symptoms	symptom	NOUN
dpc-2081	156	5	of	of	ADP
dpc-2081	156	6	the	the	DET
dpc-2081	156	7	patients	patient	NOUN
dpc-2081	156	8	with	with	ADP
dpc-2081	156	9	bipolar	bipolar	ADJ
dpc-2081	156	10	i	i	PROPN
dpc-2081	156	11	/	/	SYM
dpc-2081	156	12	ii	ii	PROPN
dpc-2081	156	13	depression	depression	NOUN
dpc-2081	156	14	improved	improve	VERB
dpc-2081	156	15	significantly	significantly	ADV
dpc-2081	156	16	under	under	ADP
dpc-2081	156	17	infliximab	infliximab	NOUN
dpc-2081	156	18	[	[	X
dpc-2081	156	19	32	32	NUM
dpc-2081	156	20	]	]	PUNCT
dpc-2081	156	21	,	,	PUNCT
dpc-2081	156	22	no	no	DET
dpc-2081	156	23	clinical	clinical	ADJ
dpc-2081	156	24	improvement	improvement	NOUN
dpc-2081	156	25	was	be	AUX
dpc-2081	156	26	evident	evident	ADJ
dpc-2081	156	27	in	in	ADP
dpc-2081	156	28	resistant	resistant	ADJ
dpc-2081	156	29	depression	depression	NOUN
dpc-2081	156	30	with	with	ADP
dpc-2081	156	31	infliximab	infliximab	NOUN
dpc-2081	156	32	in	in	ADP
dpc-2081	156	33	two	two	NUM
dpc-2081	156	34	other	other	ADJ
dpc-2081	156	35	placebo	placebo	NOUN
dpc-2081	156	36	-	-	PUNCT
dpc-2081	156	37	controlled	control	VERB
dpc-2081	156	38	clinical	clinical	ADJ
dpc-2081	156	39	trials	trial	NOUN
dpc-2081	156	40	[	[	X
dpc-2081	156	41	33,34	33,34	NOUN
dpc-2081	156	42	]	]	X
dpc-2081	156	43	.	.	PUNCT
dpc-2081	157	1	even	even	ADV
dpc-2081	157	2	if	if	SCONJ
dpc-2081	157	3	there	there	PRON
dpc-2081	157	4	is	be	VERB
dpc-2081	157	5	no	no	DET
dpc-2081	157	6	clinical	clinical	ADJ
dpc-2081	157	7	benefit	benefit	NOUN
dpc-2081	157	8	,	,	PUNCT
dpc-2081	157	9	a	a	DET
dpc-2081	157	10	considerable	considerable	ADJ
dpc-2081	157	11	reduction	reduction	NOUN
dpc-2081	157	12	in	in	ADP
dpc-2081	157	13	highly	highly	ADV
dpc-2081	157	14	sensitive	sensitive	ADJ
dpc-2081	157	15	c	c	NOUN
dpc-2081	157	16	-	-	NOUN
dpc-2081	157	17	reactive	reactive	ADJ
dpc-2081	157	18	,	,	PUNCT
dpc-2081	157	19	tnfr1	tnfr1	NOUN
dpc-2081	157	20	,	,	PUNCT
dpc-2081	157	21	and	and	CCONJ
dpc-2081	157	22	nuclear	nuclear	ADJ
dpc-2081	157	23	factor	factor	NOUN
dpc-2081	157	24	-	-	PUNCT
dpc-2081	157	25	kappa	kappa	PROPN
dpc-2081	157	26	b	b	PROPN
dpc-2081	157	27	(	(	PUNCT
dpc-2081	157	28	nf	nf	NOUN
dpc-2081	157	29	-	-	PUNCT
dpc-2081	157	30	κb	κb	NOUN
dpc-2081	157	31	)	)	PUNCT
dpc-2081	157	32	proteins	protein	NOUN
dpc-2081	157	33	were	be	AUX
dpc-2081	157	34	remarkable	remarkable	ADJ
dpc-2081	157	35	for	for	ADP
dpc-2081	157	36	bipolar	bipolar	ADJ
dpc-2081	157	37	depression	depression	NOUN
dpc-2081	157	38	[	[	X
dpc-2081	157	39	34,35	34,35	NOUN
dpc-2081	157	40	]	]	PUNCT
dpc-2081	157	41	.	.	PUNCT
dpc-2081	158	1	currently	currently	ADV
dpc-2081	158	2	,	,	PUNCT
dpc-2081	158	3	the	the	DET
dpc-2081	158	4	only	only	ADJ
dpc-2081	158	5	fda	fda	PROPN
dpc-2081	158	6	-	-	PUNCT
dpc-2081	158	7	approved	approve	VERB
dpc-2081	158	8	treatment	treatment	NOUN
dpc-2081	158	9	for	for	ADP
dpc-2081	158	10	hs	hs	PROPN
dpc-2081	158	11	is	be	AUX
dpc-2081	158	12	adalimumab	adalimumab	NOUN
dpc-2081	158	13	[	[	X
dpc-2081	158	14	1	1	NUM
dpc-2081	158	15	]	]	PUNCT
dpc-2081	158	16	.	.	PUNCT
dpc-2081	159	1	although	although	SCONJ
dpc-2081	159	2	the	the	DET
dpc-2081	159	3	direct	direct	ADJ
dpc-2081	159	4	efficacy	efficacy	NOUN
dpc-2081	159	5	of	of	ADP
dpc-2081	159	6	adalimumab	adalimumab	NOUN
dpc-2081	159	7	on	on	ADP
dpc-2081	159	8	bd	bd	PROPN
dpc-2081	159	9	has	have	AUX
dpc-2081	159	10	not	not	PART
dpc-2081	159	11	been	be	AUX
dpc-2081	159	12	reported	report	VERB
dpc-2081	159	13	,	,	PUNCT
dpc-2081	159	14	the	the	DET
dpc-2081	159	15	available	available	ADJ
dpc-2081	159	16	data	datum	NOUN
dpc-2081	159	17	from	from	ADP
dpc-2081	159	18	crohn	crohn	PROPN
dpc-2081	159	19	disease	disease	PROPN
dpc-2081	159	20	,	,	PUNCT
dpc-2081	159	21	rheumatoid	rheumatoid	NOUN
dpc-2081	159	22	arthritis	arthritis	NOUN
dpc-2081	159	23	,	,	PUNCT
dpc-2081	159	24	and	and	CCONJ
dpc-2081	159	25	ankylosing	ankylose	VERB
dpc-2081	159	26	spondylitis	spondylitis	NOUN
dpc-2081	159	27	cohorts	cohort	NOUN
dpc-2081	159	28	receiving	receive	VERB
dpc-2081	159	29	adalimumab	adalimumab	NOUN
dpc-2081	159	30	report	report	NOUN
dpc-2081	159	31	lower	low	ADJ
dpc-2081	159	32	depression	depression	NOUN
dpc-2081	159	33	scores	score	NOUN
dpc-2081	159	34	,	,	PUNCT
dpc-2081	159	35	improvement	improvement	NOUN
dpc-2081	159	36	in	in	ADP
dpc-2081	159	37	somatic	somatic	ADJ
dpc-2081	159	38	symptoms	symptom	NOUN
dpc-2081	159	39	,	,	PUNCT
dpc-2081	159	40	and	and	CCONJ
dpc-2081	159	41	mental	mental	ADJ
dpc-2081	159	42	scores	score	NOUN
dpc-2081	159	43	amelioration	amelioration	NOUN
dpc-2081	159	44	[	[	X
dpc-2081	159	45	36	36	NUM
dpc-2081	159	46	]	]	PUNCT
dpc-2081	159	47	.	.	PUNCT
dpc-2081	160	1	in	in	ADP
dpc-2081	160	2	the	the	DET
dpc-2081	160	3	current	current	ADJ
dpc-2081	160	4	study	study	NOUN
dpc-2081	160	5	,	,	PUNCT
dpc-2081	160	6	5/9	5/9	NUM
dpc-2081	160	7	patients	patient	NOUN
dpc-2081	160	8	with	with	ADP
dpc-2081	160	9	bd	bd	PROPN
dpc-2081	160	10	and	and	CCONJ
dpc-2081	160	11	hs	hs	PROPN
dpc-2081	160	12	have	have	AUX
dpc-2081	160	13	been	be	AUX
dpc-2081	160	14	taking	take	VERB
dpc-2081	160	15	adalimumab	adalimumab	NOUN
dpc-2081	160	16	for	for	ADP
dpc-2081	160	17	6	6	NUM
dpc-2081	160	18	months	month	NOUN
dpc-2081	160	19	determining	determine	VERB
dpc-2081	160	20	novel	novel	ADJ
dpc-2081	160	21	treatment	treatment	NOUN
dpc-2081	160	22	strategies	strategy	NOUN
dpc-2081	160	23	.	.	PUNCT
dpc-2081	161	1	in	in	ADP
dpc-2081	161	2	this	this	DET
dpc-2081	161	3	study	study	NOUN
dpc-2081	161	4	,	,	PUNCT
dpc-2081	161	5	the	the	DET
dpc-2081	161	6	hs	hs	PROPN
dpc-2081	161	7	patients	patient	NOUN
dpc-2081	161	8	with	with	ADP
dpc-2081	161	9	bd	bd	PROPN
dpc-2081	161	10	were	be	AUX
dpc-2081	161	11	analyzed	analyze	VERB
dpc-2081	161	12	in	in	ADP
dpc-2081	161	13	detail	detail	NOUN
dpc-2081	161	14	for	for	ADP
dpc-2081	161	15	the	the	DET
dpc-2081	161	16	presence	presence	NOUN
dpc-2081	161	17	of	of	ADP
dpc-2081	161	18	common	common	ADJ
dpc-2081	161	19	predisposing	predispose	VERB
dpc-2081	161	20	factors	factor	NOUN
dpc-2081	161	21	.	.	PUNCT
dpc-2081	162	1	of	of	ADP
dpc-2081	162	2	these	these	DET
dpc-2081	162	3	9	9	NUM
dpc-2081	162	4	patients	patient	NOUN
dpc-2081	162	5	,	,	PUNCT
dpc-2081	162	6	4	4	NUM
dpc-2081	162	7	(	(	PUNCT
dpc-2081	162	8	44.4	44.4	NUM
dpc-2081	162	9	%	%	NOUN
dpc-2081	162	10	)	)	PUNCT
dpc-2081	162	11	had	have	VERB
dpc-2081	162	12	metabolic	metabolic	NOUN
dpc-2081	162	13	syndrome	syndrome	NOUN
dpc-2081	162	14	(	(	PUNCT
dpc-2081	162	15	table	table	NOUN
dpc-2081	162	16	2	2	NUM
dpc-2081	162	17	)	)	PUNCT
dpc-2081	162	18	.	.	PUNCT
dpc-2081	163	1	three	three	NUM
dpc-2081	163	2	(	(	PUNCT
dpc-2081	163	3	33.3	33.3	NUM
dpc-2081	163	4	%	%	NOUN
dpc-2081	163	5	)	)	PUNCT
dpc-2081	163	6	patients	patient	NOUN
dpc-2081	163	7	were	be	AUX
dpc-2081	163	8	overweight	overweight	ADJ
dpc-2081	163	9	,	,	PUNCT
dpc-2081	163	10	and	and	CCONJ
dpc-2081	163	11	6	6	NUM
dpc-2081	163	12	(	(	PUNCT
dpc-2081	163	13	66.6	66.6	NUM
dpc-2081	163	14	%	%	NOUN
dpc-2081	163	15	)	)	PUNCT
dpc-2081	163	16	patients	patient	NOUN
dpc-2081	163	17	bmi	bmi	VERB
dpc-2081	163	18	were	be	AUX
dpc-2081	163	19	over	over	ADP
dpc-2081	163	20	30	30	NUM
dpc-2081	163	21	.	.	PUNCT
dpc-2081	164	1	furthermore	furthermore	ADV
dpc-2081	164	2	,	,	PUNCT
dpc-2081	164	3	6	6	NUM
dpc-2081	164	4	(	(	PUNCT
dpc-2081	164	5	66.6	66.6	NUM
dpc-2081	164	6	%	%	NOUN
dpc-2081	164	7	)	)	PUNCT
dpc-2081	164	8	of	of	ADP
dpc-2081	164	9	them	they	PRON
dpc-2081	164	10	were	be	AUX
dpc-2081	164	11	active	active	ADJ
dpc-2081	164	12	smokers	smoker	NOUN
dpc-2081	164	13	.	.	PUNCT
dpc-2081	165	1	these	these	DET
dpc-2081	165	2	findings	finding	NOUN
dpc-2081	165	3	suggest	suggest	VERB
dpc-2081	165	4	the	the	DET
dpc-2081	165	5	contribution	contribution	NOUN
dpc-2081	165	6	of	of	ADP
dpc-2081	165	7	extrinsic	extrinsic	ADJ
dpc-2081	165	8	factors	factor	NOUN
dpc-2081	165	9	to	to	ADP
dpc-2081	165	10	the	the	DET
dpc-2081	165	11	hs	hs	PROPN
dpc-2081	165	12	-	-	PROPN
dpc-2081	165	13	bd	bd	PROPN
dpc-2081	165	14	co	co	NOUN
dpc-2081	165	15	-	-	NOUN
dpc-2081	165	16	existence	existence	NOUN
dpc-2081	165	17	.	.	PUNCT
dpc-2081	166	1	among	among	ADP
dpc-2081	166	2	psychiatric	psychiatric	ADJ
dpc-2081	166	3	research	research	NOUN
dpc-2081	166	4	,	,	PUNCT
dpc-2081	166	5	genome	genome	NOUN
dpc-2081	166	6	wide	wide	ADJ
dpc-2081	166	7	association	association	NOUN
dpc-2081	166	8	studies	study	NOUN
dpc-2081	166	9	(	(	PUNCT
dpc-2081	166	10	gwas	gwas	PROPN
dpc-2081	166	11	)	)	PUNCT
dpc-2081	166	12	have	have	AUX
dpc-2081	166	13	introduced	introduce	VERB
dpc-2081	166	14	interesting	interesting	ADJ
dpc-2081	166	15	perspectives	perspective	NOUN
dpc-2081	166	16	on	on	ADP
dpc-2081	166	17	the	the	DET
dpc-2081	166	18	intricate	intricate	ADJ
dpc-2081	166	19	relationship	relationship	NOUN
dpc-2081	166	20	of	of	ADP
dpc-2081	166	21	psychiatric	psychiatric	ADJ
dpc-2081	166	22	disorders	disorder	NOUN
dpc-2081	166	23	with	with	ADP
dpc-2081	166	24	concurrent	concurrent	ADJ
dpc-2081	166	25	co	co	NOUN
dpc-2081	166	26	-	-	NOUN
dpc-2081	166	27	morbidities	morbidity	NOUN
dpc-2081	166	28	,	,	PUNCT
dpc-2081	166	29	especially	especially	ADV
dpc-2081	166	30	obesity	obesity	NOUN
dpc-2081	166	31	and	and	CCONJ
dpc-2081	166	32	metabolic	metabolic	NOUN
dpc-2081	166	33	syndrome	syndrome	NOUN
dpc-2081	167	1	[	[	X
dpc-2081	167	2	22	22	NUM
dpc-2081	167	3	]	]	PUNCT
dpc-2081	167	4	.	.	PUNCT
dpc-2081	168	1	on	on	ADP
dpc-2081	168	2	the	the	DET
dpc-2081	168	3	other	other	ADJ
dpc-2081	168	4	hand	hand	NOUN
dpc-2081	168	5	,	,	PUNCT
dpc-2081	168	6	more	more	ADV
dpc-2081	168	7	recently	recently	ADV
dpc-2081	168	8	,	,	PUNCT
dpc-2081	168	9	hs	hs	PROPN
dpc-2081	168	10	and	and	CCONJ
dpc-2081	168	11	neuropsychiatric	neuropsychiatric	ADJ
dpc-2081	168	12	disorders	disorder	NOUN
dpc-2081	168	13	’	'	PUNCT
dpc-2081	168	14	possible	possible	ADJ
dpc-2081	168	15	intrinsic	intrinsic	ADJ
dpc-2081	168	16	relationship	relationship	NOUN
dpc-2081	168	17	has	have	AUX
dpc-2081	168	18	become	become	VERB
dpc-2081	168	19	a	a	DET
dpc-2081	168	20	focus	focus	NOUN
dpc-2081	168	21	of	of	ADP
dpc-2081	168	22	attention	attention	NOUN
dpc-2081	168	23	.	.	PUNCT
dpc-2081	169	1	genetic	genetic	ADJ
dpc-2081	169	2	studies	study	NOUN
dpc-2081	169	3	point	point	VERB
dpc-2081	169	4	out	out	ADP
dpc-2081	169	5	shared	share	VERB
dpc-2081	169	6	pathogenesis	pathogenesis	NOUN
dpc-2081	169	7	for	for	ADP
dpc-2081	169	8	hs	hs	PROPN
dpc-2081	169	9	and	and	CCONJ
dpc-2081	169	10	alzheimer	alzheimer	PROPN
dpc-2081	169	11	disease	disease	NOUN
dpc-2081	169	12	(	(	PUNCT
dpc-2081	169	13	ad	ad	NOUN
dpc-2081	169	14	)	)	PUNCT
dpc-2081	169	15	,	,	PUNCT
dpc-2081	169	16	both	both	PRON
dpc-2081	169	17	revealing	reveal	VERB
dpc-2081	169	18	mutations	mutation	NOUN
dpc-2081	169	19	within	within	ADP
dpc-2081	169	20	the	the	DET
dpc-2081	169	21	adjacent	adjacent	ADJ
dpc-2081	169	22	parts	part	NOUN
dpc-2081	169	23	of	of	ADP
dpc-2081	169	24	the	the	DET
dpc-2081	169	25	gammasecretase	gammasecretase	ADJ
dpc-2081	169	26	gene	gene	NOUN
dpc-2081	169	27	[	[	X
dpc-2081	169	28	23	23	NUM
dpc-2081	169	29	]	]	PUNCT
dpc-2081	169	30	.	.	PUNCT
dpc-2081	170	1	however	however	ADV
dpc-2081	170	2	,	,	PUNCT
dpc-2081	170	3	population	population	NOUN
dpc-2081	170	4	-	-	PUNCT
dpc-2081	170	5	based	base	VERB
dpc-2081	170	6	studies	study	NOUN
dpc-2081	170	7	do	do	AUX
dpc-2081	170	8	not	not	PART
dpc-2081	170	9	detect	detect	VERB
dpc-2081	170	10	an	an	DET
dpc-2081	170	11	increased	increase	VERB
dpc-2081	170	12	risk	risk	NOUN
dpc-2081	170	13	of	of	ADP
dpc-2081	170	14	ad	ad	NOUN
dpc-2081	170	15	in	in	ADP
dpc-2081	170	16	hs	hs	PROPN
dpc-2081	170	17	patients	patient	NOUN
dpc-2081	170	18	[	[	X
dpc-2081	170	19	[	[	X
dpc-2081	170	20	24,25	24,25	NUM
dpc-2081	170	21	]	]	PUNCT
dpc-2081	170	22	.	.	PUNCT
dpc-2081	171	1	this	this	PRON
dpc-2081	171	2	is	be	AUX
dpc-2081	171	3	not	not	PART
dpc-2081	171	4	surprising	surprising	ADJ
dpc-2081	171	5	considering	consider	VERB
dpc-2081	171	6	the	the	DET
dpc-2081	171	7	relatively	relatively	ADV
dpc-2081	171	8	younger	young	ADJ
dpc-2081	171	9	age	age	NOUN
dpc-2081	171	10	of	of	ADP
dpc-2081	171	11	hs	h	NOUN
dpc-2081	171	12	 	 	SPACE
dpc-2081	171	13	patients	patient	NOUN
dpc-2081	171	14	.	.	PUNCT
dpc-2081	172	1	bd	bd	PROPN
dpc-2081	172	2	increased	increase	VERB
dpc-2081	172	3	prevalence	prevalence	NOUN
dpc-2081	172	4	among	among	ADP
dpc-2081	172	5	hs	hs	PROPN
dpc-2081	172	6	patients	patient	NOUN
dpc-2081	172	7	emerged	emerge	VERB
dpc-2081	172	8	as	as	ADP
dpc-2081	172	9	another	another	DET
dpc-2081	172	10	relevant	relevant	ADJ
dpc-2081	172	11	topic	topic	NOUN
dpc-2081	172	12	to	to	PART
dpc-2081	172	13	search	search	VERB
dpc-2081	172	14	for	for	ADP
dpc-2081	172	15	an	an	DET
dpc-2081	172	16	intrinsic	intrinsic	ADJ
dpc-2081	172	17	relationship	relationship	NOUN
dpc-2081	172	18	.	.	PUNCT
dpc-2081	173	1	for	for	ADP
dpc-2081	173	2	the	the	DET
dpc-2081	173	3	9	9	NUM
dpc-2081	173	4	patients	patient	NOUN
dpc-2081	173	5	revealing	reveal	VERB
dpc-2081	173	6	hs	hs	PROPN
dpc-2081	173	7	-	-	PROPN
dpc-2081	173	8	bd	bd	PROPN
dpc-2081	173	9	co	co	NOUN
dpc-2081	173	10	-	-	NOUN
dpc-2081	173	11	existence	existence	NOUN
dpc-2081	173	12	,	,	PUNCT
dpc-2081	173	13	4	4	NUM
dpc-2081	173	14	(	(	PUNCT
dpc-2081	173	15	44.4	44.4	NUM
dpc-2081	173	16	%	%	NOUN
dpc-2081	173	17	)	)	PUNCT
dpc-2081	173	18	had	have	VERB
dpc-2081	173	19	a	a	DET
dpc-2081	173	20	positive	positive	ADJ
dpc-2081	173	21	family	family	NOUN
dpc-2081	173	22	history	history	NOUN
dpc-2081	173	23	for	for	ADP
dpc-2081	173	24	hs	hs	PROPN
dpc-2081	173	25	and	and	CCONJ
dpc-2081	173	26	4	4	NUM
dpc-2081	173	27	(	(	PUNCT
dpc-2081	173	28	44.4	44.4	NUM
dpc-2081	173	29	%	%	NOUN
dpc-2081	173	30	)	)	PUNCT
dpc-2081	173	31	had	have	VERB
dpc-2081	173	32	a	a	DET
dpc-2081	173	33	positive	positive	ADJ
dpc-2081	173	34	family	family	NOUN
dpc-2081	173	35	history	history	NOUN
dpc-2081	173	36	for	for	ADP
dpc-2081	173	37	bd	bd	PROPN
dpc-2081	173	38	.	.	PUNCT
dpc-2081	174	1	only	only	ADV
dpc-2081	174	2	two	two	NUM
dpc-2081	174	3	(	(	PUNCT
dpc-2081	174	4	22.2	22.2	NUM
dpc-2081	174	5	%	%	NOUN
dpc-2081	174	6	)	)	PUNCT
dpc-2081	175	1	patients	patient	NOUN
dpc-2081	175	2	reported	report	VERB
dpc-2081	175	3	a	a	DET
dpc-2081	175	4	positive	positive	ADJ
dpc-2081	175	5	family	family	NOUN
dpc-2081	175	6	history	history	NOUN
dpc-2081	175	7	for	for	ADP
dpc-2081	175	8	both	both	DET
dpc-2081	175	9	bd	bd	PROPN
dpc-2081	175	10	and	and	CCONJ
dpc-2081	175	11	hs	hs	PROPN
dpc-2081	175	12	.	.	PROPN
dpc-2081	175	13	scarce	scarce	ADJ
dpc-2081	175	14	data	datum	NOUN
dpc-2081	175	15	exist	exist	VERB
dpc-2081	175	16	on	on	ADP
dpc-2081	175	17	the	the	DET
dpc-2081	175	18	co	co	NOUN
dpc-2081	175	19	-	-	NOUN
dpc-2081	175	20	existence	existence	NOUN
dpc-2081	175	21	of	of	ADP
dpc-2081	175	22	hs	hs	PROPN
dpc-2081	175	23	and	and	CCONJ
dpc-2081	175	24	bd	bd	PROPN
dpc-2081	175	25	.	.	PROPN
dpc-2081	175	26	initially	initially	ADV
dpc-2081	175	27	,	,	PUNCT
dpc-2081	175	28	tzur	tzur	PROPN
dpc-2081	175	29	bitan	bitan	PROPN
dpc-2081	175	30	et	et	PROPN
dpc-2081	175	31	al	al	PROPN
dpc-2081	175	32	.	.	PROPN
dpc-2081	175	33	reported	report	VERB
dpc-2081	175	34	a	a	DET
dpc-2081	175	35	sevenfold	sevenfold	ADJ
dpc-2081	175	36	increase	increase	NOUN
dpc-2081	175	37	in	in	ADP
dpc-2081	175	38	the	the	DET
dpc-2081	175	39	prevalence	prevalence	NOUN
dpc-2081	175	40	of	of	ADP
dpc-2081	175	41	bd	bd	PROPN
dpc-2081	175	42	among	among	ADP
dpc-2081	175	43	hs	hs	PROPN
dpc-2081	175	44	patients	patient	NOUN
dpc-2081	175	45	(	(	PUNCT
dpc-2081	175	46	0.7	0.7	NUM
dpc-2081	175	47	%	%	NOUN
dpc-2081	175	48	,	,	PUNCT
dpc-2081	175	49	29	29	NUM
dpc-2081	175	50	of	of	ADP
dpc-2081	175	51	4,191	4,191	NUM
dpc-2081	175	52	)	)	PUNCT
dpc-2081	175	53	compared	compare	VERB
dpc-2081	175	54	with	with	ADP
dpc-2081	175	55	controls	control	NOUN
dpc-2081	175	56	(	(	PUNCT
dpc-2081	175	57	0.1	0.1	NUM
dpc-2081	175	58	%	%	NOUN
dpc-2081	175	59	)	)	PUNCT
dpc-2081	175	60	in	in	ADP
dpc-2081	175	61	a	a	DET
dpc-2081	175	62	nationwide	nationwide	ADJ
dpc-2081	175	63	population	population	NOUN
dpc-2081	175	64	-	-	PUNCT
dpc-2081	175	65	based	base	VERB
dpc-2081	175	66	study	study	NOUN
dpc-2081	175	67	[	[	X
dpc-2081	175	68	2	2	NUM
dpc-2081	175	69	]	]	PUNCT
dpc-2081	175	70	.	.	PUNCT
dpc-2081	176	1	in	in	ADP
dpc-2081	176	2	another	another	DET
dpc-2081	176	3	large	large	ADJ
dpc-2081	176	4	cohort	cohort	NOUN
dpc-2081	176	5	,	,	PUNCT
dpc-2081	176	6	bd	bd	PROPN
dpc-2081	176	7	prevalence	prevalence	NOUN
dpc-2081	176	8	in	in	ADP
dpc-2081	176	9	hs	hs	PROPN
dpc-2081	176	10	was	be	AUX
dpc-2081	176	11	0.6	0.6	NUM
dpc-2081	176	12	%	%	NOUN
dpc-2081	176	13	(	(	PUNCT
dpc-2081	176	14	9	9	NUM
dpc-2081	176	15	of	of	ADP
dpc-2081	176	16	1,411	1,411	NUM
dpc-2081	176	17	hs	hs	PROPN
dpc-2081	176	18	patients	patient	NOUN
dpc-2081	176	19	)	)	PUNCT
dpc-2081	177	1	[	[	X
dpc-2081	177	2	3	3	NUM
dpc-2081	177	3	]	]	PUNCT
dpc-2081	177	4	.	.	PUNCT
dpc-2081	178	1	bd	bd	PROPN
dpc-2081	178	2	frequency	frequency	PROPN
dpc-2081	178	3	in	in	ADP
dpc-2081	178	4	hs	hs	PROPN
dpc-2081	178	5	is	be	AUX
dpc-2081	178	6	relatively	relatively	ADV
dpc-2081	178	7	lower	low	ADJ
dpc-2081	178	8	in	in	ADP
dpc-2081	178	9	these	these	DET
dpc-2081	178	10	two	two	NUM
dpc-2081	178	11	studies	study	NOUN
dpc-2081	178	12	compared	compare	VERB
dpc-2081	178	13	to	to	ADP
dpc-2081	178	14	the	the	DET
dpc-2081	178	15	current	current	ADJ
dpc-2081	178	16	research	research	NOUN
dpc-2081	178	17	[	[	X
dpc-2081	178	18	2,3	2,3	NUM
dpc-2081	178	19	]	]	PUNCT
dpc-2081	178	20	.	.	PUNCT
dpc-2081	179	1	on	on	ADP
dpc-2081	179	2	the	the	DET
dpc-2081	179	3	contrary	contrary	NOUN
dpc-2081	179	4	,	,	PUNCT
dpc-2081	179	5	a	a	DET
dpc-2081	179	6	finnish	finnish	ADJ
dpc-2081	179	7	nationwide	nationwide	ADJ
dpc-2081	179	8	registry	registry	NOUN
dpc-2081	179	9	study	study	NOUN
dpc-2081	179	10	indicated	indicate	VERB
dpc-2081	179	11	a	a	DET
dpc-2081	179	12	higher	high	ADJ
dpc-2081	179	13	figure	figure	NOUN
dpc-2081	179	14	of	of	ADP
dpc-2081	179	15	3.1	3.1	NUM
dpc-2081	179	16	%	%	NOUN
dpc-2081	179	17	in	in	ADP
dpc-2081	179	18	hs	hs	PROPN
dpc-2081	179	19	patients	patient	NOUN
dpc-2081	179	20	,	,	PUNCT
dpc-2081	179	21	similar	similar	ADJ
dpc-2081	179	22	to	to	ADP
dpc-2081	179	23	the	the	DET
dpc-2081	179	24	current	current	ADJ
dpc-2081	179	25	study	study	NOUN
dpc-2081	179	26	results	result	VERB
dpc-2081	179	27	[	[	X
dpc-2081	179	28	4	4	NUM
dpc-2081	179	29	]	]	PUNCT
dpc-2081	179	30	.	.	PUNCT
dpc-2081	180	1	the	the	DET
dpc-2081	180	2	apparent	apparent	ADJ
dpc-2081	180	3	differences	difference	NOUN
dpc-2081	180	4	between	between	ADP
dpc-2081	180	5	these	these	DET
dpc-2081	180	6	studies	study	NOUN
dpc-2081	180	7	reveal	reveal	VERB
dpc-2081	180	8	the	the	DET
dpc-2081	180	9	requirement	requirement	NOUN
dpc-2081	180	10	of	of	ADP
dpc-2081	180	11	an	an	DET
dpc-2081	180	12	additional	additional	ADJ
dpc-2081	180	13	evaluation	evaluation	NOUN
dpc-2081	180	14	for	for	ADP
dpc-2081	180	15	the	the	DET
dpc-2081	180	16	study	study	NOUN
dpc-2081	180	17	region	region	PROPN
dpc-2081	180	18	baseline	baseline	PROPN
dpc-2081	180	19	characteristics	characteristic	NOUN
dpc-2081	180	20	.	.	PUNCT
dpc-2081	181	1	studies	study	NOUN
dpc-2081	181	2	related	relate	VERB
dpc-2081	181	3	to	to	ADP
dpc-2081	181	4	bd	bd	PROPN
dpc-2081	181	5	in	in	ADP
dpc-2081	181	6	turkey	turkey	NOUN
dpc-2081	181	7	have	have	AUX
dpc-2081	181	8	exhibited	exhibit	VERB
dpc-2081	181	9	a	a	DET
dpc-2081	181	10	similar	similar	ADJ
dpc-2081	181	11	prevalence	prevalence	NOUN
dpc-2081	181	12	to	to	ADP
dpc-2081	181	13	those	those	PRON
dpc-2081	181	14	in	in	ADP
dpc-2081	181	15	other	other	ADJ
dpc-2081	181	16	countries	country	NOUN
dpc-2081	181	17	[	[	X
dpc-2081	181	18	26,27	26,27	NUM
dpc-2081	181	19	]	]	PUNCT
dpc-2081	181	20	.	.	PUNCT
dpc-2081	182	1	turkey	turkey	PROPN
dpc-2081	182	2	is	be	AUX
dpc-2081	182	3	considered	consider	VERB
dpc-2081	182	4	one	one	NUM
dpc-2081	182	5	of	of	ADP
dpc-2081	182	6	the	the	DET
dpc-2081	182	7	countries	country	NOUN
dpc-2081	182	8	with	with	ADP
dpc-2081	182	9	the	the	DET
dpc-2081	182	10	lowest	low	ADJ
dpc-2081	182	11	prevalence	prevalence	NOUN
dpc-2081	182	12	of	of	ADP
dpc-2081	182	13	mental	mental	ADJ
dpc-2081	182	14	disorders	disorder	NOUN
dpc-2081	182	15	[	[	X
dpc-2081	182	16	28	28	NUM
dpc-2081	182	17	]	]	PUNCT
dpc-2081	182	18	.	.	PUNCT
dpc-2081	183	1	geographic	geographic	ADJ
dpc-2081	183	2	location	location	NOUN
dpc-2081	183	3	can	can	AUX
dpc-2081	183	4	not	not	PART
dpc-2081	183	5	explain	explain	VERB
dpc-2081	183	6	bd	bd	PROPN
dpc-2081	183	7	increased	increase	VERB
dpc-2081	183	8	prevalence	prevalence	NOUN
dpc-2081	183	9	in	in	ADP
dpc-2081	183	10	the	the	DET
dpc-2081	183	11	current	current	ADJ
dpc-2081	183	12	study	study	NOUN
dpc-2081	183	13	.	.	PUNCT
dpc-2081	184	1	instead	instead	ADV
dpc-2081	184	2	,	,	PUNCT
dpc-2081	184	3	it	it	PRON
dpc-2081	184	4	may	may	AUX
dpc-2081	184	5	be	be	AUX
dpc-2081	184	6	related	relate	VERB
dpc-2081	184	7	to	to	ADP
dpc-2081	184	8	our	our	PRON
dpc-2081	184	9	department	department	NOUN
dpc-2081	184	10	characteristics	characteristic	NOUN
dpc-2081	184	11	as	as	ADP
dpc-2081	184	12	a	a	DET
dpc-2081	184	13	referral	referral	ADJ
dpc-2081	184	14	center	center	NOUN
dpc-2081	184	15	with	with	ADP
dpc-2081	184	16	higher	high	ADJ
dpc-2081	184	17	awareness	awareness	NOUN
dpc-2081	184	18	and	and	CCONJ
dpc-2081	184	19	clinical	clinical	ADJ
dpc-2081	184	20	experience	experience	NOUN
dpc-2081	184	21	for	for	ADP
dpc-2081	184	22	hs	hs	PROPN
dpc-2081	184	23	patients	patient	NOUN
dpc-2081	184	24	.	.	PUNCT
dpc-2081	185	1	lithium	lithium	NOUN
dpc-2081	185	2	effect	effect	NOUN
dpc-2081	185	3	on	on	ADP
dpc-2081	185	4	hs	hs	PROPN
dpc-2081	185	5	is	be	AUX
dpc-2081	185	6	possibly	possibly	ADV
dpc-2081	185	7	patho	patho	ADJ
dpc-2081	185	8	-	-	PUNCT
dpc-2081	185	9	physiologically	physiologically	ADV
dpc-2081	185	10	related	related	ADJ
dpc-2081	185	11	to	to	ADP
dpc-2081	185	12	acneiform	acneiform	ADJ
dpc-2081	185	13	eruption	eruption	NOUN
dpc-2081	185	14	induction	induction	NOUN
dpc-2081	185	15	[	[	X
dpc-2081	185	16	2	2	NUM
dpc-2081	185	17	]	]	PUNCT
dpc-2081	185	18	.	.	PUNCT
dpc-2081	186	1	benhadou	benhadou	NOUN
dpc-2081	186	2	et	et	PROPN
dpc-2081	186	3	al	al	PROPN
dpc-2081	186	4	detected	detect	VERB
dpc-2081	186	5	exacerbations	exacerbation	NOUN
dpc-2081	186	6	in	in	ADP
dpc-2081	186	7	eight	eight	NUM
dpc-2081	186	8	of	of	ADP
dpc-2081	186	9	nine	nine	NUM
dpc-2081	186	10	hs	hs	PROPN
dpc-2081	186	11	patients	patient	NOUN
dpc-2081	186	12	who	who	PRON
dpc-2081	186	13	were	be	AUX
dpc-2081	186	14	prescribed	prescribe	VERB
dpc-2081	186	15	lithium	lithium	NOUN
dpc-2081	186	16	for	for	ADP
dpc-2081	186	17	bd	bd	PROPN
dpc-2081	186	18	.	.	PROPN
dpc-2081	186	19	lithium	lithium	PROPN
dpc-2081	186	20	was	be	AUX
dpc-2081	186	21	suggested	suggest	VERB
dpc-2081	186	22	as	as	ADP
dpc-2081	186	23	the	the	DET
dpc-2081	186	24	potential	potential	ADJ
dpc-2081	186	25	cause	cause	NOUN
dpc-2081	186	26	for	for	ADP
dpc-2081	186	27	the	the	DET
dpc-2081	186	28	initiation	initiation	NOUN
dpc-2081	186	29	and	and	CCONJ
dpc-2081	186	30	worsening	worsening	NOUN
dpc-2081	186	31	of	of	ADP
dpc-2081	186	32	hs	hs	PROPN
dpc-2081	186	33	6	6	NUM
dpc-2081	186	34	original	original	ADJ
dpc-2081	186	35	article	article	NOUN
dpc-2081	187	1	|	|	ADV
dpc-2081	187	2	dermatol	dermatol	ADJ
dpc-2081	187	3	pract	pract	NOUN
dpc-2081	187	4	concept	concept	NOUN
dpc-2081	187	5	.	.	PUNCT
dpc-2081	188	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	188	2	2019;81(1):76	2019;81(1):76	NUM
dpc-2081	188	3	-	-	SYM
dpc-2081	188	4	90	90	NUM
dpc-2081	188	5	.	.	PUNCT
dpc-2081	189	1	doi	doi	NOUN
dpc-2081	189	2	:	:	PUNCT
dpc-2081	189	3	10.1016	10.1016	NUM
dpc-2081	189	4	/	/	SYM
dpc-2081	189	5	j.jaad.2019.02.067	j.jaad.2019.02.067	PROPN
dpc-2081	189	6	.	.	PUNCT
dpc-2081	190	1	pmid	pmid	NOUN
dpc-2081	190	2	:	:	PUNCT
dpc-2081	190	3	30872156	30872156	NUM
dpc-2081	190	4	.	.	PUNCT
dpc-2081	191	1	pmcid	pmcid	NOUN
dpc-2081	191	2	:	:	PUNCT
dpc-2081	191	3	pmc9131894	pmc9131894	ADJ
dpc-2081	191	4	.	.	PUNCT
dpc-2081	192	1	2	2	X
dpc-2081	192	2	.	.	X
dpc-2081	192	3	benhadou	benhadou	NOUN
dpc-2081	192	4	f	f	PROPN
dpc-2081	192	5	,	,	PUNCT
dpc-2081	192	6	villani	villani	PROPN
dpc-2081	192	7	ap	ap	PROPN
dpc-2081	192	8	,	,	PUNCT
dpc-2081	192	9	guillem	guillem	PROPN
dpc-2081	192	10	p.	p.	PROPN
dpc-2081	192	11	hidradenitis	hidradenitis	PROPN
dpc-2081	192	12	suppurativa	suppurativa	PROPN
dpc-2081	192	13	and	and	CCONJ
dpc-2081	192	14	bipolar	bipolar	ADJ
dpc-2081	192	15	disorders	disorder	NOUN
dpc-2081	192	16	:	:	PUNCT
dpc-2081	192	17	a	a	DET
dpc-2081	192	18	role	role	NOUN
dpc-2081	192	19	for	for	ADP
dpc-2081	192	20	lithium	lithium	NOUN
dpc-2081	192	21	therapy	therapy	NOUN
dpc-2081	192	22	?	?	PUNCT
dpc-2081	193	1	dermatology	dermatology	NOUN
dpc-2081	193	2	.	.	PUNCT
dpc-2081	194	1	2020;236(4):305	2020;236(4):305	NUM
dpc-2081	194	2	-	-	SYM
dpc-2081	194	3	306	306	NUM
dpc-2081	194	4	.	.	PUNCT
dpc-2081	195	1	doi	doi	NOUN
dpc-2081	195	2	:	:	PUNCT
dpc-2081	195	3	10.1159/000505912	10.1159/000505912	NUM
dpc-2081	195	4	.	.	PUNCT
dpc-2081	196	1	pmid	pmid	NOUN
dpc-2081	196	2	:	:	PUNCT
dpc-2081	196	3	32036365	32036365	NUM
dpc-2081	196	4	.	.	PUNCT
dpc-2081	197	1	3	3	X
dpc-2081	197	2	.	.	X
dpc-2081	197	3	tzur	tzur	VERB
dpc-2081	197	4	bitan	bitan	PROPN
dpc-2081	197	5	d	d	PROPN
dpc-2081	197	6	,	,	PUNCT
dpc-2081	197	7	berzin	berzin	PROPN
dpc-2081	197	8	d	d	PROPN
dpc-2081	197	9	,	,	PUNCT
dpc-2081	197	10	cohen	cohen	PROPN
dpc-2081	197	11	a.	a.	PROPN
dpc-2081	197	12	hidradenitis	hidradenitis	PROPN
dpc-2081	197	13	suppurativa	suppurativa	PROPN
dpc-2081	197	14	and	and	CCONJ
dpc-2081	197	15	bipolar	bipolar	ADJ
dpc-2081	197	16	disorders	disorder	NOUN
dpc-2081	197	17	:	:	PUNCT
dpc-2081	197	18	a	a	DET
dpc-2081	197	19	population	population	NOUN
dpc-2081	197	20	-	-	PUNCT
dpc-2081	197	21	based	base	VERB
dpc-2081	197	22	study	study	NOUN
dpc-2081	197	23	.	.	PUNCT
dpc-2081	198	1	dermatology	dermatology	NOUN
dpc-2081	198	2	.	.	PUNCT
dpc-2081	199	1	2020;236(4):298	2020;236(4):298	NUM
dpc-2081	199	2	-	-	SYM
dpc-2081	199	3	304	304	NUM
dpc-2081	199	4	.	.	PUNCT
dpc-2081	200	1	doi	doi	NOUN
dpc-2081	200	2	:	:	PUNCT
dpc-2081	200	3	10.1159/000504535	10.1159/000504535	NUM
dpc-2081	200	4	.	.	PUNCT
dpc-2081	201	1	pmid	pmid	NOUN
dpc-2081	201	2	:	:	PUNCT
dpc-2081	201	3	31910425	31910425	NUM
dpc-2081	201	4	.	.	PUNCT
dpc-2081	202	1	4	4	X
dpc-2081	202	2	.	.	X
dpc-2081	202	3	grande	grande	PROPN
dpc-2081	202	4	i	i	PROPN
dpc-2081	202	5	,	,	PUNCT
dpc-2081	202	6	berk	berk	PROPN
dpc-2081	202	7	m	m	PROPN
dpc-2081	202	8	,	,	PUNCT
dpc-2081	202	9	birmaher	birmaher	ADV
dpc-2081	202	10	b	b	PROPN
dpc-2081	202	11	,	,	PUNCT
dpc-2081	202	12	vieta	vieta	PROPN
dpc-2081	202	13	e.	e.	PROPN
dpc-2081	202	14	bipolar	bipolar	ADJ
dpc-2081	202	15	disorder	disorder	NOUN
dpc-2081	202	16	.	.	PUNCT
dpc-2081	203	1	lancet	lancet	PROPN
dpc-2081	203	2	.	.	PUNCT
dpc-2081	204	1	2016;387(10027):1561	2016;387(10027):1561	NUM
dpc-2081	204	2	-	-	SYM
dpc-2081	204	3	1572	1572	NUM
dpc-2081	204	4	.	.	PUNCT
dpc-2081	205	1	doi	doi	NOUN
dpc-2081	205	2	:	:	PUNCT
dpc-2081	205	3	10.1016	10.1016	NUM
dpc-2081	205	4	/	/	SYM
dpc-2081	205	5	s0140	s0140	PROPN
dpc-2081	205	6	-	-	PUNCT
dpc-2081	205	7	6736(15)00	6736(15)00	NUM
dpc-2081	205	8	241	241	NUM
dpc-2081	205	9	-	-	PUNCT
dpc-2081	205	10	x.	x.	NOUN
dpc-2081	205	11	pmid	pmid	PROPN
dpc-2081	205	12	:	:	PUNCT
dpc-2081	205	13	26388529	26388529	NUM
dpc-2081	205	14	.	.	PUNCT
dpc-2081	206	1	5	5	X
dpc-2081	206	2	.	.	X
dpc-2081	206	3	ingram	ingram	PROPN
dpc-2081	206	4	jr	jr	PROPN
dpc-2081	206	5	,	,	PUNCT
dpc-2081	206	6	jenkins	jenkins	PROPN
dpc-2081	206	7	-	-	PUNCT
dpc-2081	206	8	jones	jones	PROPN
dpc-2081	206	9	s	s	PROPN
dpc-2081	206	10	,	,	PUNCT
dpc-2081	206	11	knipe	knipe	PROPN
dpc-2081	206	12	dw	dw	PROPN
dpc-2081	206	13	,	,	PUNCT
dpc-2081	206	14	morgan	morgan	PROPN
dpc-2081	206	15	cli	cli	PROPN
dpc-2081	206	16	,	,	PUNCT
dpc-2081	206	17	cannings	canning	NOUN
dpc-2081	206	18	-	-	PUNCT
dpc-2081	206	19	john	john	PROPN
dpc-2081	206	20	r	r	PROPN
dpc-2081	206	21	,	,	PUNCT
dpc-2081	206	22	piguet	piguet	PROPN
dpc-2081	206	23	v.	v.	ADP
dpc-2081	206	24	population	population	NOUN
dpc-2081	206	25	-	-	PUNCT
dpc-2081	206	26	based	base	VERB
dpc-2081	206	27	clinical	clinical	ADJ
dpc-2081	206	28	practice	practice	NOUN
dpc-2081	206	29	research	research	NOUN
dpc-2081	206	30	datalink	datalink	NOUN
dpc-2081	206	31	study	study	NOUN
dpc-2081	206	32	using	use	VERB
dpc-2081	206	33	algorithm	algorithm	NOUN
dpc-2081	206	34	modelling	modelling	NOUN
dpc-2081	206	35	to	to	PART
dpc-2081	206	36	identify	identify	VERB
dpc-2081	206	37	the	the	DET
dpc-2081	206	38	true	true	ADJ
dpc-2081	206	39	burden	burden	NOUN
dpc-2081	206	40	of	of	ADP
dpc-2081	206	41	hidradenitis	hidradenitis	PROPN
dpc-2081	206	42	suppurativa	suppurativa	PROPN
dpc-2081	206	43	.	.	PUNCT
dpc-2081	207	1	br	br	PROPN
dpc-2081	207	2	j	j	PROPN
dpc-2081	207	3	dermatol	dermatol	NOUN
dpc-2081	207	4	.	.	PUNCT
dpc-2081	208	1	2018;178(4):917	2018;178(4):917	NUM
dpc-2081	208	2	-	-	SYM
dpc-2081	208	3	924	924	NUM
dpc-2081	208	4	.	.	PUNCT
dpc-2081	208	5	doi	doi	NOUN
dpc-2081	208	6	:	:	PUNCT
dpc-2081	208	7	10.1111	10.1111	NUM
dpc-2081	208	8	/	/	SYM
dpc-2081	208	9	bjd.16101	bjd.16101	NUM
dpc-2081	208	10	.	.	PUNCT
dpc-2081	209	1	pmid	pmid	NOUN
dpc-2081	209	2	:	:	PUNCT
dpc-2081	209	3	290	290	NUM
dpc-2081	209	4	94346	94346	NUM
dpc-2081	209	5	.	.	PUNCT
dpc-2081	210	1	6	6	X
dpc-2081	210	2	.	.	X
dpc-2081	210	3	jemec	jemec	PROPN
dpc-2081	210	4	gb	gb	PRON
dpc-2081	210	5	,	,	PUNCT
dpc-2081	210	6	kimball	kimball	PROPN
dpc-2081	210	7	ab	ab	PROPN
dpc-2081	210	8	.	.	PROPN
dpc-2081	210	9	hidradenitis	hidradenitis	PROPN
dpc-2081	210	10	suppurativa	suppurativa	PROPN
dpc-2081	210	11	:	:	PUNCT
dpc-2081	210	12	epidemiology	epidemiology	NOUN
dpc-2081	210	13	and	and	CCONJ
dpc-2081	210	14	scope	scope	NOUN
dpc-2081	210	15	of	of	ADP
dpc-2081	210	16	the	the	DET
dpc-2081	210	17	problem	problem	NOUN
dpc-2081	210	18	.	.	PUNCT
dpc-2081	211	1	j	j	PROPN
dpc-2081	211	2	am	be	AUX
dpc-2081	211	3	acad	acad	ADJ
dpc-2081	211	4	dermatol	dermatol	NOUN
dpc-2081	211	5	.	.	PUNCT
dpc-2081	212	1	2015;73(5	2015;73(5	NUM
dpc-2081	212	2	suppl	suppl	ADJ
dpc-2081	212	3	1):s4	1):s4	NUM
dpc-2081	212	4	-	-	PUNCT
dpc-2081	212	5	s7	s7	NOUN
dpc-2081	212	6	.	.	PUNCT
dpc-2081	213	1	doi	doi	NOUN
dpc-2081	213	2	:	:	PUNCT
dpc-2081	213	3	10.1016	10.1016	NUM
dpc-2081	213	4	/	/	SYM
dpc-2081	213	5	j.jaad.2015.07.052	j.jaad.2015.07.052	PROPN
dpc-2081	213	6	.	.	PUNCT
dpc-2081	214	1	pmid	pmid	NOUN
dpc-2081	214	2	:	:	PUNCT
dpc-2081	214	3	26470614	26470614	NUM
dpc-2081	214	4	.	.	PUNCT
dpc-2081	215	1	7	7	X
dpc-2081	215	2	.	.	X
dpc-2081	215	3	kelsoe	kelsoe	PROPN
dpc-2081	215	4	jr	jr	PROPN
dpc-2081	215	5	.	.	PUNCT
dpc-2081	215	6	arguments	argument	NOUN
dpc-2081	215	7	for	for	ADP
dpc-2081	215	8	the	the	DET
dpc-2081	215	9	genetic	genetic	ADJ
dpc-2081	215	10	basis	basis	NOUN
dpc-2081	215	11	of	of	ADP
dpc-2081	215	12	the	the	DET
dpc-2081	215	13	bipolar	bipolar	ADJ
dpc-2081	215	14	spectrum	spectrum	NOUN
dpc-2081	215	15	.	.	PUNCT
dpc-2081	216	1	j	j	PROPN
dpc-2081	216	2	affect	affect	VERB
dpc-2081	216	3	disord	disord	NOUN
dpc-2081	216	4	.	.	PUNCT
dpc-2081	217	1	2003;73(1	2003;73(1	NUM
dpc-2081	217	2	-	-	PUNCT
dpc-2081	217	3	2):183	2):183	NUM
dpc-2081	217	4	-	-	PUNCT
dpc-2081	217	5	197	197	NUM
dpc-2081	217	6	.	.	PUNCT
dpc-2081	217	7	doi	doi	NOUN
dpc-2081	217	8	:	:	PUNCT
dpc-2081	217	9	10.1016/	10.1016/	NUM
dpc-2081	217	10	s0165	s0165	VERB
dpc-2081	217	11	-	-	PUNCT
dpc-2081	217	12	0327(02)00323	0327(02)00323	NUM
dpc-2081	217	13	-	-	PUNCT
dpc-2081	217	14	3	3	NUM
dpc-2081	217	15	.	.	PUNCT
dpc-2081	218	1	pmid	pmid	NOUN
dpc-2081	218	2	:	:	PUNCT
dpc-2081	218	3	12507751	12507751	NUM
dpc-2081	218	4	.	.	PUNCT
dpc-2081	219	1	8	8	X
dpc-2081	219	2	.	.	X
dpc-2081	220	1	calkin	calkin	PROPN
dpc-2081	220	2	cv	cv	PROPN
dpc-2081	220	3	,	,	PUNCT
dpc-2081	220	4	gardner	gardner	PROPN
dpc-2081	220	5	dm	dm	PROPN
dpc-2081	220	6	,	,	PUNCT
dpc-2081	220	7	ransom	ransom	NOUN
dpc-2081	220	8	t	t	PROPN
dpc-2081	220	9	,	,	PUNCT
dpc-2081	220	10	alda	alda	PROPN
dpc-2081	220	11	m.	m.	NOUN
dpc-2081	220	12	the	the	DET
dpc-2081	220	13	relationship	relationship	NOUN
dpc-2081	220	14	between	between	ADP
dpc-2081	220	15	bipolar	bipolar	ADJ
dpc-2081	220	16	disorder	disorder	NOUN
dpc-2081	220	17	and	and	CCONJ
dpc-2081	220	18	type	type	NOUN
dpc-2081	220	19	2	2	NUM
dpc-2081	220	20	diabetes	diabetes	NOUN
dpc-2081	220	21	:	:	PUNCT
dpc-2081	220	22	more	more	ADJ
dpc-2081	220	23	than	than	ADP
dpc-2081	220	24	just	just	ADV
dpc-2081	220	25	co	co	ADJ
dpc-2081	220	26	-	-	ADJ
dpc-2081	220	27	morbid	morbid	ADJ
dpc-2081	220	28	disorders	disorder	NOUN
dpc-2081	220	29	.	.	PUNCT
dpc-2081	221	1	ann	ann	PROPN
dpc-2081	221	2	med	med	PROPN
dpc-2081	221	3	.	.	PUNCT
dpc-2081	222	1	2013;45(2):171	2013;45(2):171	NUM
dpc-2081	222	2	-	-	SYM
dpc-2081	222	3	181	181	NUM
dpc-2081	222	4	.	.	PUNCT
dpc-2081	223	1	doi	doi	NOUN
dpc-2081	223	2	:	:	PUNCT
dpc-2081	223	3	10.3109/07853890.2012.687835	10.3109/07853890.2012.687835	NUM
dpc-2081	223	4	.	.	PUNCT
dpc-2081	224	1	pmid	pmid	NOUN
dpc-2081	224	2	:	:	PUNCT
dpc-2081	224	3	22621171	22621171	NUM
dpc-2081	224	4	.	.	PUNCT
dpc-2081	225	1	9	9	X
dpc-2081	225	2	.	.	X
dpc-2081	225	3	fiedorowicz	fiedorowicz	VERB
dpc-2081	225	4	jg	jg	PROPN
dpc-2081	225	5	,	,	PUNCT
dpc-2081	225	6	palagummi	palagummi	PROPN
dpc-2081	225	7	nm	nm	PROPN
dpc-2081	225	8	,	,	PUNCT
dpc-2081	225	9	forman	forman	NOUN
dpc-2081	225	10	-	-	PUNCT
dpc-2081	225	11	hoffman	hoffman	PROPN
dpc-2081	225	12	vl	vl	PROPN
dpc-2081	225	13	,	,	PUNCT
dpc-2081	225	14	miller	miller	PROPN
dpc-2081	225	15	dd	dd	PROPN
dpc-2081	225	16	,	,	PUNCT
dpc-2081	225	17	haynes	haynes	PROPN
dpc-2081	225	18	wg	wg	PROPN
dpc-2081	225	19	.	.	PUNCT
dpc-2081	226	1	elevated	elevated	ADJ
dpc-2081	226	2	prevalence	prevalence	NOUN
dpc-2081	226	3	of	of	ADP
dpc-2081	226	4	obesity	obesity	NOUN
dpc-2081	226	5	,	,	PUNCT
dpc-2081	226	6	metabolic	metabolic	NOUN
dpc-2081	226	7	syndrome	syndrome	NOUN
dpc-2081	226	8	,	,	PUNCT
dpc-2081	226	9	and	and	CCONJ
dpc-2081	226	10	cardiovascular	cardiovascular	ADJ
dpc-2081	226	11	risk	risk	NOUN
dpc-2081	226	12	factors	factor	NOUN
dpc-2081	226	13	in	in	ADP
dpc-2081	226	14	bipolar	bipolar	ADJ
dpc-2081	226	15	disorder	disorder	NOUN
dpc-2081	226	16	.	.	PUNCT
dpc-2081	227	1	ann	ann	PROPN
dpc-2081	227	2	clin	clin	PROPN
dpc-2081	227	3	psychiatry	psychiatry	PROPN
dpc-2081	227	4	.	.	PUNCT
dpc-2081	228	1	2008;20(3):131	2008;20(3):131	NUM
dpc-2081	228	2	-	-	SYM
dpc-2081	228	3	137	137	NUM
dpc-2081	228	4	.	.	PUNCT
dpc-2081	229	1	doi	doi	NOUN
dpc-2081	229	2	:	:	PUNCT
dpc-2081	229	3	10.1080/10401230802177722	10.1080/10401230802177722	NUM
dpc-2081	229	4	.	.	PUNCT
dpc-2081	230	1	pmid	pmid	NOUN
dpc-2081	230	2	:	:	PUNCT
dpc-2081	230	3	18633739	18633739	NUM
dpc-2081	230	4	.	.	PUNCT
dpc-2081	231	1	pmcid	pmcid	NOUN
dpc-2081	231	2	:	:	PUNCT
dpc-2081	231	3	pmc2776768	pmc2776768	NOUN
dpc-2081	231	4	.	.	PUNCT
dpc-2081	232	1	10	10	NUM
dpc-2081	232	2	.	.	PUNCT
dpc-2081	233	1	weiner	weiner	NOUN
dpc-2081	233	2	m	m	PROPN
dpc-2081	233	3	,	,	PUNCT
dpc-2081	233	4	warren	warren	PROPN
dpc-2081	233	5	l	l	PROPN
dpc-2081	233	6	,	,	PUNCT
dpc-2081	233	7	fiedorowicz	fiedorowicz	VERB
dpc-2081	233	8	jg	jg	PROPN
dpc-2081	233	9	.	.	PUNCT
dpc-2081	234	1	cardiovascular	cardiovascular	ADJ
dpc-2081	234	2	morbidity	morbidity	NOUN
dpc-2081	234	3	and	and	CCONJ
dpc-2081	234	4	mortality	mortality	NOUN
dpc-2081	234	5	in	in	ADP
dpc-2081	234	6	bipolar	bipolar	ADJ
dpc-2081	234	7	disorder	disorder	NOUN
dpc-2081	234	8	.	.	PUNCT
dpc-2081	235	1	ann	ann	PROPN
dpc-2081	235	2	clin	clin	PROPN
dpc-2081	235	3	psychiatry	psychiatry	PROPN
dpc-2081	235	4	.	.	PUNCT
dpc-2081	236	1	2011;23(1):40	2011;23(1):40	NUM
dpc-2081	236	2	-	-	SYM
dpc-2081	236	3	47	47	NUM
dpc-2081	236	4	.	.	PUNCT
dpc-2081	237	1	pmid	pmid	NOUN
dpc-2081	237	2	:	:	PUNCT
dpc-2081	237	3	21318195	21318195	NUM
dpc-2081	237	4	.	.	PUNCT
dpc-2081	238	1	pmcid	pmcid	NOUN
dpc-2081	238	2	:	:	PUNCT
dpc-2081	238	3	pmc3190964	pmc3190964	ADV
dpc-2081	238	4	.	.	PUNCT
dpc-2081	239	1	11	11	NUM
dpc-2081	239	2	.	.	PUNCT
dpc-2081	240	1	zhao	zhao	PROPN
dpc-2081	240	2	z	z	PROPN
dpc-2081	240	3	,	,	PUNCT
dpc-2081	240	4	okusaga	okusaga	NOUN
dpc-2081	240	5	oo	oo	PROPN
dpc-2081	240	6	,	,	PUNCT
dpc-2081	240	7	quevedo	quevedo	PROPN
dpc-2081	240	8	j	j	PROPN
dpc-2081	240	9	,	,	PUNCT
dpc-2081	240	10	soares	soares	PROPN
dpc-2081	240	11	jc	jc	PROPN
dpc-2081	240	12	,	,	PUNCT
dpc-2081	240	13	teixeira	teixeira	PROPN
dpc-2081	240	14	al	al	PROPN
dpc-2081	240	15	.	.	PUNCT
dpc-2081	241	1	the	the	DET
dpc-2081	241	2	potential	potential	ADJ
dpc-2081	241	3	association	association	NOUN
dpc-2081	241	4	between	between	ADP
dpc-2081	241	5	obesity	obesity	NOUN
dpc-2081	241	6	and	and	CCONJ
dpc-2081	241	7	bipolar	bipolar	ADJ
dpc-2081	241	8	disorder	disorder	NOUN
dpc-2081	241	9	:	:	PUNCT
dpc-2081	241	10	a	a	DET
dpc-2081	241	11	meta	meta	ADJ
dpc-2081	241	12	-	-	PUNCT
dpc-2081	241	13	analysis	analysis	NOUN
dpc-2081	241	14	.	.	PUNCT
dpc-2081	242	1	j	j	PROPN
dpc-2081	242	2	affect	affect	VERB
dpc-2081	242	3	disord	disord	NOUN
dpc-2081	242	4	.	.	PUNCT
dpc-2081	243	1	2016;202:120	2016;202:120	NUM
dpc-2081	243	2	-	-	SYM
dpc-2081	243	3	123	123	NUM
dpc-2081	243	4	.	.	PUNCT
dpc-2081	244	1	doi	doi	NOUN
dpc-2081	244	2	:	:	PUNCT
dpc-2081	244	3	10.1016	10.1016	NUM
dpc-2081	244	4	/	/	SYM
dpc-2081	244	5	j.jad.2016.05.059	j.jad.2016.05.059	PROPN
dpc-2081	244	6	.	.	PUNCT
dpc-2081	245	1	pmid	pmid	NOUN
dpc-2081	245	2	:	:	PUNCT
dpc-2081	245	3	27262632	27262632	NUM
dpc-2081	245	4	.	.	PUNCT
dpc-2081	246	1	12	12	NUM
dpc-2081	246	2	.	.	PUNCT
dpc-2081	247	1	scala	scala	PROPN
dpc-2081	247	2	e	e	PROPN
dpc-2081	247	3	,	,	PUNCT
dpc-2081	247	4	cacciapuoti	cacciapuoti	PROPN
dpc-2081	247	5	s	s	PROPN
dpc-2081	247	6	,	,	PUNCT
dpc-2081	247	7	garzorz	garzorz	NOUN
dpc-2081	247	8	-	-	PUNCT
dpc-2081	247	9	stark	stark	PROPN
dpc-2081	247	10	n	n	CCONJ
dpc-2081	247	11	,	,	PUNCT
dpc-2081	247	12	et	et	PROPN
dpc-2081	247	13	al	al	PROPN
dpc-2081	247	14	.	.	PROPN
dpc-2081	247	15	hidradenitis	hidradenitis	PROPN
dpc-2081	247	16	suppurativa	suppurativa	PROPN
dpc-2081	247	17	:	:	PUNCT
dpc-2081	247	18	where	where	SCONJ
dpc-2081	247	19	we	we	PRON
dpc-2081	247	20	are	be	AUX
dpc-2081	247	21	and	and	CCONJ
dpc-2081	247	22	where	where	SCONJ
dpc-2081	247	23	we	we	PRON
dpc-2081	247	24	are	be	AUX
dpc-2081	247	25	going	go	VERB
dpc-2081	247	26	.	.	PUNCT
dpc-2081	248	1	cells	cell	NOUN
dpc-2081	248	2	.	.	PUNCT
dpc-2081	249	1	2021;10(8	2021;10(8	NUM
dpc-2081	249	2	)	)	PUNCT
dpc-2081	249	3	;	;	PUNCT
dpc-2081	250	1	10(8):2094	10(8):2094	NUM
dpc-2081	250	2	.	.	PUNCT
dpc-2081	250	3	doi	doi	NOUN
dpc-2081	250	4	:	:	PUNCT
dpc-2081	250	5	10.3390	10.3390	NUM
dpc-2081	250	6	/	/	SYM
dpc-2081	250	7	cells10082094	cells10082094	PROPN
dpc-2081	250	8	.	.	PUNCT
dpc-2081	251	1	pmid	pmid	NOUN
dpc-2081	251	2	:	:	PUNCT
dpc-2081	251	3	34440863	34440863	NUM
dpc-2081	251	4	.	.	PUNCT
dpc-2081	252	1	pmcid	pmcid	NOUN
dpc-2081	252	2	:	:	PUNCT
dpc-2081	253	1	pmc8392140	pmc8392140	ADJ
dpc-2081	253	2	.	.	PUNCT
dpc-2081	254	1	13	13	NUM
dpc-2081	254	2	.	.	PUNCT
dpc-2081	255	1	huilaja	huilaja	PROPN
dpc-2081	255	2	l	l	PROPN
dpc-2081	255	3	,	,	PUNCT
dpc-2081	255	4	tiri	tiri	PROPN
dpc-2081	255	5	h	h	PROPN
dpc-2081	255	6	,	,	PUNCT
dpc-2081	255	7	jokelainen	jokelainen	PROPN
dpc-2081	255	8	j	j	PROPN
dpc-2081	255	9	,	,	PUNCT
dpc-2081	255	10	timonen	timonen	PROPN
dpc-2081	255	11	m	m	NOUN
dpc-2081	255	12	,	,	PUNCT
dpc-2081	255	13	tasanen	tasanen	NOUN
dpc-2081	255	14	k.	k.	PROPN
dpc-2081	255	15	patients	patient	NOUN
dpc-2081	255	16	with	with	ADP
dpc-2081	255	17	hidradenitis	hidradenitis	PROPN
dpc-2081	255	18	suppurativa	suppurativa	PROPN
dpc-2081	255	19	have	have	VERB
dpc-2081	255	20	a	a	DET
dpc-2081	255	21	high	high	ADJ
dpc-2081	255	22	psychiatric	psychiatric	ADJ
dpc-2081	255	23	disease	disease	NOUN
dpc-2081	255	24	burden	burden	NOUN
dpc-2081	255	25	:	:	PUNCT
dpc-2081	255	26	a	a	DET
dpc-2081	255	27	finnish	finnish	ADJ
dpc-2081	255	28	nationwide	nationwide	ADJ
dpc-2081	255	29	registry	registry	PROPN
dpc-2081	255	30	study	study	NOUN
dpc-2081	255	31	.	.	PUNCT
dpc-2081	256	1	j	j	PROPN
dpc-2081	256	2	invest	invest	VERB
dpc-2081	256	3	dermatol	dermatol	NOUN
dpc-2081	256	4	.	.	PUNCT
dpc-2081	257	1	2018;138(1):46	2018;138(1):46	VERB
dpc-2081	257	2	-	-	SYM
dpc-2081	257	3	51	51	NUM
dpc-2081	257	4	.	.	PUNCT
dpc-2081	258	1	doi	doi	NOUN
dpc-2081	258	2	:	:	PUNCT
dpc-2081	258	3	10.1016	10.1016	NUM
dpc-2081	258	4	/	/	SYM
dpc-2081	258	5	j.jid.2017.06.020	j.jid.2017.06.020	PROPN
dpc-2081	258	6	.	.	PUNCT
dpc-2081	259	1	pmid	pmid	NOUN
dpc-2081	259	2	:	:	PUNCT
dpc-2081	259	3	28736236	28736236	NUM
dpc-2081	259	4	.	.	PUNCT
dpc-2081	260	1	14	14	NUM
dpc-2081	260	2	.	.	PUNCT
dpc-2081	261	1	aithal	aithal	NOUN
dpc-2081	261	2	v	v	NOUN
dpc-2081	261	3	,	,	PUNCT
dpc-2081	261	4	appaih	appaih	VERB
dpc-2081	261	5	p.	p.	NOUN
dpc-2081	261	6	lithium	lithium	NOUN
dpc-2081	261	7	induced	induce	VERB
dpc-2081	261	8	hidradenitis	hidradenitis	PROPN
dpc-2081	261	9	suppurativa	suppurativa	NOUN
dpc-2081	261	10	and	and	CCONJ
dpc-2081	261	11	acne	acne	NOUN
dpc-2081	261	12	conglobata	conglobata	NOUN
dpc-2081	261	13	.	.	PUNCT
dpc-2081	262	1	indian	indian	PROPN
dpc-2081	262	2	j	j	PROPN
dpc-2081	262	3	dermatol	dermatol	PROPN
dpc-2081	262	4	venereol	venereol	ADJ
dpc-2081	262	5	leprol	leprol	NOUN
dpc-2081	262	6	.	.	PUNCT
dpc-2081	263	1	2004;70(5):307	2004;70(5):307	NUM
dpc-2081	263	2	-	-	PUNCT
dpc-2081	263	3	309	309	NUM
dpc-2081	263	4	.	.	PUNCT
dpc-2081	264	1	pmid	pmid	NOUN
dpc-2081	264	2	:	:	PUNCT
dpc-2081	264	3	17642646	17642646	NUM
dpc-2081	264	4	.	.	PUNCT
dpc-2081	265	1	15	15	X
dpc-2081	265	2	.	.	PUNCT
dpc-2081	266	1	craddock	craddock	PROPN
dpc-2081	266	2	n	n	CCONJ
dpc-2081	266	3	,	,	PUNCT
dpc-2081	266	4	sklar	sklar	ADJ
dpc-2081	266	5	p.	p.	NOUN
dpc-2081	266	6	genetics	genetic	NOUN
dpc-2081	266	7	of	of	ADP
dpc-2081	266	8	bipolar	bipolar	ADJ
dpc-2081	266	9	disorder	disorder	NOUN
dpc-2081	266	10	.	.	PUNCT
dpc-2081	267	1	lancet	lancet	PROPN
dpc-2081	267	2	.	.	PUNCT
dpc-2081	268	1	2013;381(9878):1654	2013;381(9878):1654	NUM
dpc-2081	268	2	-	-	SYM
dpc-2081	268	3	1662	1662	NUM
dpc-2081	268	4	.	.	PUNCT
dpc-2081	269	1	doi	doi	NOUN
dpc-2081	269	2	:	:	PUNCT
dpc-2081	269	3	10.1016	10.1016	NUM
dpc-2081	269	4	/	/	SYM
dpc-2081	269	5	s0140	s0140	PROPN
dpc-2081	269	6	-	-	PUNCT
dpc-2081	269	7	6736(13	6736(13	NUM
dpc-2081	269	8	)	)	PUNCT
dpc-2081	269	9	60855	60855	NUM
dpc-2081	269	10	-	-	SYM
dpc-2081	269	11	7	7	NUM
dpc-2081	269	12	.	.	PUNCT
dpc-2081	270	1	pmid	pmid	NOUN
dpc-2081	270	2	:	:	PUNCT
dpc-2081	270	3	23663951	23663951	NUM
dpc-2081	270	4	.	.	PUNCT
dpc-2081	271	1	16	16	NUM
dpc-2081	271	2	.	.	PUNCT
dpc-2081	272	1	jfri	jfri	PROPN
dpc-2081	272	2	ah	ah	INTJ
dpc-2081	272	3	,	,	PUNCT
dpc-2081	272	4	o’brien	o’brien	PROPN
dpc-2081	272	5	ea	ea	PROPN
dpc-2081	272	6	,	,	PUNCT
dpc-2081	272	7	litvinov	litvinov	PROPN
dpc-2081	272	8	iv	iv	NUM
dpc-2081	272	9	,	,	PUNCT
dpc-2081	272	10	alavi	alavi	VERB
dpc-2081	272	11	a	a	DET
dpc-2081	272	12	,	,	PUNCT
dpc-2081	272	13	netchiporouk	netchiporouk	PROPN
dpc-2081	272	14	e.	e.	PROPN
dpc-2081	272	15	hidradenitis	hidradenitis	PROPN
dpc-2081	272	16	suppurativa	suppurativa	PROPN
dpc-2081	272	17	:	:	PUNCT
dpc-2081	272	18	comprehensive	comprehensive	ADJ
dpc-2081	272	19	review	review	NOUN
dpc-2081	272	20	of	of	ADP
dpc-2081	272	21	predisposing	predispose	VERB
dpc-2081	272	22	genetic	genetic	ADJ
dpc-2081	272	23	mutations	mutation	NOUN
dpc-2081	272	24	and	and	CCONJ
dpc-2081	272	25	changes	change	NOUN
dpc-2081	272	26	.	.	PUNCT
dpc-2081	273	1	j	j	PROPN
dpc-2081	273	2	cutan	cutan	PROPN
dpc-2081	273	3	med	med	ADJ
dpc-2081	273	4	surg	surg	NOUN
dpc-2081	273	5	.	.	PUNCT
dpc-2081	274	1	2019;23(5):519	2019;23(5):519	NUM
dpc-2081	274	2	-	-	PUNCT
dpc-2081	274	3	527	527	NUM
dpc-2081	274	4	.	.	PUNCT
dpc-2081	275	1	doi	doi	NOUN
dpc-2081	275	2	:	:	PUNCT
dpc-2081	275	3	10.1177/1203475419852049	10.1177/1203475419852049	NUM
dpc-2081	275	4	.	.	PUNCT
dpc-2081	276	1	pmid	pmid	NOUN
dpc-2081	276	2	:	:	PUNCT
dpc-2081	276	3	31167568	31167568	NUM
dpc-2081	276	4	.	.	PUNCT
dpc-2081	277	1	to	to	ADP
dpc-2081	277	2	4	4	NUM
dpc-2081	277	3	years	year	NOUN
dpc-2081	277	4	.	.	PUNCT
dpc-2081	278	1	authors	author	NOUN
dpc-2081	278	2	observations	observation	NOUN
dpc-2081	278	3	for	for	ADP
dpc-2081	278	4	these	these	DET
dpc-2081	278	5	5	5	NUM
dpc-2081	278	6	patients	patient	NOUN
dpc-2081	278	7	upon	upon	SCONJ
dpc-2081	278	8	physician	physician	NOUN
dpc-2081	278	9	-	-	PUNCT
dpc-2081	278	10	patient	patient	NOUN
dpc-2081	278	11	interactions	interaction	NOUN
dpc-2081	278	12	can	can	AUX
dpc-2081	278	13	be	be	AUX
dpc-2081	278	14	reported	report	VERB
dpc-2081	278	15	as	as	ADP
dpc-2081	278	16	a	a	DET
dpc-2081	278	17	remarkable	remarkable	ADJ
dpc-2081	278	18	improvement	improvement	NOUN
dpc-2081	278	19	for	for	ADP
dpc-2081	278	20	both	both	DET
dpc-2081	278	21	diseases	disease	NOUN
dpc-2081	278	22	during	during	ADP
dpc-2081	278	23	adalimumab	adalimumab	NOUN
dpc-2081	278	24	treatment	treatment	NOUN
dpc-2081	278	25	,	,	PUNCT
dpc-2081	278	26	but	but	CCONJ
dpc-2081	278	27	without	without	ADP
dpc-2081	278	28	any	any	DET
dpc-2081	278	29	objective	objective	ADJ
dpc-2081	278	30	assessments	assessment	NOUN
dpc-2081	278	31	for	for	ADP
dpc-2081	278	32	bd	bd	PROPN
dpc-2081	278	33	.	.	PROPN
dpc-2081	278	34	however	however	ADV
dpc-2081	278	35	,	,	PUNCT
dpc-2081	278	36	attributing	attribute	VERB
dpc-2081	278	37	all	all	DET
dpc-2081	278	38	improvements	improvement	NOUN
dpc-2081	278	39	to	to	PART
dpc-2081	278	40	adalimumab	adalimumab	VERB
dpc-2081	278	41	in	in	ADP
dpc-2081	278	42	bd	bd	PROPN
dpc-2081	278	43	does	do	AUX
dpc-2081	278	44	not	not	PART
dpc-2081	278	45	seem	seem	VERB
dpc-2081	278	46	appropriate	appropriate	ADJ
dpc-2081	278	47	as	as	SCONJ
dpc-2081	278	48	all	all	DET
dpc-2081	278	49	five	five	NUM
dpc-2081	278	50	patients	patient	NOUN
dpc-2081	278	51	have	have	AUX
dpc-2081	278	52	continued	continue	VERB
dpc-2081	278	53	psychiatric	psychiatric	ADJ
dpc-2081	278	54	drugs	drug	NOUN
dpc-2081	278	55	simultaneously	simultaneously	ADV
dpc-2081	278	56	for	for	ADP
dpc-2081	278	57	the	the	DET
dpc-2081	278	58	treatment	treatment	NOUN
dpc-2081	278	59	of	of	ADP
dpc-2081	278	60	bd	bd	PROPN
dpc-2081	278	61	(	(	PUNCT
dpc-2081	278	62	table	table	NOUN
dpc-2081	278	63	2	2	NUM
dpc-2081	278	64	)	)	PUNCT
dpc-2081	278	65	.	.	PUNCT
dpc-2081	279	1	additionally	additionally	ADV
dpc-2081	279	2	,	,	PUNCT
dpc-2081	279	3	the	the	DET
dpc-2081	279	4	improvement	improvement	NOUN
dpc-2081	279	5	of	of	ADP
dpc-2081	279	6	underlying	underlie	VERB
dpc-2081	279	7	disease	disease	NOUN
dpc-2081	279	8	severity	severity	NOUN
dpc-2081	279	9	and	and	CCONJ
dpc-2081	279	10	quality	quality	NOUN
dpc-2081	279	11	of	of	ADP
dpc-2081	279	12	life	life	NOUN
dpc-2081	279	13	measures	measure	NOUN
dpc-2081	279	14	under	under	ADP
dpc-2081	279	15	adalimumab	adalimumab	NOUN
dpc-2081	279	16	treatment	treatment	NOUN
dpc-2081	279	17	will	will	AUX
dpc-2081	279	18	undoubtedly	undoubtedly	ADV
dpc-2081	279	19	affect	affect	VERB
dpc-2081	279	20	bd	bd	PROPN
dpc-2081	279	21	positively	positively	ADV
dpc-2081	279	22	.	.	PUNCT
dpc-2081	280	1	the	the	DET
dpc-2081	280	2	current	current	ADJ
dpc-2081	280	3	study	study	NOUN
dpc-2081	280	4	period	period	NOUN
dpc-2081	280	5	comprises	comprise	VERB
dpc-2081	280	6	the	the	DET
dpc-2081	280	7	pandemic	pandemic	ADJ
dpc-2081	280	8	period	period	NOUN
dpc-2081	280	9	.	.	PUNCT
dpc-2081	281	1	therefore	therefore	ADV
dpc-2081	281	2	,	,	PUNCT
dpc-2081	281	3	the	the	DET
dpc-2081	281	4	results	result	NOUN
dpc-2081	281	5	of	of	ADP
dpc-2081	281	6	the	the	DET
dpc-2081	281	7	study	study	NOUN
dpc-2081	281	8	offered	offer	VERB
dpc-2081	281	9	the	the	DET
dpc-2081	281	10	chance	chance	NOUN
dpc-2081	281	11	to	to	PART
dpc-2081	281	12	observe	observe	VERB
dpc-2081	281	13	the	the	DET
dpc-2081	281	14	disease	disease	NOUN
dpc-2081	281	15	course	course	NOUN
dpc-2081	281	16	of	of	ADP
dpc-2081	281	17	covid-19	covid-19	PROPN
dpc-2081	281	18	in	in	ADP
dpc-2081	281	19	hs	hs	PROPN
dpc-2081	281	20	patients	patient	NOUN
dpc-2081	281	21	,	,	PUNCT
dpc-2081	281	22	apart	apart	ADV
dpc-2081	281	23	from	from	ADP
dpc-2081	281	24	revealing	reveal	VERB
dpc-2081	281	25	the	the	DET
dpc-2081	281	26	frequency	frequency	NOUN
dpc-2081	281	27	of	of	ADP
dpc-2081	281	28	bd	bd	PROPN
dpc-2081	281	29	in	in	ADP
dpc-2081	281	30	hs	hs	PROPN
dpc-2081	281	31	patients	patient	NOUN
dpc-2081	281	32	.	.	PUNCT
dpc-2081	282	1	although	although	SCONJ
dpc-2081	282	2	the	the	DET
dpc-2081	282	3	course	course	NOUN
dpc-2081	282	4	of	of	ADP
dpc-2081	282	5	covid-19	covid-19	PROPN
dpc-2081	282	6	in	in	ADP
dpc-2081	282	7	hs	hs	PROPN
dpc-2081	282	8	patients	patient	NOUN
dpc-2081	282	9	was	be	AUX
dpc-2081	282	10	not	not	PART
dpc-2081	282	11	an	an	DET
dpc-2081	282	12	outcome	outcome	NOUN
dpc-2081	282	13	measure	measure	NOUN
dpc-2081	282	14	for	for	ADP
dpc-2081	282	15	this	this	DET
dpc-2081	282	16	study	study	NOUN
dpc-2081	282	17	,	,	PUNCT
dpc-2081	282	18	the	the	DET
dpc-2081	282	19	authors	author	NOUN
dpc-2081	282	20	observations	observation	NOUN
dpc-2081	282	21	are	be	AUX
dpc-2081	282	22	the	the	DET
dpc-2081	282	23	line	line	NOUN
dpc-2081	282	24	with	with	ADP
dpc-2081	282	25	the	the	DET
dpc-2081	282	26	findings	finding	NOUN
dpc-2081	282	27	of	of	ADP
dpc-2081	282	28	the	the	DET
dpc-2081	282	29	recent	recent	ADJ
dpc-2081	282	30	report	report	NOUN
dpc-2081	282	31	by	by	ADP
dpc-2081	282	32	dewigne	dewigne	PROPN
dpc-2081	282	33	et	et	PROPN
dpc-2081	282	34	al	al	PROPN
dpc-2081	282	35	and	and	CCONJ
dpc-2081	282	36	support	support	VERB
dpc-2081	282	37	that	that	SCONJ
dpc-2081	282	38	the	the	DET
dpc-2081	282	39	prevalence	prevalence	NOUN
dpc-2081	282	40	of	of	ADP
dpc-2081	282	41	covid-19	covid-19	PROPN
dpc-2081	282	42	is	be	AUX
dpc-2081	282	43	not	not	PART
dpc-2081	282	44	higher	high	ADJ
dpc-2081	282	45	in	in	ADP
dpc-2081	282	46	hs	hs	PROPN
dpc-2081	282	47	patients	patient	NOUN
dpc-2081	282	48	,	,	PUNCT
dpc-2081	282	49	despite	despite	SCONJ
dpc-2081	282	50	the	the	DET
dpc-2081	282	51	many	many	ADJ
dpc-2081	282	52	accompanying	accompanying	ADJ
dpc-2081	282	53	medical	medical	ADJ
dpc-2081	282	54	comorbidities	comorbiditie	NOUN
dpc-2081	282	55	and	and	CCONJ
dpc-2081	282	56	risk	risk	NOUN
dpc-2081	282	57	factors	factor	NOUN
dpc-2081	282	58	in	in	ADP
dpc-2081	282	59	hs	hs	PROPN
dpc-2081	282	60	[	[	X
dpc-2081	282	61	37	37	NUM
dpc-2081	282	62	]	]	PUNCT
dpc-2081	282	63	.	.	PUNCT
dpc-2081	283	1	during	during	ADP
dpc-2081	283	2	the	the	DET
dpc-2081	283	3	period	period	NOUN
dpc-2081	283	4	of	of	ADP
dpc-2081	283	5	this	this	DET
dpc-2081	283	6	study	study	NOUN
dpc-2081	283	7	,	,	PUNCT
dpc-2081	283	8	only	only	ADV
dpc-2081	283	9	1	1	NUM
dpc-2081	283	10	patient	patient	NOUN
dpc-2081	283	11	in	in	ADP
dpc-2081	283	12	our	our	PRON
dpc-2081	283	13	hs	hs	PROPN
dpc-2081	283	14	study	study	PROPN
dpc-2081	283	15	group	group	NOUN
dpc-2081	283	16	(	(	PUNCT
dpc-2081	283	17	n	n	NOUN
dpc-2081	283	18	=	=	SYM
dpc-2081	283	19	247	247	NUM
dpc-2081	283	20	)	)	PUNCT
dpc-2081	283	21	died	die	VERB
dpc-2081	283	22	in	in	ADP
dpc-2081	283	23	the	the	DET
dpc-2081	283	24	intensive	intensive	ADJ
dpc-2081	283	25	care	care	NOUN
dpc-2081	283	26	unit	unit	NOUN
dpc-2081	283	27	due	due	ADP
dpc-2081	283	28	to	to	ADP
dpc-2081	283	29	covid-19	covid-19	PROPN
dpc-2081	283	30	.	.	PUNCT
dpc-2081	284	1	this	this	DET
dpc-2081	284	2	case	case	NOUN
dpc-2081	284	3	had	have	VERB
dpc-2081	284	4	concomitant	concomitant	ADJ
dpc-2081	284	5	rheumatoid	rheumatoid	VERB
dpc-2081	284	6	arthritis	arthritis	NOUN
dpc-2081	284	7	and	and	CCONJ
dpc-2081	284	8	familial	familial	ADJ
dpc-2081	284	9	mediterranean	mediterranean	ADJ
dpc-2081	284	10	fever	fever	NOUN
dpc-2081	284	11	and	and	CCONJ
dpc-2081	284	12	was	be	AUX
dpc-2081	284	13	under	under	ADP
dpc-2081	284	14	6	6	NUM
dpc-2081	284	15	-	-	PUNCT
dpc-2081	284	16	month	month	NOUN
dpc-2081	284	17	certolizumab	certolizumab	NOUN
dpc-2081	284	18	pegol	pegol	NOUN
dpc-2081	284	19	treatment	treatment	NOUN
dpc-2081	284	20	for	for	ADP
dpc-2081	284	21	hs	hs	PROPN
dpc-2081	284	22	.	.	PUNCT
dpc-2081	285	1	the	the	DET
dpc-2081	285	2	small	small	ADJ
dpc-2081	285	3	sample	sample	NOUN
dpc-2081	285	4	size	size	NOUN
dpc-2081	285	5	and	and	CCONJ
dpc-2081	285	6	the	the	DET
dpc-2081	285	7	retrospective	retrospective	ADJ
dpc-2081	285	8	nature	nature	NOUN
dpc-2081	285	9	were	be	AUX
dpc-2081	285	10	the	the	DET
dpc-2081	285	11	major	major	ADJ
dpc-2081	285	12	limitations	limitation	NOUN
dpc-2081	285	13	of	of	ADP
dpc-2081	285	14	the	the	DET
dpc-2081	285	15	current	current	ADJ
dpc-2081	285	16	study	study	NOUN
dpc-2081	285	17	.	.	PUNCT
dpc-2081	286	1	since	since	SCONJ
dpc-2081	286	2	our	our	PRON
dpc-2081	286	3	center	center	NOUN
dpc-2081	286	4	is	be	AUX
dpc-2081	286	5	a	a	DET
dpc-2081	286	6	referral	referral	ADJ
dpc-2081	286	7	tertiary	tertiary	ADJ
dpc-2081	286	8	healthcare	healthcare	NOUN
dpc-2081	286	9	institution	institution	NOUN
dpc-2081	286	10	with	with	ADP
dpc-2081	286	11	special	special	ADJ
dpc-2081	286	12	hs	hs	PROPN
dpc-2081	286	13	outpatient	outpatient	NOUN
dpc-2081	286	14	clinic	clinic	NOUN
dpc-2081	286	15	,	,	PUNCT
dpc-2081	286	16	this	this	PRON
dpc-2081	286	17	affects	affect	VERB
dpc-2081	286	18	the	the	DET
dpc-2081	286	19	generalizability	generalizability	NOUN
dpc-2081	286	20	of	of	ADP
dpc-2081	286	21	our	our	PRON
dpc-2081	286	22	results	result	NOUN
dpc-2081	286	23	.	.	PUNCT
dpc-2081	287	1	however	however	ADV
dpc-2081	287	2	,	,	PUNCT
dpc-2081	287	3	from	from	ADP
dpc-2081	287	4	a	a	DET
dpc-2081	287	5	deductive	deductive	ADJ
dpc-2081	287	6	perspective	perspective	NOUN
dpc-2081	287	7	,	,	PUNCT
dpc-2081	287	8	we	we	PRON
dpc-2081	287	9	believe	believe	VERB
dpc-2081	287	10	that	that	SCONJ
dpc-2081	287	11	this	this	DET
dpc-2081	287	12	case	case	NOUN
dpc-2081	287	13	series	series	NOUN
dpc-2081	287	14	will	will	AUX
dpc-2081	287	15	complement	complement	VERB
dpc-2081	287	16	the	the	DET
dpc-2081	287	17	available	available	ADJ
dpc-2081	287	18	nationwide	nationwide	ADJ
dpc-2081	287	19	surveys	survey	NOUN
dpc-2081	287	20	on	on	ADP
dpc-2081	287	21	this	this	DET
dpc-2081	287	22	relatively	relatively	ADV
dpc-2081	287	23	novel	novel	ADJ
dpc-2081	287	24	subject	subject	NOUN
dpc-2081	287	25	to	to	PART
dpc-2081	287	26	provide	provide	VERB
dpc-2081	287	27	essential	essential	ADJ
dpc-2081	287	28	insights	insight	NOUN
dpc-2081	287	29	.	.	PUNCT
dpc-2081	288	1	the	the	DET
dpc-2081	288	2	current	current	ADJ
dpc-2081	288	3	retrospective	retrospective	ADJ
dpc-2081	288	4	analysis	analysis	NOUN
dpc-2081	288	5	results	result	NOUN
dpc-2081	288	6	verify	verify	VERB
dpc-2081	288	7	that	that	SCONJ
dpc-2081	288	8	the	the	DET
dpc-2081	288	9	prevalence	prevalence	NOUN
dpc-2081	288	10	of	of	ADP
dpc-2081	288	11	bd	bd	PROPN
dpc-2081	288	12	in	in	ADP
dpc-2081	288	13	hs	hs	PROPN
dpc-2081	288	14	patients	patient	NOUN
dpc-2081	288	15	is	be	AUX
dpc-2081	288	16	higher	high	ADJ
dpc-2081	288	17	than	than	ADP
dpc-2081	288	18	psoriasis	psoriasis	NOUN
dpc-2081	288	19	patients	patient	NOUN
dpc-2081	288	20	and	and	CCONJ
dpc-2081	288	21	controls	control	NOUN
dpc-2081	288	22	.	.	PUNCT
dpc-2081	289	1	another	another	DET
dpc-2081	289	2	factor	factor	NOUN
dpc-2081	289	3	to	to	PART
dpc-2081	289	4	keep	keep	VERB
dpc-2081	289	5	in	in	ADP
dpc-2081	289	6	mind	mind	NOUN
dpc-2081	289	7	is	be	AUX
dpc-2081	289	8	that	that	SCONJ
dpc-2081	289	9	the	the	DET
dpc-2081	289	10	real	real	ADJ
dpc-2081	289	11	-	-	PUNCT
dpc-2081	289	12	life	life	NOUN
dpc-2081	289	13	prevalence	prevalence	NOUN
dpc-2081	289	14	of	of	ADP
dpc-2081	289	15	bd	bd	PROPN
dpc-2081	289	16	in	in	ADP
dpc-2081	289	17	hs	hs	PRON
dpc-2081	289	18	could	could	AUX
dpc-2081	289	19	be	be	AUX
dpc-2081	289	20	higher	high	ADJ
dpc-2081	289	21	than	than	SCONJ
dpc-2081	289	22	expected	expect	VERB
dpc-2081	289	23	due	due	ADP
dpc-2081	289	24	to	to	ADP
dpc-2081	289	25	the	the	DET
dpc-2081	289	26	underdiagnosis	underdiagnosis	NOUN
dpc-2081	289	27	of	of	ADP
dpc-2081	289	28	hs	hs	PROPN
dpc-2081	289	29	.	.	PUNCT
dpc-2081	289	30	different	different	ADJ
dpc-2081	289	31	aspects	aspect	NOUN
dpc-2081	289	32	of	of	ADP
dpc-2081	289	33	this	this	DET
dpc-2081	289	34	co	co	NOUN
dpc-2081	289	35	-	-	NOUN
dpc-2081	289	36	existence	existence	NOUN
dpc-2081	289	37	need	need	VERB
dpc-2081	289	38	to	to	PART
dpc-2081	289	39	be	be	AUX
dpc-2081	289	40	elucidated	elucidate	VERB
dpc-2081	289	41	in	in	ADP
dpc-2081	289	42	the	the	DET
dpc-2081	289	43	future	future	NOUN
dpc-2081	289	44	with	with	ADP
dpc-2081	289	45	an	an	DET
dpc-2081	289	46	ideal	ideal	ADJ
dpc-2081	289	47	treatment	treatment	NOUN
dpc-2081	289	48	strategy	strategy	NOUN
dpc-2081	289	49	to	to	PART
dpc-2081	289	50	prevent	prevent	VERB
dpc-2081	289	51	these	these	DET
dpc-2081	289	52	patients	patient	NOUN
dpc-2081	289	53	from	from	ADP
dpc-2081	289	54	lithium	lithium	NOUN
dpc-2081	289	55	-	-	PUNCT
dpc-2081	289	56	induced	induce	VERB
dpc-2081	289	57	exacerbations	exacerbation	NOUN
dpc-2081	289	58	.	.	PUNCT
dpc-2081	290	1	a	a	DET
dpc-2081	290	2	detailed	detailed	ADJ
dpc-2081	290	3	understanding	understanding	NOUN
dpc-2081	290	4	of	of	ADP
dpc-2081	290	5	the	the	DET
dpc-2081	290	6	common	common	ADJ
dpc-2081	290	7	immunologic	immunologic	ADJ
dpc-2081	290	8	and	and	CCONJ
dpc-2081	290	9	possibly	possibly	ADV
dpc-2081	290	10	genetic	genetic	ADJ
dpc-2081	290	11	alterations	alteration	NOUN
dpc-2081	290	12	in	in	ADP
dpc-2081	290	13	both	both	DET
dpc-2081	290	14	diseases	disease	NOUN
dpc-2081	290	15	seems	seem	VERB
dpc-2081	290	16	crucial	crucial	ADJ
dpc-2081	290	17	in	in	ADP
dpc-2081	290	18	identifying	identify	VERB
dpc-2081	290	19	a	a	DET
dpc-2081	290	20	targeted	target	VERB
dpc-2081	290	21	therapy	therapy	NOUN
dpc-2081	290	22	or	or	CCONJ
dpc-2081	290	23	optimal	optimal	ADJ
dpc-2081	290	24	treatment	treatment	NOUN
dpc-2081	290	25	combination	combination	NOUN
dpc-2081	290	26	in	in	ADP
dpc-2081	290	27	patients	patient	NOUN
dpc-2081	290	28	with	with	ADP
dpc-2081	290	29	bd	bd	PROPN
dpc-2081	290	30	and	and	CCONJ
dpc-2081	290	31	hs	hs	PROPN
dpc-2081	290	32	.	.	PROPN
dpc-2081	290	33	references	reference	NOUN
dpc-2081	290	34	1	1	NUM
dpc-2081	290	35	.	.	PUNCT
dpc-2081	291	1	alikhan	alikhan	PROPN
dpc-2081	291	2	a	a	PROPN
dpc-2081	291	3	,	,	PUNCT
dpc-2081	291	4	sayed	sayed	ADJ
dpc-2081	291	5	c	c	PROPN
dpc-2081	291	6	,	,	PUNCT
dpc-2081	291	7	alavi	alavi	VERB
dpc-2081	291	8	a	a	PRON
dpc-2081	291	9	,	,	PUNCT
dpc-2081	291	10	et	et	PROPN
dpc-2081	291	11	al	al	PROPN
dpc-2081	291	12	.	.	PROPN
dpc-2081	292	1	north	north	PROPN
dpc-2081	292	2	american	american	PROPN
dpc-2081	292	3	clinical	clinical	ADJ
dpc-2081	292	4	management	management	NOUN
dpc-2081	292	5	guidelines	guideline	NOUN
dpc-2081	292	6	for	for	ADP
dpc-2081	292	7	hidradenitis	hidradenitis	PROPN
dpc-2081	292	8	suppurativa	suppurativa	NOUN
dpc-2081	292	9	:	:	PUNCT
dpc-2081	292	10	a	a	DET
dpc-2081	292	11	publication	publication	NOUN
dpc-2081	292	12	from	from	ADP
dpc-2081	292	13	the	the	DET
dpc-2081	292	14	united	united	PROPN
dpc-2081	292	15	states	states	PROPN
dpc-2081	292	16	and	and	CCONJ
dpc-2081	292	17	canadian	canadian	ADJ
dpc-2081	292	18	hidradenitis	hidradenitis	PROPN
dpc-2081	292	19	suppurativa	suppurativa	PROPN
dpc-2081	292	20	foundations	foundation	NOUN
dpc-2081	292	21	:	:	PUNCT
dpc-2081	292	22	part	part	NOUN
dpc-2081	292	23	i	i	PRON
dpc-2081	292	24	:	:	PUNCT
dpc-2081	292	25	diagnosis	diagnosis	NOUN
dpc-2081	292	26	,	,	PUNCT
dpc-2081	292	27	evaluation	evaluation	NOUN
dpc-2081	292	28	,	,	PUNCT
dpc-2081	292	29	and	and	CCONJ
dpc-2081	292	30	the	the	DET
dpc-2081	292	31	use	use	NOUN
dpc-2081	292	32	of	of	ADP
dpc-2081	292	33	complementary	complementary	ADJ
dpc-2081	292	34	and	and	CCONJ
dpc-2081	292	35	procedural	procedural	ADJ
dpc-2081	292	36	management	management	NOUN
dpc-2081	292	37	.	.	PUNCT
dpc-2081	293	1	j	j	PROPN
dpc-2081	293	2	am	be	AUX
dpc-2081	293	3	acad	acad	ADJ
dpc-2081	293	4	dermatol	dermatol	NOUN
dpc-2081	293	5	.	.	PUNCT
dpc-2081	294	1	original	original	ADJ
dpc-2081	294	2	article	article	NOUN
dpc-2081	294	3	|	|	ADV
dpc-2081	294	4	dermatol	dermatol	ADJ
dpc-2081	294	5	pract	pract	NOUN
dpc-2081	294	6	concept	concept	NOUN
dpc-2081	294	7	.	.	PUNCT
dpc-2081	295	1	2022;12(4):e2022208	2022;12(4):e2022208	NUM
dpc-2081	295	2	7	7	NUM
dpc-2081	295	3	epidemiology	epidemiology	NOUN
dpc-2081	295	4	.	.	PUNCT
dpc-2081	296	1	bull	bull	PROPN
dpc-2081	296	2	world	world	PROPN
dpc-2081	296	3	health	health	NOUN
dpc-2081	296	4	organ	organ	NOUN
dpc-2081	296	5	.	.	PUNCT
dpc-2081	297	1	2000;78(4):413	2000;78(4):413	NUM
dpc-2081	297	2	-	-	PUNCT
dpc-2081	297	3	426	426	NUM
dpc-2081	297	4	.	.	PUNCT
dpc-2081	298	1	pmid	pmid	NOUN
dpc-2081	298	2	:	:	PUNCT
dpc-2081	298	3	10885160	10885160	NUM
dpc-2081	298	4	.	.	PUNCT
dpc-2081	299	1	pmcid	pmcid	ADJ
dpc-2081	299	2	:	:	PUNCT
dpc-2081	299	3	pmc2560724.29	pmc2560724.29	NOUN
dpc-2081	299	4	.	.	PUNCT
dpc-2081	300	1	scala	scala	PROPN
dpc-2081	300	2	e	e	PROPN
dpc-2081	300	3	,	,	PUNCT
dpc-2081	300	4	di	di	X
dpc-2081	300	5	caprio	caprio	PROPN
dpc-2081	300	6	r	r	PROPN
dpc-2081	300	7	,	,	PUNCT
dpc-2081	300	8	cacciapuoti	cacciapuoti	NOUN
dpc-2081	300	9	s	s	PROPN
dpc-2081	300	10	,	,	PUNCT
dpc-2081	300	11	et	et	PROPN
dpc-2081	300	12	al	al	PROPN
dpc-2081	300	13	.	.	PUNCT
dpc-2081	301	1	a	a	DET
dpc-2081	301	2	new	new	ADJ
dpc-2081	301	3	t	t	PROPN
dpc-2081	301	4	helper	helper	NOUN
dpc-2081	301	5	17	17	NUM
dpc-2081	301	6	cytokine	cytokine	NOUN
dpc-2081	301	7	in	in	ADP
dpc-2081	301	8	hidradenitis	hidradenitis	PROPN
dpc-2081	301	9	suppurativa	suppurativa	NOUN
dpc-2081	301	10	:	:	PUNCT
dpc-2081	301	11	antimicrobial	antimicrobial	ADJ
dpc-2081	301	12	and	and	CCONJ
dpc-2081	301	13	proinflammatory	proinflammatory	ADJ
dpc-2081	301	14	role	role	NOUN
dpc-2081	301	15	of	of	ADP
dpc-2081	301	16	interleukin-26	interleukin-26	PROPN
dpc-2081	301	17	.	.	PUNCT
dpc-2081	302	1	br	br	PROPN
dpc-2081	302	2	j	j	PROPN
dpc-2081	302	3	dermatol	dermatol	NOUN
dpc-2081	302	4	.	.	PUNCT
dpc-2081	303	1	2019;181(5):1038	2019;181(5):1038	NUM
dpc-2081	303	2	-	-	PUNCT
dpc-2081	303	3	1045	1045	NUM
dpc-2081	303	4	.	.	PUNCT
dpc-2081	304	1	doi	doi	NOUN
dpc-2081	304	2	:	:	PUNCT
dpc-2081	304	3	10.1111	10.1111	NUM
dpc-2081	304	4	/	/	SYM
dpc-2081	304	5	bjd.17854	bjd.17854	X
dpc-2081	304	6	.	.	PUNCT
dpc-2081	305	1	pmid	pmid	NOUN
dpc-2081	305	2	:	:	PUNCT
dpc-2081	305	3	30829398	30829398	NUM
dpc-2081	305	4	.	.	PUNCT
dpc-2081	306	1	29	29	NUM
dpc-2081	306	2	.	.	PUNCT
dpc-2081	307	1	ryan	ryan	PROPN
dpc-2081	307	2	c	c	PROPN
dpc-2081	307	3	,	,	PUNCT
dpc-2081	307	4	sobell	sobell	PROPN
dpc-2081	307	5	jm	jm	PROPN
dpc-2081	307	6	,	,	PUNCT
dpc-2081	307	7	leonardi	leonardi	PROPN
dpc-2081	307	8	cl	cl	PROPN
dpc-2081	307	9	,	,	PUNCT
dpc-2081	307	10	et	et	PROPN
dpc-2081	307	11	al	al	PROPN
dpc-2081	307	12	.	.	PROPN
dpc-2081	307	13	safety	safety	NOUN
dpc-2081	307	14	of	of	ADP
dpc-2081	307	15	adalimumab	adalimumab	NOUN
dpc-2081	307	16	dosed	dose	VERB
dpc-2081	307	17	every	every	DET
dpc-2081	307	18	week	week	NOUN
dpc-2081	307	19	and	and	CCONJ
dpc-2081	307	20	every	every	DET
dpc-2081	307	21	other	other	ADJ
dpc-2081	307	22	week	week	NOUN
dpc-2081	307	23	:	:	PUNCT
dpc-2081	307	24	focus	focus	VERB
dpc-2081	307	25	on	on	ADP
dpc-2081	307	26	patients	patient	NOUN
dpc-2081	307	27	with	with	ADP
dpc-2081	307	28	hidradenitis	hidradenitis	PROPN
dpc-2081	307	29	suppurativa	suppurativa	NOUN
dpc-2081	307	30	or	or	CCONJ
dpc-2081	307	31	psoriasis	psoriasis	NOUN
dpc-2081	307	32	.	.	PUNCT
dpc-2081	308	1	am	be	AUX
dpc-2081	308	2	j	j	PROPN
dpc-2081	308	3	clin	clin	PROPN
dpc-2081	308	4	dermatol	dermatol	NOUN
dpc-2081	308	5	.	.	PUNCT
dpc-2081	309	1	2018;19(3):437	2018;19(3):437	NUM
dpc-2081	309	2	-	-	SYM
dpc-2081	309	3	447	447	NUM
dpc-2081	309	4	.	.	PUNCT
dpc-2081	309	5	doi	doi	NOUN
dpc-2081	309	6	:	:	PUNCT
dpc-2081	309	7	10.1007	10.1007	NUM
dpc-2081	309	8	/	/	SYM
dpc-2081	309	9	s40257	s40257	NOUN
dpc-2081	309	10	-	-	PUNCT
dpc-2081	309	11	017	017	NUM
dpc-2081	309	12	-	-	PUNCT
dpc-2081	309	13	0341	0341	NUM
dpc-2081	309	14	-	-	PUNCT
dpc-2081	309	15	6	6	NUM
dpc-2081	309	16	.	.	PUNCT
dpc-2081	310	1	pmid	pmid	NOUN
dpc-2081	310	2	:	:	PUNCT
dpc-2081	310	3	29380251	29380251	NUM
dpc-2081	310	4	.	.	PUNCT
dpc-2081	311	1	pmcid	pmcid	NOUN
dpc-2081	311	2	:	:	PUNCT
dpc-2081	311	3	pmc5945711	pmc5945711	NOUN
dpc-2081	311	4	.	.	PUNCT
dpc-2081	312	1	30	30	NUM
dpc-2081	312	2	.	.	PUNCT
dpc-2081	313	1	hao	hao	PROPN
dpc-2081	313	2	y	y	PROPN
dpc-2081	313	3	,	,	PUNCT
dpc-2081	313	4	zhu	zhu	PROPN
dpc-2081	313	5	yj	yj	PROPN
dpc-2081	313	6	,	,	PUNCT
dpc-2081	313	7	zou	zou	PROPN
dpc-2081	313	8	s	s	PROPN
dpc-2081	313	9	,	,	PUNCT
dpc-2081	313	10	et	et	PROPN
dpc-2081	313	11	al	al	PROPN
dpc-2081	313	12	.	.	PROPN
dpc-2081	313	13	metabolic	metabolic	PROPN
dpc-2081	313	14	syndrome	syndrome	NOUN
dpc-2081	313	15	and	and	CCONJ
dpc-2081	313	16	psoriasis	psoriasis	NOUN
dpc-2081	313	17	:	:	PUNCT
dpc-2081	313	18	mechanisms	mechanism	NOUN
dpc-2081	313	19	and	and	CCONJ
dpc-2081	313	20	future	future	ADJ
dpc-2081	313	21	directions	direction	NOUN
dpc-2081	313	22	.	.	PUNCT
dpc-2081	314	1	front	front	ADJ
dpc-2081	314	2	immunol	immunol	NOUN
dpc-2081	314	3	.	.	PUNCT
dpc-2081	315	1	2021;12:711060	2021;12:711060	X
dpc-2081	315	2	.	.	PUNCT
dpc-2081	315	3	doi	doi	NOUN
dpc-2081	315	4	:	:	PUNCT
dpc-2081	315	5	10.3389	10.3389	NUM
dpc-2081	315	6	/	/	SYM
dpc-2081	315	7	fimmu.2021.711060	fimmu.2021.711060	NOUN
dpc-2081	315	8	.	.	PUNCT
dpc-2081	316	1	pmid	pmid	NOUN
dpc-2081	316	2	:	:	PUNCT
dpc-2081	316	3	34367173	34367173	NUM
dpc-2081	316	4	.	.	PUNCT
dpc-2081	317	1	pmcid	pmcid	NOUN
dpc-2081	317	2	:	:	PUNCT
dpc-2081	317	3	pmc8343100	pmc8343100	NOUN
dpc-2081	317	4	.	.	PUNCT
dpc-2081	318	1	31	31	NUM
dpc-2081	318	2	.	.	PUNCT
dpc-2081	319	1	lee	lee	PROPN
dpc-2081	319	2	y	y	PROPN
dpc-2081	319	3	,	,	PUNCT
dpc-2081	319	4	mansur	mansur	PROPN
dpc-2081	319	5	rb	rb	PROPN
dpc-2081	319	6	,	,	PUNCT
dpc-2081	319	7	brietzke	brietzke	NOUN
dpc-2081	319	8	e	e	PROPN
dpc-2081	319	9	,	,	PUNCT
dpc-2081	319	10	et	et	PROPN
dpc-2081	319	11	al	al	PROPN
dpc-2081	319	12	.	.	PROPN
dpc-2081	319	13	efficacy	efficacy	NOUN
dpc-2081	319	14	of	of	ADP
dpc-2081	319	15	adjunctive	adjunctive	ADJ
dpc-2081	319	16	infliximab	infliximab	NOUN
dpc-2081	319	17	vs.	vs.	ADP
dpc-2081	319	18	placebo	placebo	NOUN
dpc-2081	319	19	in	in	ADP
dpc-2081	319	20	the	the	DET
dpc-2081	319	21	treatment	treatment	NOUN
dpc-2081	319	22	of	of	ADP
dpc-2081	319	23	anhedonia	anhedonia	NOUN
dpc-2081	319	24	in	in	ADP
dpc-2081	319	25	bipolar	bipolar	ADJ
dpc-2081	319	26	i	i	PROPN
dpc-2081	319	27	/	/	SYM
dpc-2081	319	28	ii	ii	PROPN
dpc-2081	319	29	depression	depression	NOUN
dpc-2081	319	30	.	.	PUNCT
dpc-2081	320	1	brain	brain	NOUN
dpc-2081	320	2	behav	behav	PROPN
dpc-2081	320	3	immun	immun	PROPN
dpc-2081	320	4	.	.	PUNCT
dpc-2081	321	1	2020;88:631	2020;88:631	PROPN
dpc-2081	321	2	-	-	PUNCT
dpc-2081	321	3	639	639	NUM
dpc-2081	321	4	.	.	PUNCT
dpc-2081	322	1	doi	doi	NOUN
dpc-2081	322	2	:	:	PUNCT
dpc-2081	322	3	10.1016	10.1016	NUM
dpc-2081	322	4	/	/	SYM
dpc-2081	322	5	j.bbi.2020.04.063	j.bbi.2020.04.063	PROPN
dpc-2081	322	6	.	.	PUNCT
dpc-2081	323	1	e	e	X
dpc-2081	323	2	pmid	pmid	NOUN
dpc-2081	323	3	:	:	PUNCT
dpc-2081	323	4	32380271	32380271	NUM
dpc-2081	323	5	.	.	PUNCT
dpc-2081	324	1	32	32	NUM
dpc-2081	324	2	.	.	PUNCT
dpc-2081	325	1	mcintyre	mcintyre	PROPN
dpc-2081	325	2	rs	rs	PROPN
dpc-2081	325	3	,	,	PUNCT
dpc-2081	325	4	subramaniapillai	subramaniapillai	PROPN
dpc-2081	325	5	m	m	PROPN
dpc-2081	325	6	,	,	PUNCT
dpc-2081	325	7	lee	lee	PROPN
dpc-2081	325	8	y	y	PROPN
dpc-2081	325	9	,	,	PUNCT
dpc-2081	325	10	et	et	PROPN
dpc-2081	325	11	al	al	PROPN
dpc-2081	325	12	.	.	PROPN
dpc-2081	325	13	efficacy	efficacy	NOUN
dpc-2081	325	14	of	of	ADP
dpc-2081	325	15	adjunctive	adjunctive	ADJ
dpc-2081	325	16	infliximab	infliximab	NOUN
dpc-2081	325	17	vs	vs	ADP
dpc-2081	325	18	placebo	placebo	NOUN
dpc-2081	325	19	in	in	ADP
dpc-2081	325	20	the	the	DET
dpc-2081	325	21	treatment	treatment	NOUN
dpc-2081	325	22	of	of	ADP
dpc-2081	325	23	adults	adult	NOUN
dpc-2081	325	24	with	with	ADP
dpc-2081	325	25	bipolar	bipolar	ADJ
dpc-2081	325	26	i	i	PROPN
dpc-2081	325	27	/	/	SYM
dpc-2081	325	28	ii	ii	NOUN
dpc-2081	325	29	depression	depression	NOUN
dpc-2081	325	30	:	:	PUNCT
dpc-2081	325	31	a	a	DET
dpc-2081	325	32	randomized	randomized	ADJ
dpc-2081	325	33	clinical	clinical	ADJ
dpc-2081	325	34	trial	trial	NOUN
dpc-2081	325	35	.	.	PUNCT
dpc-2081	326	1	ama	ama	PROPN
dpc-2081	326	2	psychiatry	psychiatry	NOUN
dpc-2081	326	3	.	.	PUNCT
dpc-2081	327	1	2019;76(8):783	2019;76(8):783	NUM
dpc-2081	327	2	-	-	PUNCT
dpc-2081	327	3	790	790	NUM
dpc-2081	327	4	.	.	PUNCT
dpc-2081	328	1	doi	doi	NOUN
dpc-2081	328	2	:	:	PUNCT
dpc-2081	328	3	10.1001	10.1001	NUM
dpc-2081	328	4	/	/	SYM
dpc-2081	328	5	jamapsychiatry.2019.0779	jamapsychiatry.2019.0779	PROPN
dpc-2081	328	6	.	.	PUNCT
dpc-2081	329	1	pmid	pmid	NOUN
dpc-2081	329	2	:	:	PUNCT
dpc-2081	329	3	31066887	31066887	NUM
dpc-2081	329	4	.	.	PUNCT
dpc-2081	330	1	pmcid	pmcid	ADJ
dpc-2081	330	2	:	:	PUNCT
dpc-2081	330	3	pmc6506894	pmc6506894	ADJ
dpc-2081	330	4	.	.	PUNCT
dpc-2081	331	1	33	33	NUM
dpc-2081	331	2	.	.	PUNCT
dpc-2081	332	1	raison	raison	NOUN
dpc-2081	332	2	cl	cl	PROPN
dpc-2081	332	3	,	,	PUNCT
dpc-2081	332	4	rutherford	rutherford	PROPN
dpc-2081	332	5	re	re	PROPN
dpc-2081	332	6	,	,	PUNCT
dpc-2081	332	7	woolwine	woolwine	VERB
dpc-2081	332	8	bj	bj	VERB
dpc-2081	332	9	,	,	PUNCT
dpc-2081	332	10	et	et	PROPN
dpc-2081	332	11	al	al	PROPN
dpc-2081	332	12	.	.	PUNCT
dpc-2081	333	1	a	a	DET
dpc-2081	333	2	randomized	randomized	ADJ
dpc-2081	333	3	controlled	control	VERB
dpc-2081	333	4	trial	trial	NOUN
dpc-2081	333	5	of	of	ADP
dpc-2081	333	6	the	the	DET
dpc-2081	333	7	tumor	tumor	NOUN
dpc-2081	333	8	necrosis	necrosis	NOUN
dpc-2081	333	9	factor	factor	NOUN
dpc-2081	333	10	antagonist	antagonist	NOUN
dpc-2081	333	11	infliximab	infliximab	NOUN
dpc-2081	333	12	for	for	ADP
dpc-2081	333	13	treatment	treatment	NOUN
dpc-2081	333	14	-	-	PUNCT
dpc-2081	333	15	resistant	resistant	ADJ
dpc-2081	333	16	depression	depression	NOUN
dpc-2081	333	17	:	:	PUNCT
dpc-2081	333	18	the	the	DET
dpc-2081	333	19	role	role	NOUN
dpc-2081	333	20	of	of	ADP
dpc-2081	333	21	baseline	baseline	ADJ
dpc-2081	333	22	inflammatory	inflammatory	ADJ
dpc-2081	333	23	biomarkers	biomarker	NOUN
dpc-2081	333	24	.	.	PUNCT
dpc-2081	334	1	jama	jama	PROPN
dpc-2081	334	2	psychiatry	psychiatry	PROPN
dpc-2081	334	3	.	.	PUNCT
dpc-2081	335	1	2013;70(1):3141	2013;70(1):3141	X
dpc-2081	335	2	.	.	PUNCT
dpc-2081	336	1	doi	doi	NOUN
dpc-2081	336	2	:	:	PUNCT
dpc-2081	336	3	10.1001/2013.jamapsychiatry.4	10.1001/2013.jamapsychiatry.4	NUM
dpc-2081	336	4	.	.	PUNCT
dpc-2081	337	1	pmid	pmid	NOUN
dpc-2081	337	2	:	:	PUNCT
dpc-2081	337	3	22945416	22945416	NUM
dpc-2081	337	4	.	.	PUNCT
dpc-2081	338	1	pmcid	pmcid	NOUN
dpc-2081	338	2	:	:	PUNCT
dpc-2081	338	3	pmc4015348	pmc4015348	ADJ
dpc-2081	338	4	.	.	PUNCT
dpc-2081	339	1	34	34	NUM
dpc-2081	339	2	.	.	PUNCT
dpc-2081	340	1	mansur	mansur	PROPN
dpc-2081	340	2	rb	rb	PROPN
dpc-2081	340	3	,	,	PUNCT
dpc-2081	340	4	delgado	delgado	NOUN
dpc-2081	340	5	-	-	PUNCT
dpc-2081	340	6	peraza	peraza	NOUN
dpc-2081	340	7	f	f	PROPN
dpc-2081	340	8	,	,	PUNCT
dpc-2081	340	9	subramaniapillai	subramaniapillai	PROPN
dpc-2081	340	10	m	m	PROPN
dpc-2081	340	11	,	,	PUNCT
dpc-2081	340	12	et	et	PROPN
dpc-2081	340	13	al	al	PROPN
dpc-2081	340	14	.	.	PROPN
dpc-2081	340	15	extracellular	extracellular	ADJ
dpc-2081	340	16	vesicle	vesicle	NOUN
dpc-2081	340	17	biomarkers	biomarker	NOUN
dpc-2081	340	18	reveal	reveal	VERB
dpc-2081	340	19	inhibition	inhibition	NOUN
dpc-2081	340	20	of	of	ADP
dpc-2081	340	21	neuroinflammation	neuroinflammation	NOUN
dpc-2081	340	22	by	by	ADP
dpc-2081	340	23	infliximab	infliximab	NOUN
dpc-2081	340	24	in	in	ADP
dpc-2081	340	25	association	association	NOUN
dpc-2081	340	26	with	with	ADP
dpc-2081	340	27	antidepressant	antidepressant	ADJ
dpc-2081	340	28	response	response	NOUN
dpc-2081	340	29	in	in	ADP
dpc-2081	340	30	adults	adult	NOUN
dpc-2081	340	31	with	with	ADP
dpc-2081	340	32	bipolar	bipolar	ADJ
dpc-2081	340	33	depression	depression	NOUN
dpc-2081	340	34	.	.	PUNCT
dpc-2081	341	1	cells	cell	NOUN
dpc-2081	341	2	.	.	PUNCT
dpc-2081	342	1	2020;9(4);895	2020;9(4);895	X
dpc-2081	342	2	.	.	PUNCT
dpc-2081	342	3	doi	doi	NOUN
dpc-2081	342	4	:	:	PUNCT
dpc-2081	342	5	10.3390	10.3390	NUM
dpc-2081	342	6	/	/	SYM
dpc-2081	342	7	cells9040895	cells9040895	PROPN
dpc-2081	342	8	.	.	PUNCT
dpc-2081	343	1	pmid	pmid	NOUN
dpc-2081	343	2	:	:	PUNCT
dpc-2081	343	3	32268604	32268604	NUM
dpc-2081	343	4	.	.	PUNCT
dpc-2081	344	1	pmcid	pmcid	NOUN
dpc-2081	344	2	:	:	PUNCT
dpc-2081	344	3	pmc72	pmc72	PROPN
dpc-2081	344	4	26726	26726	NUM
dpc-2081	344	5	.	.	PUNCT
dpc-2081	345	1	35	35	NUM
dpc-2081	345	2	.	.	PUNCT
dpc-2081	345	3	soczynska	soczynska	PROPN
dpc-2081	345	4	jk	jk	PROPN
dpc-2081	345	5	,	,	PUNCT
dpc-2081	345	6	kennedy	kennedy	PROPN
dpc-2081	345	7	sh	sh	PROPN
dpc-2081	345	8	,	,	PUNCT
dpc-2081	345	9	goldstein	goldstein	PROPN
dpc-2081	345	10	bi	bi	PROPN
dpc-2081	345	11	,	,	PUNCT
dpc-2081	345	12	lachowski	lachowski	NOUN
dpc-2081	345	13	a	a	NOUN
dpc-2081	345	14	,	,	PUNCT
dpc-2081	345	15	woldeyohannes	woldeyohannes	PROPN
dpc-2081	345	16	ho	ho	PROPN
dpc-2081	345	17	,	,	PUNCT
dpc-2081	345	18	mcintyre	mcintyre	PROPN
dpc-2081	345	19	rsjn	rsjn	VERB
dpc-2081	345	20	.	.	PUNCT
dpc-2081	346	1	the	the	DET
dpc-2081	346	2	effect	effect	NOUN
dpc-2081	346	3	of	of	ADP
dpc-2081	346	4	tumor	tumor	NOUN
dpc-2081	346	5	necrosis	necrosis	NOUN
dpc-2081	346	6	factor	factor	NOUN
dpc-2081	346	7	antagonists	antagonist	NOUN
dpc-2081	346	8	on	on	ADP
dpc-2081	346	9	mood	mood	NOUN
dpc-2081	346	10	and	and	CCONJ
dpc-2081	346	11	mental	mental	ADJ
dpc-2081	346	12	health	health	NOUN
dpc-2081	346	13	-	-	PUNCT
dpc-2081	346	14	associated	associate	VERB
dpc-2081	346	15	quality	quality	NOUN
dpc-2081	346	16	of	of	ADP
dpc-2081	346	17	life	life	NOUN
dpc-2081	346	18	:	:	PUNCT
dpc-2081	346	19	novel	novel	ADJ
dpc-2081	346	20	hypothesis	hypothesis	NOUN
dpc-2081	346	21	-	-	PUNCT
dpc-2081	346	22	driven	drive	VERB
dpc-2081	346	23	treatments	treatment	NOUN
dpc-2081	346	24	for	for	ADP
dpc-2081	346	25	bipolar	bipolar	ADJ
dpc-2081	346	26	depression	depression	NOUN
dpc-2081	346	27	?	?	PUNCT
dpc-2081	347	1	neurotoxicology	neurotoxicology	NOUN
dpc-2081	347	2	.	.	PUNCT
dpc-2081	348	1	2009;30(4):497	2009;30(4):497	NUM
dpc-2081	348	2	-	-	SYM
dpc-2081	348	3	521	521	NUM
dpc-2081	348	4	.	.	PUNCT
dpc-2081	348	5	doi	doi	NOUN
dpc-2081	348	6	:	:	PUNCT
dpc-2081	348	7	10.1016	10.1016	NUM
dpc-2081	348	8	/	/	SYM
dpc-2081	348	9	j.	j.	PROPN
dpc-2081	348	10	neuro.2009.03.004	neuro.2009.03.004	PROPN
dpc-2081	348	11	.	.	PUNCT
dpc-2081	349	1	pmid	pmid	NOUN
dpc-2081	349	2	:	:	PUNCT
dpc-2081	349	3	19477018	19477018	NUM
dpc-2081	349	4	.	.	PUNCT
dpc-2081	350	1	36	36	NUM
dpc-2081	350	2	.	.	PUNCT
dpc-2081	351	1	dewigne	dewigne	PROPN
dpc-2081	351	2	m	m	PROPN
dpc-2081	351	3	,	,	PUNCT
dpc-2081	351	4	orte	orte	PROPN
dpc-2081	351	5	cano	cano	PROPN
dpc-2081	351	6	c	c	PROPN
dpc-2081	351	7	,	,	PUNCT
dpc-2081	351	8	daoud	daoud	PROPN
dpc-2081	351	9	m	m	PROPN
dpc-2081	351	10	,	,	PUNCT
dpc-2081	351	11	del	del	PROPN
dpc-2081	351	12	marmol	marmol	PROPN
dpc-2081	351	13	v	v	PROPN
dpc-2081	351	14	,	,	PUNCT
dpc-2081	351	15	benhadou	benhadou	NOUN
dpc-2081	351	16	f.	f.	PROPN
dpc-2081	351	17	low	low	ADJ
dpc-2081	351	18	incidence	incidence	NOUN
dpc-2081	351	19	of	of	ADP
dpc-2081	351	20	covid-19	covid-19	PROPN
dpc-2081	351	21	in	in	ADP
dpc-2081	351	22	hidradenitis	hidradenitis	PROPN
dpc-2081	351	23	suppurativa	suppurativa	NOUN
dpc-2081	351	24	:	:	PUNCT
dpc-2081	351	25	how	how	SCONJ
dpc-2081	351	26	to	to	PART
dpc-2081	351	27	interpret	interpret	VERB
dpc-2081	351	28	it	it	PRON
dpc-2081	351	29	?	?	PUNCT
dpc-2081	352	1	exp	exp	NOUN
dpc-2081	352	2	dermatol	dermatol	NOUN
dpc-2081	352	3	.	.	PUNCT
dpc-2081	353	1	2022;31(3):435436	2022;31(3):435436	NUM
dpc-2081	353	2	.	.	PUNCT
dpc-2081	354	1	doi	doi	NOUN
dpc-2081	354	2	:	:	PUNCT
dpc-2081	354	3	10.1111	10.1111	NUM
dpc-2081	354	4	/	/	SYM
dpc-2081	354	5	exd.14475	exd.14475	PROPN
dpc-2081	354	6	.	.	PUNCT
dpc-2081	355	1	pmid	pmid	NOUN
dpc-2081	355	2	:	:	PUNCT
dpc-2081	355	3	34679208	34679208	NUM
dpc-2081	355	4	.	.	PUNCT
dpc-2081	356	1	pmcid	pmcid	NOUN
dpc-2081	356	2	:	:	PUNCT
dpc-2081	356	3	pmc8652693	pmc8652693	ADJ
dpc-2081	356	4	.	.	PUNCT
dpc-2081	357	1	17	17	NUM
dpc-2081	357	2	.	.	PUNCT
dpc-2081	358	1	jalenques	jalenque	NOUN
dpc-2081	358	2	i	i	PRON
dpc-2081	358	3	,	,	PUNCT
dpc-2081	358	4	ciortianu	ciortianu	PROPN
dpc-2081	358	5	l	l	PROPN
dpc-2081	358	6	,	,	PUNCT
dpc-2081	358	7	pereira	pereira	PROPN
dpc-2081	358	8	b	b	PROPN
dpc-2081	358	9	,	,	PUNCT
dpc-2081	358	10	d’incan	d’incan	PROPN
dpc-2081	358	11	m	m	PROPN
dpc-2081	358	12	,	,	PUNCT
dpc-2081	358	13	lauron	lauron	PROPN
dpc-2081	358	14	s	s	PROPN
dpc-2081	358	15	,	,	PUNCT
dpc-2081	358	16	rondepierre	rondepierre	PROPN
dpc-2081	358	17	f.	f.	PROPN
dpc-2081	358	18	the	the	DET
dpc-2081	358	19	prevalence	prevalence	NOUN
dpc-2081	358	20	and	and	CCONJ
dpc-2081	358	21	odds	odd	NOUN
dpc-2081	358	22	of	of	ADP
dpc-2081	358	23	anxiety	anxiety	NOUN
dpc-2081	358	24	and	and	CCONJ
dpc-2081	358	25	depression	depression	NOUN
dpc-2081	358	26	in	in	ADP
dpc-2081	358	27	children	child	NOUN
dpc-2081	358	28	and	and	CCONJ
dpc-2081	358	29	adults	adult	NOUN
dpc-2081	358	30	with	with	ADP
dpc-2081	358	31	hidradenitis	hidradenitis	PROPN
dpc-2081	358	32	suppurativa	suppurativa	PROPN
dpc-2081	358	33	:	:	PUNCT
dpc-2081	358	34	systematic	systematic	ADJ
dpc-2081	358	35	review	review	NOUN
dpc-2081	358	36	and	and	CCONJ
dpc-2081	358	37	meta	meta	ADJ
dpc-2081	358	38	-	-	PUNCT
dpc-2081	358	39	analysis	analysis	NOUN
dpc-2081	358	40	.	.	PUNCT
dpc-2081	359	1	j	j	PROPN
dpc-2081	359	2	am	be	AUX
dpc-2081	359	3	acad	acad	ADJ
dpc-2081	359	4	dermatol	dermatol	NOUN
dpc-2081	359	5	.	.	PUNCT
dpc-2081	360	1	2020;83(2):542	2020;83(2):542	NUM
dpc-2081	360	2	-	-	PUNCT
dpc-2081	360	3	553	553	NUM
dpc-2081	360	4	.	.	PUNCT
dpc-2081	360	5	doi	doi	NOUN
dpc-2081	360	6	:	:	PUNCT
dpc-2081	360	7	10.1016	10.1016	NUM
dpc-2081	360	8	/	/	SYM
dpc-2081	360	9	j.jaad.2020.03.041	j.jaad.2020.03.041	PROPN
dpc-2081	360	10	.	.	PUNCT
dpc-2081	361	1	pmid	pmid	NOUN
dpc-2081	361	2	:	:	PUNCT
dpc-2081	361	3	32222447	32222447	NUM
dpc-2081	361	4	.	.	PUNCT
dpc-2081	362	1	18	18	NUM
dpc-2081	362	2	.	.	PUNCT
dpc-2081	362	3	machado	machado	PROPN
dpc-2081	362	4	mo	mo	PROPN
dpc-2081	362	5	,	,	PUNCT
dpc-2081	362	6	stergiopoulos	stergiopoulos	PROPN
dpc-2081	362	7	v	v	PROPN
dpc-2081	362	8	,	,	PUNCT
dpc-2081	362	9	maes	maes	PROPN
dpc-2081	362	10	m	m	PROPN
dpc-2081	362	11	,	,	PUNCT
dpc-2081	362	12	et	et	PROPN
dpc-2081	362	13	al	al	PROPN
dpc-2081	362	14	.	.	PUNCT
dpc-2081	362	15	depression	depression	NOUN
dpc-2081	362	16	and	and	CCONJ
dpc-2081	362	17	anxiety	anxiety	NOUN
dpc-2081	362	18	in	in	ADP
dpc-2081	362	19	adults	adult	NOUN
dpc-2081	362	20	with	with	ADP
dpc-2081	362	21	hidradenitis	hidradenitis	PROPN
dpc-2081	362	22	suppurativa	suppurativa	PROPN
dpc-2081	362	23	:	:	PUNCT
dpc-2081	362	24	a	a	DET
dpc-2081	362	25	systematic	systematic	ADJ
dpc-2081	362	26	review	review	NOUN
dpc-2081	362	27	and	and	CCONJ
dpc-2081	362	28	meta	meta	ADJ
dpc-2081	362	29	-	-	PUNCT
dpc-2081	362	30	analysis	analysis	NOUN
dpc-2081	362	31	.	.	PUNCT
dpc-2081	363	1	jama	jama	PROPN
dpc-2081	363	2	dermatol	dermatol	NOUN
dpc-2081	363	3	.	.	PUNCT
dpc-2081	364	1	2019;155(8):939	2019;155(8):939	NUM
dpc-2081	364	2	-	-	SYM
dpc-2081	364	3	945	945	NUM
dpc-2081	364	4	.	.	PUNCT
dpc-2081	364	5	doi	doi	NOUN
dpc-2081	364	6	:	:	PUNCT
dpc-2081	364	7	10.1001	10.1001	NUM
dpc-2081	364	8	/	/	SYM
dpc-2081	364	9	jamadermatol.2019.0759	jamadermatol.2019.0759	NOUN
dpc-2081	364	10	.	.	PUNCT
dpc-2081	365	1	pmid	pmid	NOUN
dpc-2081	365	2	:	:	PUNCT
dpc-2081	365	3	31166590	31166590	NUM
dpc-2081	365	4	.	.	PUNCT
dpc-2081	366	1	pmcid	pmcid	ADJ
dpc-2081	366	2	:	:	PUNCT
dpc-2081	366	3	pmc6551580	pmc6551580	NOUN
dpc-2081	366	4	.	.	PUNCT
dpc-2081	367	1	19	19	NUM
dpc-2081	367	2	.	.	PUNCT
dpc-2081	367	3	pavon	pavon	PROPN
dpc-2081	367	4	blanco	blanco	PROPN
dpc-2081	367	5	a	a	PROPN
dpc-2081	367	6	,	,	PUNCT
dpc-2081	367	7	turner	turner	PROPN
dpc-2081	367	8	ma	ma	PROPN
dpc-2081	367	9	,	,	PUNCT
dpc-2081	367	10	petrof	petrof	NOUN
dpc-2081	367	11	g	g	PROPN
dpc-2081	367	12	,	,	PUNCT
dpc-2081	367	13	weinman	weinman	PROPN
dpc-2081	367	14	j.	j.	PROPN
dpc-2081	367	15	to	to	ADP
dpc-2081	367	16	what	what	DET
dpc-2081	367	17	extent	extent	NOUN
dpc-2081	367	18	do	do	AUX
dpc-2081	367	19	disease	disease	NOUN
dpc-2081	367	20	severity	severity	NOUN
dpc-2081	367	21	and	and	CCONJ
dpc-2081	367	22	illness	illness	NOUN
dpc-2081	367	23	perceptions	perception	NOUN
dpc-2081	367	24	explain	explain	VERB
dpc-2081	367	25	depression	depression	NOUN
dpc-2081	367	26	,	,	PUNCT
dpc-2081	367	27	anxiety	anxiety	NOUN
dpc-2081	367	28	and	and	CCONJ
dpc-2081	367	29	quality	quality	NOUN
dpc-2081	367	30	of	of	ADP
dpc-2081	367	31	life	life	NOUN
dpc-2081	367	32	in	in	ADP
dpc-2081	367	33	hidradenitis	hidradenitis	PROPN
dpc-2081	367	34	suppurativa	suppurativa	PROPN
dpc-2081	367	35	?	?	PUNCT
dpc-2081	367	36	br	br	PROPN
dpc-2081	367	37	j	j	PROPN
dpc-2081	367	38	dermatol	dermatol	NOUN
dpc-2081	367	39	.	.	PUNCT
dpc-2081	368	1	2019;180(2):338	2019;180(2):338	NUM
dpc-2081	368	2	-	-	SYM
dpc-2081	368	3	345	345	NUM
dpc-2081	368	4	.	.	PUNCT
dpc-2081	369	1	doi	doi	NOUN
dpc-2081	369	2	:	:	PUNCT
dpc-2081	369	3	10.1111	10.1111	NUM
dpc-2081	369	4	/	/	SYM
dpc-2081	369	5	bjd.17123	bjd.17123	NOUN
dpc-2081	369	6	.	.	PUNCT
dpc-2081	370	1	pmid	pmid	NOUN
dpc-2081	370	2	:	:	PUNCT
dpc-2081	370	3	30171696	30171696	NUM
dpc-2081	370	4	.	.	PUNCT
dpc-2081	371	1	20	20	NUM
dpc-2081	371	2	.	.	X
dpc-2081	372	1	akoglu	akoglu	PROPN
dpc-2081	372	2	g	g	PROPN
dpc-2081	372	3	,	,	PUNCT
dpc-2081	372	4	yildiz	yildiz	PROPN
dpc-2081	372	5	i	i	PROPN
dpc-2081	372	6	,	,	PUNCT
dpc-2081	372	7	karaismailoglu	karaismailoglu	PROPN
dpc-2081	372	8	e	e	PROPN
dpc-2081	372	9	,	,	PUNCT
dpc-2081	372	10	esme	esme	PROPN
dpc-2081	372	11	p.	p.	PROPN
dpc-2081	372	12	disease	disease	NOUN
dpc-2081	372	13	severity	severity	NOUN
dpc-2081	372	14	and	and	CCONJ
dpc-2081	372	15	poor	poor	ADJ
dpc-2081	372	16	mental	mental	ADJ
dpc-2081	372	17	health	health	NOUN
dpc-2081	372	18	are	be	AUX
dpc-2081	372	19	the	the	DET
dpc-2081	372	20	main	main	ADJ
dpc-2081	372	21	predictors	predictor	NOUN
dpc-2081	372	22	of	of	ADP
dpc-2081	372	23	stigmatization	stigmatization	NOUN
dpc-2081	372	24	in	in	ADP
dpc-2081	372	25	patients	patient	NOUN
dpc-2081	372	26	with	with	ADP
dpc-2081	372	27	hidradenitis	hidradenitis	PROPN
dpc-2081	372	28	suppurativa	suppurativa	PROPN
dpc-2081	372	29	.	.	PROPN
dpc-2081	373	1	dermatol	dermatol	NOUN
dpc-2081	373	2	ther	ther	ADV
dpc-2081	373	3	.	.	PUNCT
dpc-2081	374	1	2021;34(3):e14910	2021;34(3):e14910	X
dpc-2081	374	2	.	.	X
dpc-2081	374	3	doi	doi	NOUN
dpc-2081	374	4	:	:	PUNCT
dpc-2081	374	5	10.1111	10.1111	NUM
dpc-2081	374	6	/	/	SYM
dpc-2081	374	7	dth.14910	dth.14910	PROPN
dpc-2081	374	8	.	.	PUNCT
dpc-2081	375	1	pmid	pmid	NOUN
dpc-2081	375	2	:	:	PUNCT
dpc-2081	375	3	33619860	33619860	NUM
dpc-2081	375	4	.	.	PUNCT
dpc-2081	376	1	21	21	NUM
dpc-2081	376	2	.	.	X
dpc-2081	376	3	zouboulis	zouboulis	PROPN
dpc-2081	376	4	cc	cc	PROPN
dpc-2081	376	5	,	,	PUNCT
dpc-2081	376	6	benhadou	benhadou	NOUN
dpc-2081	376	7	f	f	NOUN
dpc-2081	376	8	,	,	PUNCT
dpc-2081	376	9	byrd	byrd	PROPN
dpc-2081	376	10	as	as	ADP
dpc-2081	376	11	,	,	PUNCT
dpc-2081	376	12	et	et	PROPN
dpc-2081	376	13	al	al	PROPN
dpc-2081	376	14	.	.	PUNCT
dpc-2081	377	1	what	what	PRON
dpc-2081	377	2	causes	cause	VERB
dpc-2081	377	3	hidradenitis	hidradenitis	NOUN
dpc-2081	377	4	suppurativa	suppurativa	NOUN
dpc-2081	377	5	?	?	PUNCT
dpc-2081	377	6	-15	-15	NUM
dpc-2081	377	7	years	year	NOUN
dpc-2081	377	8	after	after	ADV
dpc-2081	377	9	.	.	PUNCT
dpc-2081	378	1	exp	exp	NOUN
dpc-2081	378	2	dermatol	dermatol	NOUN
dpc-2081	378	3	.	.	PUNCT
dpc-2081	379	1	2020;29(12):11541170	2020;29(12):11541170	X
dpc-2081	379	2	.	.	PUNCT
dpc-2081	379	3	doi	doi	NOUN
dpc-2081	379	4	:	:	PUNCT
dpc-2081	379	5	10.1111	10.1111	NUM
dpc-2081	379	6	/	/	SYM
dpc-2081	379	7	exd.14214	exd.14214	X
dpc-2081	379	8	.	.	PUNCT
dpc-2081	380	1	pmid	pmid	NOUN
dpc-2081	380	2	:	:	PUNCT
dpc-2081	380	3	33058306	33058306	NUM
dpc-2081	380	4	.	.	PUNCT
dpc-2081	381	1	22	22	NUM
dpc-2081	381	2	.	.	PUNCT
dpc-2081	382	1	horwitz	horwitz	PROPN
dpc-2081	382	2	t	t	PROPN
dpc-2081	382	3	,	,	PUNCT
dpc-2081	382	4	lam	lam	PROPN
dpc-2081	382	5	k	k	PROPN
dpc-2081	382	6	,	,	PUNCT
dpc-2081	382	7	chen	chen	PROPN
dpc-2081	382	8	y	y	PROPN
dpc-2081	382	9	,	,	PUNCT
dpc-2081	382	10	xia	xia	PROPN
dpc-2081	382	11	y	y	PROPN
dpc-2081	382	12	,	,	PUNCT
dpc-2081	382	13	liu	liu	PROPN
dpc-2081	382	14	c.	c.	PROPN
dpc-2081	382	15	a	a	DET
dpc-2081	382	16	decade	decade	NOUN
dpc-2081	382	17	in	in	ADP
dpc-2081	382	18	psychiatric	psychiatric	ADJ
dpc-2081	382	19	gwas	gwas	PROPN
dpc-2081	382	20	research	research	NOUN
dpc-2081	382	21	.	.	PUNCT
dpc-2081	383	1	mol	mol	ADP
dpc-2081	383	2	psychiatry	psychiatry	NOUN
dpc-2081	383	3	.	.	PUNCT
dpc-2081	384	1	2019;24(3):378	2019;24(3):378	NUM
dpc-2081	384	2	-	-	PUNCT
dpc-2081	384	3	389	389	NUM
dpc-2081	384	4	.	.	PUNCT
dpc-2081	385	1	doi	doi	NOUN
dpc-2081	385	2	:	:	PUNCT
dpc-2081	385	3	10.1038	10.1038	NUM
dpc-2081	385	4	/	/	SYM
dpc-2081	385	5	s41380	s41380	NOUN
dpc-2081	385	6	-	-	PUNCT
dpc-2081	385	7	018	018	NUM
dpc-2081	385	8	-	-	PUNCT
dpc-2081	385	9	0055	0055	NUM
dpc-2081	385	10	-	-	PUNCT
dpc-2081	385	11	z.	z.	PROPN
dpc-2081	385	12	pmid	pmid	PROPN
dpc-2081	385	13	:	:	PUNCT
dpc-2081	385	14	29942042	29942042	NUM
dpc-2081	385	15	.	.	PUNCT
dpc-2081	386	1	pmcid	pmcid	NOUN
dpc-2081	386	2	:	:	PUNCT
dpc-2081	386	3	pmc6372350	pmc6372350	PROPN
dpc-2081	386	4	.	.	PUNCT
dpc-2081	387	1	23	23	NUM
dpc-2081	387	2	.	.	PUNCT
dpc-2081	388	1	anstey	anstey	PROPN
dpc-2081	388	2	av	av	PROPN
dpc-2081	388	3	.	.	PUNCT
dpc-2081	389	1	γ	γ	PROPN
dpc-2081	389	2	-	-	PUNCT
dpc-2081	389	3	secretase	secretase	ADJ
dpc-2081	389	4	gene	gene	NOUN
dpc-2081	389	5	mutations	mutation	NOUN
dpc-2081	389	6	link	link	VERB
dpc-2081	389	7	acne	acne	NOUN
dpc-2081	389	8	inversa	inversa	NOUN
dpc-2081	389	9	with	with	ADP
dpc-2081	389	10	alzheimer	alzheimer	PROPN
dpc-2081	389	11	’s	’s	PART
dpc-2081	389	12	disease	disease	NOUN
dpc-2081	389	13	.	.	PUNCT
dpc-2081	390	1	br	br	PROPN
dpc-2081	390	2	j	j	PROPN
dpc-2081	390	3	dermatol	dermatol	NOUN
dpc-2081	390	4	.	.	PUNCT
dpc-2081	391	1	2011;164(2):235	2011;164(2):235	NUM
dpc-2081	391	2	-	-	SYM
dpc-2081	391	3	236	236	NUM
dpc-2081	391	4	.	.	PUNCT
dpc-2081	392	1	doi	doi	NOUN
dpc-2081	392	2	:	:	PUNCT
dpc-2081	392	3	10.1111	10.1111	NUM
dpc-2081	392	4	/	/	SYM
dpc-2081	392	5	j.1365	j.1365	NOUN
dpc-2081	392	6	-	-	PUNCT
dpc-2081	392	7	2133.2011.10221.x	2133.2011.10221.x	NOUN
dpc-2081	392	8	.	.	PUNCT
dpc-2081	393	1	pmid	pmid	NOUN
dpc-2081	393	2	:	:	PUNCT
dpc-2081	393	3	21271991	21271991	NUM
dpc-2081	393	4	.	.	PUNCT
dpc-2081	394	1	24	24	NUM
dpc-2081	394	2	.	.	PUNCT
dpc-2081	395	1	garg	garg	PROPN
dpc-2081	395	2	a	a	PRON
dpc-2081	395	3	,	,	PUNCT
dpc-2081	395	4	strunk	strunk	NOUN
dpc-2081	395	5	a.	a.	NOUN
dpc-2081	395	6	risk	risk	NOUN
dpc-2081	395	7	of	of	ADP
dpc-2081	395	8	alzheimer	alzheimer	PROPN
dpc-2081	395	9	’s	’s	PART
dpc-2081	395	10	disease	disease	NOUN
dpc-2081	395	11	is	be	AUX
dpc-2081	395	12	not	not	PART
dpc-2081	395	13	increased	increase	VERB
dpc-2081	395	14	among	among	ADP
dpc-2081	395	15	patients	patient	NOUN
dpc-2081	395	16	with	with	ADP
dpc-2081	395	17	hidradenitis	hidradenitis	PROPN
dpc-2081	395	18	suppurativa	suppurativa	PROPN
dpc-2081	395	19	:	:	PUNCT
dpc-2081	395	20	a	a	DET
dpc-2081	395	21	retrospective	retrospective	ADJ
dpc-2081	395	22	population	population	NOUN
dpc-2081	395	23	-	-	PUNCT
dpc-2081	395	24	based	base	VERB
dpc-2081	395	25	cohort	cohort	NOUN
dpc-2081	395	26	analysis	analysis	NOUN
dpc-2081	395	27	.	.	PUNCT
dpc-2081	396	1	j	j	PROPN
dpc-2081	396	2	am	be	AUX
dpc-2081	396	3	acad	acad	ADJ
dpc-2081	396	4	dermatol	dermatol	NOUN
dpc-2081	396	5	.	.	PUNCT
dpc-2081	397	1	2017;77(1):176177	2017;77(1):176177	NUM
dpc-2081	397	2	.	.	PUNCT
dpc-2081	398	1	doi	doi	NOUN
dpc-2081	398	2	:	:	PUNCT
dpc-2081	398	3	10.1016	10.1016	NUM
dpc-2081	398	4	/	/	SYM
dpc-2081	398	5	j.jaad.2017.02.055	j.jaad.2017.02.055	NOUN
dpc-2081	398	6	.	.	PUNCT
dpc-2081	399	1	pmid	pmid	NOUN
dpc-2081	399	2	:	:	PUNCT
dpc-2081	399	3	28619561	28619561	NUM
dpc-2081	399	4	.	.	PUNCT
dpc-2081	400	1	25	25	NUM
dpc-2081	400	2	.	.	PUNCT
dpc-2081	400	3	theut	theut	NOUN
dpc-2081	400	4	riis	rii	VERB
dpc-2081	400	5	p	p	PROPN
dpc-2081	400	6	,	,	PUNCT
dpc-2081	400	7	egeberg	egeberg	PROPN
dpc-2081	400	8	a	a	PROPN
dpc-2081	400	9	,	,	PUNCT
dpc-2081	400	10	gislason	gislason	PROPN
dpc-2081	400	11	gh	gh	PROPN
dpc-2081	400	12	,	,	PUNCT
dpc-2081	400	13	jemec	jemec	VERB
dpc-2081	400	14	gb	gb	ADP
dpc-2081	400	15	.	.	PUNCT
dpc-2081	401	1	patients	patient	NOUN
dpc-2081	401	2	with	with	ADP
dpc-2081	401	3	hidradenitis	hidradenitis	PROPN
dpc-2081	401	4	suppurativa	suppurativa	PROPN
dpc-2081	401	5	have	have	VERB
dpc-2081	401	6	no	no	DET
dpc-2081	401	7	increased	increase	VERB
dpc-2081	401	8	risk	risk	NOUN
dpc-2081	401	9	of	of	ADP
dpc-2081	401	10	alzheimer	alzheimer	PROPN
dpc-2081	401	11	disease	disease	NOUN
dpc-2081	401	12	.	.	PUNCT
dpc-2081	402	1	br	br	PROPN
dpc-2081	402	2	j	j	PROPN
dpc-2081	402	3	dermatol	dermatol	NOUN
dpc-2081	402	4	.	.	PUNCT
dpc-2081	403	1	2017;177(1):273	2017;177(1):273	NUM
dpc-2081	403	2	-	-	PUNCT
dpc-2081	403	3	275	275	NUM
dpc-2081	403	4	.	.	PUNCT
dpc-2081	403	5	doi	doi	NOUN
dpc-2081	403	6	:	:	PUNCT
dpc-2081	403	7	10.1111/	10.1111/	NUM
dpc-2081	403	8	bjd.15064	bjd.15064	NOUN
dpc-2081	403	9	.	.	PUNCT
dpc-2081	404	1	pmid	pmid	NOUN
dpc-2081	404	2	:	:	PUNCT
dpc-2081	404	3	27639074	27639074	NUM
dpc-2081	404	4	.	.	PUNCT
dpc-2081	405	1	26	26	NUM
dpc-2081	405	2	.	.	X
dpc-2081	405	3	gültekin	gültekin	PROPN
dpc-2081	405	4	bk	bk	PROPN
dpc-2081	405	5	,	,	PUNCT
dpc-2081	405	6	kesebir	kesebir	PROPN
dpc-2081	405	7	s	s	PROPN
dpc-2081	405	8	,	,	PUNCT
dpc-2081	405	9	tamam	tamam	PROPN
dpc-2081	405	10	l.	l.	PROPN
dpc-2081	405	11	bipolar	bipolar	ADJ
dpc-2081	405	12	disorder	disorder	NOUN
dpc-2081	405	13	in	in	ADP
dpc-2081	405	14	turkey	turkey	NOUN
dpc-2081	405	15	.	.	PUNCT
dpc-2081	406	1	2014;6(2):199	2014;6(2):199	X
dpc-2081	406	2	-	-	SYM
dpc-2081	406	3	209	209	NUM
dpc-2081	406	4	.	.	PUNCT
dpc-2081	407	1	psikiyatride	psikiyatride	PROPN
dpc-2081	407	2	güncel	güncel	VERB
dpc-2081	407	3	yaklaşımlar	yaklaşımlar	ADJ
dpc-2081	407	4	-	-	PUNCT
dpc-2081	407	5	current	current	ADJ
dpc-2081	407	6	approaches	approach	NOUN
dpc-2081	407	7	in	in	ADP
dpc-2081	407	8	psychiatry	psychiatry	NOUN
dpc-2081	407	9	.	.	PUNCT
dpc-2081	408	1	2014;6(2):199	2014;6(2):199	X
dpc-2081	408	2	-	-	SYM
dpc-2081	408	3	209	209	NUM
dpc-2081	408	4	.	.	PUNCT
dpc-2081	409	1	doi	doi	NOUN
dpc-2081	409	2	:	:	PUNCT
dpc-2081	409	3	10.5455/	10.5455/	NUM
dpc-2081	409	4	cap.20130920014550	cap.20130920014550	X
dpc-2081	409	5	.	.	PROPN
dpc-2081	410	1	27	27	NUM
dpc-2081	410	2	.	.	PUNCT
dpc-2081	411	1	özdemir	özdemir	PROPN
dpc-2081	411	2	ö	ö	PROPN
dpc-2081	411	3	,	,	PUNCT
dpc-2081	411	4	doğan	doğan	PROPN
dpc-2081	411	5	o.	o.	PROPN
dpc-2081	411	6	sivas	sivas	PROPN
dpc-2081	411	7	il	il	PROPN
dpc-2081	411	8	merkezinde	merkezinde	PROPN
dpc-2081	411	9	iki	iki	PROPN
dpc-2081	411	10	uçlu	uçlu	PROPN
dpc-2081	411	11	duygudurum	duygudurum	PROPN
dpc-2081	411	12	bozukluğunun	bozukluğunun	PROPN
dpc-2081	411	13	yaygınlığı	yaygınlığı	NOUN
dpc-2081	411	14	,	,	PUNCT
dpc-2081	411	15	psikiyatrik	psikiyatrik	VERB
dpc-2081	411	16	eş	eş	DET
dpc-2081	411	17	tanıları	tanıları	PROPN
dpc-2081	411	18	ve	ve	VERB
dpc-2081	411	19	hastaların	hastaların	PROPN
dpc-2081	411	20	yaşam	yaşam	ADJ
dpc-2081	411	21	kalitesi	kalitesi	NOUN
dpc-2081	411	22	.	.	PUNCT
dpc-2081	412	1	2014	2014	NUM
dpc-2081	412	2	.	.	PUNCT
dpc-2081	413	1	28	28	NUM
dpc-2081	413	2	.	.	PUNCT
dpc-2081	414	1	cross	cross	ADJ
dpc-2081	414	2	-	-	ADJ
dpc-2081	414	3	national	national	ADJ
dpc-2081	414	4	comparisons	comparison	NOUN
dpc-2081	414	5	of	of	ADP
dpc-2081	414	6	the	the	DET
dpc-2081	414	7	prevalences	prevalence	NOUN
dpc-2081	414	8	and	and	CCONJ
dpc-2081	414	9	correlates	correlate	VERB
dpc-2081	414	10	of	of	ADP
dpc-2081	414	11	mental	mental	ADJ
dpc-2081	414	12	disorders	disorder	NOUN
dpc-2081	414	13	.	.	PUNCT
dpc-2081	415	1	who	who	PRON
dpc-2081	415	2	international	international	ADJ
dpc-2081	415	3	consortium	consortium	NOUN
dpc-2081	415	4	in	in	ADP
dpc-2081	415	5	psychiatric	psychiatric	NOUN